WO2024028963A1 - Eye drop assistance apparatus - Google Patents

Eye drop assistance apparatus Download PDF

Info

Publication number
WO2024028963A1
WO2024028963A1 PCT/JP2022/029571 JP2022029571W WO2024028963A1 WO 2024028963 A1 WO2024028963 A1 WO 2024028963A1 JP 2022029571 W JP2022029571 W JP 2022029571W WO 2024028963 A1 WO2024028963 A1 WO 2024028963A1
Authority
WO
WIPO (PCT)
Prior art keywords
eye drop
eye
drop container
air
patient
Prior art date
Application number
PCT/JP2022/029571
Other languages
French (fr)
Japanese (ja)
Inventor
加藤千比呂
原直子
Original Assignee
合同会社クオビス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 合同会社クオビス filed Critical 合同会社クオビス
Priority to PCT/JP2022/029571 priority Critical patent/WO2024028963A1/en
Priority to JP2022554277A priority patent/JP7179399B1/en
Priority to JP2022179195A priority patent/JP2024020115A/en
Publication of WO2024028963A1 publication Critical patent/WO2024028963A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body

Definitions

  • the present invention relates to an eye drop aid for instilling a medical solution in an eye drop container onto the cornea of a patient's eye.
  • the first choice of treatment is to instill a medicinal solution onto the corneal surface, and continuous instillation of a prescribed amount on a regular basis leads to effective treatment.
  • Ordinary eye drops are performed by placing a drop of medicine on the cornea from an eyedropper containing the medicine while the patient is in an upward position.
  • eye drops are not limited to one drug, but often three or four drugs are instilled into the eyes, making it complicated for patients to administer the eye drops.
  • an eye-drop assisting device which solves the problem of stability of the drop position and drop amount during eye-dropping work and allows easier and more reliable eye-dropping.
  • the eye drop aid described in Patent Document 1 and Patent Document 2 discloses a configuration in which the eye drop container can be stably placed at a predetermined position in front of the patient's eyes, and the eye drop can be instilled into the patient's eyes from diagonally above. ing.
  • the eye drop aids described in Patent Document 3 and Patent Document 4 discharge the medicinal solution horizontally using a manual pump or a piezoelectric micropump, so that the eye drop can be administered while the patient's line of sight is horizontal, and the amount of medicine dispensed at one time is also small.
  • a configuration is disclosed that remains constant.
  • the droplet generating device described in Patent Document 5 discloses a configuration in which a medicinal solution is turned into atomized microparticles and discharged horizontally, thereby making it possible to instill a fixed amount into the eyes while the patient's line of sight is horizontal.
  • Patent Document 6 discloses a monitoring system that uses a wireless communication function such as WiFi to send eye drop data obtained from a sensor of an eye drop aid to an external smartphone, etc., and allows doctors and patients themselves to check eye drop history etc. via the Internet. has been done.
  • a wireless communication function such as WiFi
  • the medical solution must be stored in a tank housing within the eye drop device, and a normal eye drop container cannot be used as is. Furthermore, since the chemical liquid comes into contact with the tank housing and the piezoelectric ejector, there is a possibility that the chemical liquid may be contaminated. Furthermore, when using multiple eye drops, this droplet generation device is required for each, which poses a problem in terms of cost.
  • Patent Document 6 discloses a monitoring system that allows doctors and patients to check the history of eye drops and alert them to forgetting to use the eye drops. However, no means of supporting patients is disclosed, and there is a problem of how to support patients and improve adherence.
  • the present invention has been made in view of the above-mentioned problems, and is an eye drop aid that does not require the patient to look up when instilling the drug solution in the eye drop container, and allows the patient to instill an appropriate amount of the drug solution into the eye in a comfortable horizontal position.
  • the purpose is to provide
  • the present invention provides an eye drop aid for administering a medical solution in an eye drop container to a patient's eye, which includes an air fan and an air chamber that serves as an air chamber for the air flow discharged from the air fan.
  • An eye drop in which a chamber, a cylindrical air duct communicating with the air chamber, and the eye drop container are replaceably attached, and the nozzle of the eye drop container is fixed to the upper wall of the air duct in a horizontal state with the nozzle facing downward.
  • the tube includes a container fixing attachment, an eye drop container pressing mechanism that presses a predetermined position on the side surface of the eye drop container attached to the eye drop container fixing attachment, and a trigger arm that controls the operation of the eye drop container pressing mechanism.
  • One end side of the opening of the shaped air duct serves as an inlet through which the air flow discharged from the air fan flows through the air chamber, while the other end side of the opening serves as an eyepiece opening with which the patient's eyelid periphery comes into contact.
  • a liquid medicine introduction hole is formed in the upper wall of the air duct for introducing into the air duct the liquid drops dropped from the nozzle of the eye drop container attached to the eye drop container fixing attachment. do.
  • This eye drop aid further includes an operating means for operating the air duct into a horizontal state or into an inclined state where the eyepiece port is higher than the inlet port when the patient administers the drug in the eye drop container. It is preferable.
  • the drops of the drug solution that are moved horizontally by the airflow can move horizontally due to inertia, pass through the eyepiece port, and reach the cornea.
  • the air duct is arranged horizontally or so that the eyepiece side at the other end is slightly above the inlet side at the end of the air duct, and if the horizontal is 0 degrees, the angle of the air duct is arranged between 0 degrees horizontally and 20 degrees diagonally upward. The angle can be determined by considering the appropriate placement of the air fan, air duct, and eyepiece.
  • At least one airflow exhaust port is formed in the side wall of the air duct near the eyepiece port.
  • the eye drop aid further includes: the air duct has an opening height of 10 mm or more and 25 mm or less, and a horizontal distance from the drug solution dripping port of the eye drop container to the eyepiece port of 20 mm or more and 50 mm or less; Calculate the relative flow velocity of the air flow in the air duct with respect to the drug droplet, which is necessary to horizontally move the drug droplet dropped from the drug droplet of the eye drop container into the air duct, using the following (Equation 1). Further, it is preferable to include an air fan control means for controlling the air fan so that the flow velocity in the air duct is 10 m/sec or more and 40 m/sec or less based on the obtained relative flow velocity.
  • U relative velocity between the flow rate of the air flow in the air duct and the droplet of the drug solution
  • L horizontal distance from the droplet of the eye dropper to the center (cornea) of the air duct eyepiece
  • H droplet of the eyedropper Vertical distance from to the center of the air duct eyepiece (cornea) (difference in height between the droplet and the center of the eyepiece)
  • m mass of the droplet of the drug solution
  • density of air
  • d diameter of the droplet of the drug solution
  • the eye drop container fixing attachment includes a set plate on which the eye drop container can be attached facing downward, and a pressing position adjustment mechanism that adjusts the pressing position of the eye drop container, and the inner surface of the set plate.
  • a support guide is arranged to press and support the side surface of the eye drop container, and the lower end of the set plate is removably fitted into a set guide groove formed on the outer wall of the air duct, and the lower end of the set plate It is preferable that the side region is provided with an open space that allows the cap of the eye drop container to be opened and closed when the eye drop container is attached.
  • the eye drop container fixing attachment is placed on the upper surface of the air duct on the flow path between the air duct inlet and outlet, and the nozzle of the eye drop container is inserted into the drug solution introduction hole provided on the upper surface of the air duct, and the eye drop container fixing attachment is placed on the upper surface of the air duct on the flow path between the air duct inlet and outlet.
  • the eye drop container is attached to the eye drop container fixing attachment so that the eye drop container is fixed such that the eye drop opening is near the inner upper surface of the air duct, and the air duct is provided with a set plate provided at the lower part of the eye drop container fixing attachment. It is possible to have an attachment/detachment mechanism that allows easy fixation, such as by inserting it into a fixed guide.
  • the eye drop container pressing mechanism is connected to a trigger arm rotation axis that is a rotation axis of the trigger arm, and is connected to the trigger arm so that when the trigger arm is pulled, the eye drop container pressing mechanism It is preferable to include a pressing rod that acts in a direction to press the eye drop container from the side.
  • the eye drop container pressing mechanism includes an electric drive means that is electrically driven in conjunction with the trigger arm, and when the trigger arm is pulled, the eye drop container is pressed from the side using the electric drive means. It is preferable to include a pressing rod that acts in a direction to press the container.
  • the pressing mechanism that presses a part of the eye drop container is arranged to face the side surface of the eye drop container fixing attachment, and directly presses the side surface of the eye drop container fixed at a predetermined position of the eye drop container fixing attachment.
  • the eye drop container is pressed via a pressing position adjustment mechanism provided in the eye drop container fixing attachment.
  • a pressing rod or a pressing cam is provided to press the side of the eye drop container or the pressing position adjustment mechanism of the eye drop container fixing attachment.
  • the pressing rod is either integrated with the trigger arm or driven by a link mechanism.
  • the pressing cam can be driven by converting the movement of the trigger arm into rotational movement of the cam using a gear or link that interlocks with the trigger arm, or the pressing rod or pressing cam can be driven by an electromagnetic actuator, a motor, or the like.
  • the eye drop aid further includes an air flow inflow control valve disposed near the inlet of the air duct, and the eye drop container pressing mechanism interlocked with the trigger arm to apply a maximum pressure within a pressing range. It is preferable to include a valve driving mechanism that opens the inflow control valve when the inflow control valve reaches a position near the position, and closes the inflow control valve when the trigger arm is released.
  • an inflow control valve may be arranged between the air chamber and the chemical liquid introduction hole of the air duct to control the inflow of air flow.
  • the inflow control valve When the inflow control valve is closed, it can stop unnecessary air from flowing in and increase the air pressure inside the air chamber, allowing it to function as a plenum air chamber that temporarily increases the air pressure.
  • the inflow control valve opens, the air pressure inside the plenum air chamber is high, so the airflow temporarily flows in at a high flow rate, but after a predetermined time, the flow rate becomes steady, and this temporarily high flow rate causes the air flow to flow in at a high flow rate.
  • the inflow control valve is opened and closed in conjunction with the movement of the trigger arm.
  • the pressing mechanism that presses the eye drop container in conjunction with the movement and the drug solution dripping mechanism open the inflow control valve in synchronization with the timing at which the drug solution is discharged as a droplet from the eye drop container;
  • the instantaneous high-speed airflow accelerates the chemical liquid in the horizontal direction as it falls. If the horizontal acceleration is sufficiently faster than the falling acceleration, the medical solution moves approximately horizontally within the air duct, passes through the eyepiece port of the air duct, and reaches the cornea of the patient's eye.
  • the inflow control valve is closed and the inflow of air is stopped, which is preferable because unnecessary air inflow is also eliminated.
  • the eye drop aid further include communication means capable of transmitting data to an external terminal via a wired/wireless network.
  • the present invention provides an eye drop aid for administering a medical solution in an eye drop container to a patient's eye, which comprises an air fan and an air discharged from the air fan in communication with the air fan.
  • a cylindrical air duct through which the air flows; an eye drop container fixing attachment to which the eye drop container is replaceably attached and fixed to the upper wall of the air duct in a horizontal state with the nozzle of the eye drop container facing downward; an eye drop container pressing mechanism that presses a predetermined position on a side surface of the eye drop container attached to a container fixing attachment; and a trigger arm that controls the operation of the eye drop container pressing mechanism; one end of the opening of the cylindrical air duct;
  • the side of the air duct serves as an inlet for the airflow discharged from the air fan, while the other end of the opening serves as an eyepiece opening into which the patient's eyelids come into contact.
  • the eye dropper is characterized in that a drug solution introduction hole is formed for introducing the drug solution drops dropped from the nozzle of the eye
  • the present invention is an eye dropper, which is characterized by comprising the eye drop aid described above and an eye drop container.
  • the eye drop aid according to the present invention includes an air fan, an air chamber serving as an air chamber for the air flow discharged from the air fan, a cylindrical air duct communicating with the air chamber, and an eye drop container that are replaceably attached.
  • an eye drop container fixing attachment that fixes the eye drop container with the nozzle facing downward to the upper wall of the air duct in a horizontal state; and an eye drop container pressing mechanism that presses a predetermined position on the side surface of the eye drop container attached to the eye drop container fixing attachment.
  • a trigger arm that controls the operation of the eye drop container pressing mechanism.
  • a drug solution introduction hole is formed in the upper wall of the air duct for introducing into the air duct the drug solution drops dropped from the nozzle of the eye drop container attached to the eye drop container fixing attachment.
  • FIG. 1 is a perspective view showing a state in which an eyedropper including an eyedropper aid according to Embodiment 1 of the present invention is used. It is a sectional view of the eyedropper same as the above.
  • FIG. 3 is a diagram showing an example of a fan air volume vs. static pressure characteristic graph. It is a figure showing an example of an eye drop container. (a) A cross-sectional view taken along the line BB' of the eye drop container fixing attachment provided in the eye drop aid as above, and (b) a cross-sectional view taken along the line AA' of the eye drop container fixing attachment same as the above.
  • FIG. 2 is a configuration diagram showing an example of a patient support system using an external device.
  • 1 is a configuration diagram showing an example of a patient support system via a network system.
  • 3 is a flowchart illustrating an example of the operation of patient support software. It is a figure showing an example of an eye drop instruction screen. It is a figure which shows an example of the display screen of an encouragement message. It is a figure which shows an example of the graph showing the relationship between a test result, a score, and various events.
  • the eye drop aid drops droplets of eye drops to be instilled into the eyes of a patient for the treatment of eye diseases, etc., into an air stream flowing horizontally or diagonally upward within 20 degrees to the horizontal. Then, the droplets of the eye drops are moved approximately horizontally by the drag force of the air flow and delivered to the patient's eyes.
  • Embodiment 1 of the present invention will be described in the following order.
  • Basic structure of the drug delivery means that horizontally delivers the eye drops dropped from the eye drop container to the patient's eye
  • Structure of the eye drop container fixing attachment (3)
  • Structure of the eye drop container pressing mechanism (4)
  • Air (5)
  • Automatic detection of the patient's left and right eyes (7)
  • Configuration and electrical system of the eye drop aid (Functional block diagram of eye drop aid)
  • FIG. 1 shows a perspective view of the eyedropper 1 according to the first embodiment in use.
  • the patient grasps the grip 109 provided on the eyedropper aid 100 with either the left or right hand and holds the eyedropper 100. Keep it almost horizontal.
  • the trigger arm 107 by pressing the trigger arm 107 with a finger, the medical solution in the eye drop container is administered to the patient's eye at the patient's own timing.
  • FIG. 2 is a cross-sectional view of the eyedropper 1 according to the first embodiment, in which the drug solution is dropped from the generation of airflow, and the drug solution is moved by the combined force of the drag force caused by the airflow and gravity to reach the corneal surface of the patient.
  • An example of the basic configuration to be achieved is shown.
  • the air fan 101 in FIG. 2 is a fan driven by a motor, and the air flow blown from the air outlet 101a flows into the air chamber 102, and then flows from the outlet 102a of the air chamber 102 to the inlet 104a of the air duct 104.
  • the airflow is discharged upward and laterally from an exhaust port 104b arranged near the eyepiece port 104d on the opposite side of the air duct 104 from the inflow port 104a.
  • An inflow control valve 103 is arranged between the air chamber 102 and the air duct 104 to control opening and closing of air flow.
  • a liquid medicine introduction hole 104c is formed on the upper surface of the air duct 104 between the inlet port 104a and the exhaust port 104b of the air duct 104, for introducing the liquid droplets dropped from the eye drop container 106 into the air duct 104.
  • the eye drop container fixing attachment 105 is connected to the drug solution introduction hole 104c, and the eye drop container 106 is fixed to the eye drop container fixing attachment 105 so that the drug solution dripping port 106a of the eye drop container 106 is on the lower side. It is arranged near the chemical liquid introduction hole 104c of the air duct 104.
  • a droplet passage sensor may be placed above the eyedropper 104d, and can detect whether the droplet of the drug solution that has moved horizontally through the air duct 104 has normally passed through the eyedropper 104d. Further, the patient may fixate the patient's eyes by looking at the fixation target LED 116 through the eyepiece 110 and the air duct 104 and the half mirror 117. When the camera 111 takes pictures using infrared light, the half mirror 117 may be a cold mirror. Note that the air fan 101 is not limited to a means for rotating a fan by a motor, and may be any other means for blowing air.
  • the air chamber 102 has a sufficient volume to function as a plenum air chamber, and the air chamber 102 has a sufficient volume to function as a plenum air chamber. It is preferable to adjust the volume in consideration of the capacity of the air fan 101 within a range of 5 ⁇ 10 ⁇ 5 m 3 to 40 ⁇ 10 ⁇ 5 m 3 as a volume that does not cause problems.
  • the air blowing performance of the air fan 101 is generally indicated by the maximum air volume and maximum static pressure.
  • the air volume when there is no air resistance and the wind pressure is 0 is the maximum air volume, and when the air outlet is sealed, the air volume is 0.
  • the air pressure at which this happens is the maximum static pressure.
  • the characteristics of the air fan 101 are as shown in FIG. 3, on a graph where the horizontal axis is the air volume and the vertical axis is the static pressure, from the maximum air volume point 1501 on the horizontal axis to the maximum static pressure point 1502 on the vertical axis. It is shown as an air volume-static pressure characteristic (P-Q characteristic) by a connecting curve.
  • P-Q characteristic air volume-static pressure characteristic
  • the flow rate of the air flow to generate the drag force necessary for acceleration by such an air flow is determined by the drag coefficient from the Reynolds number of the dropped particle, which can be calculated from the diameter of the dropped particle of the chemical solution and the relative velocity of the air flow to the dropped particle. It is preferable to calculate the flow velocity of the airflow by calculating CD and calculating from the resistance coefficient CD and the effect F required for acceleration.
  • the treatment of the drag force that particles in a fluid receive from the fluid is usually divided into three areas.
  • the relative velocity between the fluid and particles is very small and the particle size is small, that is, when the Reynolds number is 2 or less, it is treated as the Stokes region, and when the relative velocity between the fluid and particles is very high and the particle size is between 500 and 100,000, the Reynolds number is 2 or less.
  • the case where the Reynolds number between the above two regions is between 2 and 500 is called the Allen region.
  • the eye drop container 106 is commercially available in various shapes from eye drop manufacturers, but the average volume of each drop of medicine dropped from the eye drop container 106 is generally about 0.04 ml. Calculating backwards from the formula for the volume of a sphere, the diameter of one droplet dropped from the eye drop container 106 is 4.24 mm.
  • the horizontal distance from the drug solution dripping port 106a of the eye drop container 106 to the eyepiece port 104d of the air duct 104 is 30 mm, and the air duct 104 is arranged so that the angle is horizontal, the drug solution The dropped drop reaches the corneal apex by moving horizontally 30 mm while falling 7 mm, which is half of the vertical dimension of 14 mm.
  • the flow velocity of the air flow in the air duct 104 and the horizontal relative velocity U of the dropped droplets of the chemical solution can be determined from the following [Equation 8].
  • U relative velocity between the flow rate of the air flow in the air duct and the droplet of the drug solution
  • L horizontal distance from the droplet of the eye dropper to the center (cornea) of the air duct eyepiece
  • H droplet of the eyedropper Vertical distance from to the center of the air duct eyepiece (cornea) (difference in height between the droplet and the center of the eyepiece)
  • m mass of the droplet of the drug solution
  • density of air
  • d diameter of the droplet of the drug solution
  • the flow velocity required for the air flow in the air duct 104 to move the droplets of the medical solution to the cornea through the eyepiece port 104d of the air duct 104 is determined by the vertical dimensions of the air duct 104 and from the drug solution dripping port 106a of the eye drop container 106 to the eyepiece port 104d of the air duct 104. It changes depending on the distance. The larger the vertical dimension, the smaller the acceleration should be, and the larger the distance to the eyepiece port 104d, the larger the acceleration should be.
  • the opening height of the air duct 104 as a component of the eye drop aid 100 is approximately 10 mm to 25 mm, and the horizontal distance from the drug solution drip opening of the eye drop container 106 to the eyepiece port 104d is approximately 20 mm to 50 mm, depending on the size of the eye drop container 106 and the like. This is an applicable size depending on the shape of the patient's face surface, etc., and it is not preferable to set the distance from the drug solution dripping port 106a of the eyedropper container 106 to the eyepiece port 104d to be 50 mm or more because the required flow velocity required for the airflow becomes significantly large.
  • the flow velocity of the air flow required to blow the dropped drops of the chemical solution to a predetermined position may be adjusted within the range of 12.97 m/sec to 32.42 m/sec, and the flow velocity of the air flow required is influenced by the internal shape and angle of the air duct 104, temperature, atmospheric pressure, etc., so it can be adjusted within the range of 10 m/sec to 40 m/sec.
  • the air flow blown by the air fan 101 flows into the air chamber 102, and when the inflow control valve 103 is closed, the air flow stops and the air pressure inside the air chamber 102 increases, and after a certain period of time, the air flow stops.
  • the air pressure inside the air chamber 102 is increased to around the maximum static pressure of the air fan 101.
  • the inflow control valve 103 opens in accordance with the operation of the trigger arm 107, the air in the air chamber 102 flows into the air duct 104 at once, and the air flow speed increases to the maximum flow speed in a short time.
  • the air volume converges to a steady air volume determined by the balance between the air blowing capacity of the air chamber 102 and the pressure loss Q of the air flow inside the air chamber 102 and the air duct 104.
  • the pressure loss P is expressed by the pressure loss coefficient C and the air volume Q as shown in [Equation 9] below. [Number 9]
  • P pressure loss
  • C pressure loss coefficient
  • Q air volume
  • the inner diameter is 14 mm when the opening height is 14 mm
  • the air flow pressure loss of the air duct 104 is calculated assuming that the distance from the inlet 104a to the exhaust port 104b is 50 mm.
  • the air flow velocity within the air duct 104 for delivering drops of the drug solution to the cornea is between 21.2 m/sec and 22.79 m/sec, assuming that the horizontal distance from the drug drop opening 106a of the eye drop container 106 to the cornea is 30 mm. It has been mentioned above that the range is adjusted. Since the air chamber 102 has a large space, pressure loss is ignored.
  • Rep Reynolds number
  • Um average flow velocity
  • d inner diameter of pipe (inner diameter of air duct)
  • kinematic viscosity coefficient
  • the amount of air flowing into the air duct 104 needs to be 0.203 m 3 /min. Since the pressure loss of the air duct 104 is 103.2 Pa, the performance required of the air fan 101 requires that the air fan 101 has a wind pressure of 103.2 Pa or more when the air volume is 0.203 m 3 /min.
  • the air volume required to increase the air pressure within the air chamber 102 by 103.2 Pa within 0.1 seconds is 0.085 m 3 /sec or more, but this is much smaller than the air volume of 0.203 m 3 /min to ensure the required flow velocity in the air duct 104, so there is no problem.
  • the inner diameter is 10 mm to 25 mm
  • the moving distance from the drug solution dripping port 106a of the eye drop container 106 to the cornea is 20 mm to 50 mm
  • the air duct 104 has an inflow port 104a to an exhaust port.
  • An appropriate size for the distance to 104b is from 40 mm to 70 mm, considering the operation of the eye drop aid 100 and the ease of holding it. From this range, when the inner diameter of the air duct 104 is 25 mm and the horizontal movement distance from the drug solution dripping port 106a to the cornea is 20 mm, the required average flow velocity in the air duct 104 is the lowest, about 12.97 m/sec.
  • the average flow velocity is the highest, about 32.4 m/sec.
  • the respective required air volumes are 0.382 m 3 /min when the inner diameter is 25 mm and the horizontal movement distance to the cornea is 20 mm, and when the inner diameter is 10 mm and the horizontal movement distance to the cornea is 50 mm, it is 0.153 m 3 /min.
  • the pressure loss from the distance from the inlet 104a to the exhaust port 104b of the air duct 104 from 40 mm to 70 mm
  • the inner diameter is 25 mm
  • the horizontal movement distance of the dropped particles is 20 mm
  • it is 16.1 Pa
  • the pressure is 483 Pa.
  • the air blowing capacity required for the air fan 101 must be greater than the air volume and pressure loss calculated from the average flow velocity in the air duct 104 and the cross-sectional area perpendicular to the air flow of the air duct 104.
  • the air pressure in the air chamber 102 has been increased to around the maximum static pressure of the air fan 101, which temporarily provides an air volume higher than the air blowing capacity of the air fan 101, making it possible to lower the air volume of the air fan 101.
  • the air fan 101 of the first embodiment uses a sirocco fan (centrifugal fan), an axial fan may be used depending on the required air blowing capacity.
  • the eye drop container fixing attachment 105 removably attaches the eye drop container 106 to the eye drop container fixing attachment 105, and is further removably fixed at a predetermined position above the air duct 104.
  • the drug solution dripping port 106a of the eye drop container 106 is placed at an appropriate position with respect to the air duct 104, and the drug solution can be dropped into the air duct 104.
  • a plurality of types of eye drop container fixing attachments 105 may be prepared according to the shape and dimensions of the eye drop container 106, but the drug solution drip opening 106a of the eye drop container 106 is arranged at the same position regardless of which eye drop container 106 is used.
  • the configuration is as follows.
  • the eye drop container 106 is provided with a pressing position adjustment mechanism for applying the force exerted by the pressing portion 108a of the pressing point adjustment arm 108 to the appropriate position of the eye drop container 106. There is.
  • FIG. 4 is an example of a general eye drop container 106.
  • An eye drop container 106 for general eye drops prescribed in ophthalmology facilities, etc. includes a drug solution filling container 401 filled with eye drops, a removable cap 402, a threaded portion 403 for screwing the cap, and an eye drop container for dropping the eye drops.
  • a nozzle 404 is provided. There is a drip opening 405 at the tip of the eye drop nozzle 404, the drug solution filling container 401 has a cylindrical shape or a shape with dimples on the side of the cylinder, and the eye drop nozzle 404 is fitted inside the threaded part 403. ing.
  • the diameter of the drug solution filling container 401 is 18 mm to 24 mm, the height is 20 mm to 30 mm, the outer diameter of the threaded part 403 is 11 mm to 17 mm, the height is 13 mm to 16 mm, and the eye drop nozzle 404 The diameter is about 4 mm to 6 mm, and the height is about 9 mm to 11 mm.
  • FIG. 5 is an example of a configuration diagram of the eye drop container fixing attachment 105.
  • the eye drop container fixing attachment 105 is equipped with a side support guide 302 and a rear support guide 303 that support the side and rear surfaces of the eye drop container 106 inside the eye drop container insertion barrel 301 (set plate 305), and the left and right side support guides 302a, 302c are
  • the eye drop container 306 is fixed from the side by being pressed inward by left and right support guide pressing leaf springs 302b and 302d, respectively.
  • the spring constant and deflection range of the support guide pressing plate springs 302b and 302d are determined so that the side support guides 302a and 302c can be pressed from 18 mm to 24 mm in accordance with the diameter of the drug solution filling container of the eye drop container 306.
  • the rear support guide is adjusted by the rear position adjustment plunger 303a to match the diameter of the drug solution filling container of the eye drop container 306.
  • the eye drop container fixing attachment 105 fixes the eye drop container 306 by means of a side support guide 302 and a rear support guide 303 to form an integral unit.
  • a lower opening 301a is opened at the lower part of the eye drop container insertion barrel 301, into which the threaded portion 306a of the eye drop container 306 and the eye drop nozzle 306b are inserted.
  • the diameter of the lower opening 301a is larger than the diameter of the cap of the eye drop container 306, so that the cap can be attached to the eye drop container 306 even when the eye drop container 306 is attached to the eye drop container fixing attachment 105.
  • the eye drop container 106 is pressed by the pressing part 108a of the pressure point adjustment arm 108 from the air fan 101 side of the eye drop container fixing attachment 105 to drip the medicine, but the pressing position differs depending on the diameter and height of the eye drop container 106. , it is necessary to position the pressing portion 108a appropriately in accordance with the eye drop container 106.
  • the pressing rod pressing point 107b of the pressing rod 107a integrated with the trigger arm 107 is fixed, and can be adjusted to the appropriate position according to the size of the eye drop container 106 via the pressing position adjustment mechanism 304 of the eye drop container fixing attachment 105.
  • the pressing position adjustment mechanism includes first pressing means (309, 310, 311) that can adjust the vertical position of the pressing position of the eye drop container 106 and the pressing width of the eye drop container 106, and the first pressing means (309, 310, 311). and a second pressing means (303a) located at a position facing the eye drop container 106 and capable of adjusting the pressing width of the eye drop container 106.
  • a pressing plunger 309 is inserted into a slit 311 of a pressing point adjusting arm 108 that rotates around an adjusting arm rotation shaft 308 disposed at the upper part of an eye drop container fixing attachment 105, and is fixed with a double nut 310.
  • the rear nut 310b is stopped so as not to rotate, and the pressing plunger 309 is screwed into the rear nut 310b until the amount of pressure is appropriate.
  • the pressing plunger 309 is moved along the slit 311 so that the height position of the eye drop container 306 becomes an appropriate height position, and the front nut 310a is tightened and fixed.
  • the pressing plunger 309 connected to the pressing point adjusting arm 107 presses the eye drop container 306 at a prescribed position.
  • the pressing position can be set to an appropriate position, and a certain amount of the drug solution can be reliably dropped from the eye drop container 306.
  • FIG. 6 shows a state in which the eye drop container fixing attachment 105 is removed.
  • the eye drop container fixing attachment 105 is provided with a set plate 305 for easily replacing the eye drop container fixing attachment 105 and administering the eye drops to a patient who is instilling a plurality of drugs into the eye.
  • FIG. 6(a) by simply inserting the set plate 305 that connects the eye drop container fixing attachment 300 to the air duct 104 of the eye drop aid 100 into the set guide 312 for the attachment set provided on the side of the air duct 104, the eye drop container fixing attachment 300 can be dropped.
  • the container fixing attachment 105 is easily fixed to the top of the air duct 104.
  • the eye drop container fixing attachment 105 includes the set plate 305 to which the eye drop container 106 can be attached facing downward, and the pressing position adjustment mechanism that adjusts the pressing position of the eye drop container 106.
  • Support guides (side support guide 302 and rear support guide 303) that press and support the side surfaces of the eye drop container 106 are disposed on the inner surface of the set plate 305, and the lower end of the set plate 305 is connected to a set formed on the outer wall of the air duct 104.
  • the set plate 305 is removably fitted into the guide 312, and an open space S1 is provided in the lower region of the set plate 305 so that the cap of the eye drop container 106 can be opened and closed when the eye drop container 106 is attached.
  • each eye drop container fixing attachment 105 is equipped with a tag, an electronic chip such as RFID, a bar code, or a QR code (registered trademark) in order to assign a unique tag or ID to each eye drop container fixing attachment 105.
  • the attachment 105 may be provided with a shape-based identification means (which serves as an identifier for identifying at least one of the types of the fixed attachment 105) or a notch in the attachment 105.
  • the eye drop aid 100 in FIG. 2 includes a tag reading sensor 114 such as a sensor, an RFID reading chip, and a camera for reading these tags and IDs.
  • the eye drop aid 100 is equipped with this means for identifying these tags and IDs, by reading the tags of each eye drop container fixing attachment 105, the tag of the eye drop container fixing attachment 105 and the type of eye drops attached are registered in advance. If so, it would be possible to record which eye drops were applied each time.
  • FIGS. 7 and 8 The pressing point of the pressing rod of the eye drop container pressing mechanism may be configured to directly press the eye drop container, but in FIGS. 7 and 8, the pressing rod is configured to An example of a pressing mechanism for pressing the eye drop container via the pressing position adjustment mechanism of the eye drop container fixing attachment and causing the eye drop solution to drip into the air duct is shown.
  • FIG. 7 shows an example of manual pressing
  • FIG. 8 shows an example of an eye drop container pressing mechanism that presses electrically.
  • a trigger arm 107 rotates around a trigger arm rotation axis 501 disposed above the air duct 104, and the trigger arm 107 applies force by a finger of a patient or an eye drop assistant.
  • the manual point 502 is pulled toward the eyepiece 104d, the eye drops are dripped from the eyedrop container 106, and the drops are moved approximately horizontally toward the eyepiece 104d by the drag force caused by the air flow in the air duct 104, and reach the cornea. Eye drops are applied.
  • the eye drop container pressing mechanism is connected to the trigger arm rotation shaft 501 which is the rotation axis of the trigger arm 107, and when the trigger arm 107 is pulled, the eye drop container pressing mechanism A pressing rod 107a that acts in a direction to press the eye drop container 106 is provided.
  • the pressing rod 107a is arranged at an appropriate height between the trigger arm rotating shaft 501 and the air duct 104, and the trigger arm 107 and the pressing rod 107a operate together.
  • the pressing point 107b of the pressing rod 107a also moves toward the eyepiece.
  • the pressing rod 107a When the pressing rod 107a returns, the pressing force applied to the eye drop container 106 is released and the eye drop container 106 returns to its original shape. Since the eye drop container 106 is always fixed downward, the medicine in the eye drop container 106 also accumulates in the lower part of the eye drop container 106 and in the eye drop nozzle, and the air inside the container accumulates above the eye drop container 106. The amount of chemical liquid that is pressed is always dropped, and a constant amount of chemical liquid (one drop of chemical liquid) is always dropped.
  • FIG. 8 shows the driving of the pressing rod 605 by an electromagnetic solenoid 606 as a mechanism for pressing the eye drop container 106 using an electric mechanism.
  • the eye drop container pressing mechanism uses an electromagnetic solenoid (electric drive means) 606 that is electrically driven in conjunction with the trigger arm 601, and when the trigger arm 601 is pulled, the eye drop container is pressed from the side using the electromagnetic solenoid 606.
  • a pressing rod 605 that acts in a direction to press 609 is provided.
  • the pressing rod 605 can be electrically driven by an electric motor or an electromagnetic actuator such as an electromagnetic solenoid or a voice coil motor.
  • FIG. 8 shows an example in which a pressing rod 605 is disposed on the shaft of an electromagnetic solenoid 606, and the pressing rod 605 directly drives the pressing point adjustment arm 610 of the eye drop container fixing attachment.
  • a predetermined angular position of the trigger arm 601 is detected by a trigger arm position sensor 602.
  • the trigger arm position sensor 602 is a reflective photointerrupter, and is arranged so as to be able to detect the photointerrupter reflective tape 603 attached to the trigger arm 601, and is configured to detect a predetermined angular position of the trigger arm 601. It has become.
  • the first angular position where the trigger arm 601 is not operated is defined as the "trigger arm start position", and the trigger arm 601 is pulled toward the eyepiece 604a side of the air duct 604 to a predetermined position, and the trigger arm 601 is pressed integrally with the trigger arm 601.
  • the angular position at which the rod 605 starts pressing the eye drop container 609 via the eye drop container pressing mechanism is defined as the "trigger arm pressing position.”
  • the electromagnetic solenoid 606 is turned on and the pressing rod 605 starts pressing. Since the stroke of the electromagnetic solenoid 606 is constant, the amount of pressure is also constant.
  • the pressing rod 605 driven by the electromagnetic solenoid 606 presses the eye drop container 609 via the pressing point adjustment arm 610 to drip the medical solution. Since the operating range in which the pressing rod 605 operates is constant, the eye drop container 609 is always pressed to a constant position, and the amount of liquid medicine to be dropped is also constant.
  • the trigger arm 601 When the operator releases the trigger arm 601, the trigger arm 601 is returned to the trigger arm start position by a trigger arm return spring 608 disposed coaxially with the trigger arm rotation axis 607, and returned to the trigger arm start position by the trigger arm position sensor 602.
  • the electromagnetic solenoid 606 When this is detected, the electromagnetic solenoid 606 is turned off, the pressure on the eye drop container 609 is released, and the eye drop container 609 returns to its original shape.
  • a dropped droplet passage sensor 611 is provided at the upper part near the eyepiece port 604a, and detects whether the droplet of drug solution dropped from the eyedropper container 609 has passed normally through the eyepiece port 604a, and sends the data to the control unit. .
  • This dropped droplet passage sensor 611 allows it to be confirmed whether the pressing mechanism operates properly and whether the eye drops have normally passed through the eyepiece opening 604a.
  • the dropped particle passage sensor 611 in FIG. 8 is composed of a reflective photointerrupter, and detects the reflected light from the lower surface of the air duct 604 when the droplet of the chemical solution passes through, because it is no longer returned to the sensor due to reflection or refraction on the surface of the dropped particle. . Note that this dropped particle passage sensor 611 can also be detected by a transmission type photointerrupter, an ultrasonic sensor, etc., and can also be placed on the side surface of the air duct 604.
  • the drive and voltage of the air fan 101 shown in FIG. 9 are controlled by a control unit 113, and the control unit 113 receives a signal from a trigger arm position sensor 701, a signal from a contact sensor 703 disposed at the operating portion of the trigger arm 107, or
  • the air fan 101 is activated by recognizing the start of the eyedrop operation by the operator based on a signal that detects whether the patient's eye is close to the eyepiece 110 of the eyedropper aid 100 by an eyepiece detection contact sensor placed near the eyepiece port 104d of the air duct 104. make it work.
  • FIG. 13 which will be described later, is an example of the electrical system configuration of the eye drop aid 100, and the air fan 1804 is controlled by an air fan control section 1801a provided in the control unit 1801, and the drive ON/OFF and drive voltage are controlled manually or automatically. be controlled.
  • the air fan 101 operates only when the eye is instilled, thereby preventing wasteful air from flowing into the air chamber 102 or the air duct 104, and by controlling the drive voltage, the air fan 101 is operated only when the eye is instilled, and by controlling the drive voltage, the air fan 101 is operated only when the eye is instilled. It is possible to adjust the discharge amount, which has the effect of minimizing power consumption and extending the life of the motor. Furthermore, when the patient's eye comes into contact with the eyepiece 110 or when the operator starts pulling the trigger arm 107, the air fan 101 starts operating and sends air to the air chamber 102, and the operator pulls the trigger arm 107 and applies eye drops.
  • the air fan 101 has the ability to blow air such that the air pressure in the air chamber 102 can be raised to a predetermined pressure within the time until the liquid is dropped from the eye drop container 106. In a normal operation, this operation elapsed time is 0.3 seconds or more, which is sufficient time to increase the pressure in the air chamber 102 to an appropriate pressure.
  • FIGS. 10 and 11 are diagrams showing the configuration of an inflow control valve that controls air inflow into the air duct 802.
  • FIG. 10 is an example of the configuration of an inflow control valve using a manual mechanism
  • FIG. 11 is an example of an inflow control valve using an electric mechanism. This is an example of the configuration of a valve.
  • a swing type check valve 801 is placed immediately after the inflow port 802a of the air duct 802 as an inflow control valve to control the inflow of air from the air chamber 803. ing.
  • the swing type check valve 801 has a rotation reset arm 801 a and a rotation stop arm 801 b that are interlocked by a rotation shaft 806 and are arranged outside the air duct 802 .
  • the claw portion 804a of the rotation stopper 804 engages the rotation stopper arm 801b, and the claw portion 804a is pushed upward by the spring 804b, so that the valve is braked so as not to open.
  • the swing type check valve 801 is normally closed, and even when the air fan starts blowing air, the air flow remains in the air chamber, increasing the air pressure inside the air chamber.
  • the rotation stopper 804 operates in conjunction with the movement of the trigger arm 805, and the trigger arm 805 is pulled toward the eyepiece port 802b of the air duct 802 by the operator, and the eye drop container is pressed through the eye drop container pressing mechanism to release the eye drop solution.
  • the trigger arm 805 moves to the dripping position, the claw portion 804a of the rotation stopper 804 is pushed downward by the release cam 805a attached to the trigger arm 805 and moves in the direction of releasing the brake, and the swing type check valve 801 is braked.
  • the high air pressure inside the air chamber 803 causes the valve to open all at once, allowing air to flow into the air duct.
  • the air flow within the air duct 802 generated by this operation passes through the air duct 802 at a high flow rate and blows the droplets of the drug solution dropped from the eye drop container toward the patient's cornea.
  • the trigger arm 805 is provided with a valve reset bar 805b for returning the swing type check valve 801 to the closed position.
  • the swing type check valve 801 acts on the rotating reset arm 801a in the closing direction.
  • the valve reset bar 805b pushes the cam 801c to return the swing type check valve 801 to the closed position via the rotating reset arm 801a.
  • the claw portion 804a of the rotation stopper 804 has a gently tapered shape so as not to hinder the closing movement of the swing type check valve 801, and when the swing type check valve 801 returns to the completely closed position, the claw portion 804a swings. It is caught on the upper side of the swing type check valve 801, and the swing type check valve 801 maintains the closed state.
  • Such a manually operated inflow control valve generates a high-speed air flow in the air duct 802 to ensure that the droplets of the drug solution are delivered to the cornea, and when the eye drop operation is completed, the inflow control valve is automatically closed and the next The reset operation for eye drop operation is completed.
  • a valve mechanism such as a butterfly valve, ball valve, reed valve, or diaphragm may also be used.
  • the inflow control valve is a swing type check valve 901, and is connected to the rotating shaft of the swing type check valve 901 via a motor 902 and a worm gear 903. ing.
  • the swing type check valve 901 can detect the open/closed state of the swing type check valve 901 using a valve position sensor 904 that detects the open/closed state of the valve.
  • the motor 902 is controlled by a control unit 906, and a valve position sensor 904 that detects the open/closed state of the swing type check valve 901 and a trigger arm position sensor 905 that detects the position of the trigger arm are connected to the control unit 906.
  • the motor 902 When the trigger arm 805 of the swing type check valve 901 is at the trigger arm start position, the motor 902 is rotated until the swing type check valve 901 is in the closing position, thereby closing the swing type check valve 901.
  • the control unit 906 drives the motor 902 to open the swing type check valve 901.
  • the control unit 906 reversely drives the motor 902 to rotate the swing type check valve 901 to the closed position and maintains that position.
  • the inflow control valve of such a motorized mechanism generates a high-speed airflow in the air duct 802 to ensure that the droplets of the drug solution are delivered to the cornea, and when the eye drop operation is completed, the inflow control valve is automatically closed and the next The reset operation for eye drop operation is completed.
  • a swing type check valve other valve mechanisms such as butterfly valves, ball valves, reed valves, diaphragms, etc. may also be used.
  • Eye drops are administered to patients in various patterns depending on the type, degree, and symptoms of the eye disease. Depending on the patient, multiple eye drops may be instilled, the prescription for eye drops may be different for the left and right eyes, and the number of eye drops may vary, so patients must manage which type of eye drops to use, when and how many times. However, in daily life, it often happens that people forget to apply eye drops or make mistakes.
  • FIG. 12 is an example of a detection method (left and right eye detection means) that automatically detects which eye, left or right, the eye drop aid is in close contact with.
  • Examples of commonly used methods for detecting whether the patient's eyes are left or right include analyzing an image of the patient's face or eyes captured by a camera to determine whether it is the left or right eye, or by placing the patient's face on a chin rest. If the eye dropper is fixed, there is a method of detecting the position of the eye dropper with respect to the chinrest for discrimination, but for a portable eye dropper 1, a simpler discrimination method is desirable.
  • a reflective optical sensor 1003 is used to detect and determine which side of the eyedropper the patient's nose is located near. It shows.
  • a left reflective optical sensor 1003a and a right reflective optical sensor 1003b are arranged at the bottom of both sides of an air duct 1001 of the eye drop aid.
  • These reflective optical sensors 1003 detect that when a patient's nose is near the sensor, infrared light emitted from the reflective optical sensor 1003 is reflected or scattered on the patient's nasal surface and returns to the reflective optical sensor 1003. The presence of the nose is detected by receiving the light coming from the nose.
  • the left reflective optical sensor 1003a and the right reflective optical sensor 1003b are connected to the control unit 1004 and transmit detected signals. If there is no nose detection signal from either sensor, or if a detection signal is being sent from both sensors, the control unit 1004 determines whether the eye drop aid is not in the designated position or is blocked by the operator's hand or the like. If it is determined that the right eyelid is in contact with the eyepiece 1002, and a detection signal is sent only from the left reflective optical sensor 1003a, it is determined that the eyelid of the right eye is in contact with the eyepiece 1002, and a detection signal is transmitted only from the right reflective optical sensor 1003b. If so, it is determined that the eyelid of the left eye is in contact with the eyepiece 1002.
  • Information on the left and right eyes discriminated by the control unit 1004 is transmitted to an external device such as a smartphone via a communication means, and is effectively used as information for evaluating the eye drop condition and information on the eye drop history.
  • the discrimination information of the left eye/right eye automatic detection function determines whether or not to perform the eye drop operation to ensure that the eye drop is administered reliably. It is possible to operate the
  • this eye drop aid can easily detect the left and right eyes that are close to each other and optimize the operation of the eye drop aid.
  • This allows patient support software on external devices and patient support systems on the Internet to evaluate eye drop conditions and record eye drop history.
  • a reflective optical sensor is used as the nose detection sensor, but the sensor may also be an ultrasonic sensor, a capacitance sensor, a pyroelectric sensor, or the like.
  • FIG. 13 shows an example of an electrical system configuration in the case of an electric push mechanism and an inflow control valve in the eye drop aid 100.
  • An electromagnetic solenoid 1803 is used as an electric eye drop container pressing mechanism, and a valve drive by a motor 1805 is used for inflow control.
  • a control unit 1801 provided in the eye drop aid 100 is configured to control the entire system and drive the air fan 1804, solenoid 1803, and motor 1805.
  • the sensor unit 1802 includes a sensor communication board 1802a, a trigger arm position sensor 1802b, a valve position sensor 1802c, an eyepiece sensor 1802d, a droplet passing sensor 1802e, a contact sensor 1802f, a left and right eye detection sensor 1802g, and a tag reading sensor 1802h, and performs sensor communication.
  • the board 1802a is configured to convert the values of each sensor into digital values and communicate with the control unit.
  • the eye drop aid 100 includes a dropped droplet passage sensor 1802e that can detect droplets of the drug solution passing through the air duct 104 at a predetermined position in the air duct 104 to detect whether the drug solution has normally reached the cornea. I can do it. Additionally, a trigger arm position detection sensor 1802b detects the position of the trigger arm 107, a valve position sensor 1802c detects the opening/closing angle of the inflow control valve, a G sensor detects the tilt and movement of the eye drop aid 100, and a G sensor detects whether the patient's left or right eye By arranging the left and right eye detection sensor 1802g that detects whether the patient's eyes are close to It is possible to evaluate whether there are any abnormalities.
  • a camera 1809 capable of photographing the patient's eyes is placed inside the air chamber 102 or near the inlet 104a of the air duct 104, the opening of the eyelids when the eye drops are delivered to the patient's eyes is possible.
  • the condition and position, as well as the adhesion state of the eye drops delivered to the cornea, can be evaluated using captured images.
  • the chemical droplet passage sensor 1802e disposed in the air duct 104 detects the droplet passage using an optical transmission type or reflection type sensor or an ultrasonic sensor.
  • the trigger arm position detection sensor 1802b is detected by a potentiometer or encoder that is linked to the trigger arm 107, detection of an optical slit or reflector using an optical transmission type or reflection type sensor, a magnetic sensor, or the like.
  • the valve position sensor 1802c is preferably a switch that is linked to the valve, a potentiometer or encoder that is linked to the rotation axis of the valve, or a transmission or reflection type optical sensor that directly detects the open/closed state. Note that, in this electrical system, for example, when the eye drop aid 100 is a manual eye drop container pressing mechanism and an inflow control valve, unnecessary functional units can be omitted depending on the system configuration.
  • control unit 1801 includes an air fan control section 1801a, and the air flow in the air duct 104 necessary for horizontally moving the droplets of the drug droplet dropped from the eye drop container 106 into the air duct 104 relative to the droplet droplet of the drug solution.
  • control unit 1801 can store image data transmitted from the anterior eye camera (imaging means) 1809, and can communicate with the smartphone via short-range communication such as WiFi or Bluetooth (registered trademark) via the communication unit (communication means) 1808. , communicates data with external devices such as personal computers and tablet PCs. Communication unit 1808 transmits various detection data to an external terminal via a wired/wireless network.
  • the camera 1809 is disposed within the air chamber 102 or near the inlet 104a of the air duct 104, and photographs the ocular surface through the air duct 104. Since the on-off valve disposed in the air duct 104 blocks the inflow port 104a, it is preferable that the blocking wall is made of a transparent material that allows light to pass through so that the patient's eyes can be photographed.
  • the eye drop aid 100 can constitute an external communication means, and can be connected to an external device such as an external smartphone, personal computer, tablet PC, or Wi-Fi terminal through the communication unit 1808. Then, the data detected by the above-described sensors 1802b to 1802h arranged in the eyedropper aid 100, the eyedropper status, the evaluation results, and the image of the patient's eye taken by the camera 1809 are transmitted. In addition, the transmitted data and images are sent to servers and cloud systems on the Internet via smartphones and computers, and these data can be shared by patients, patients' families, caregivers and other supporters, and medical institutions for viewing and viewing. A home monitoring system that can be evaluated and support patient treatment can be realized.
  • a control unit 1801 controls the system using data values and image data sent from a sensor unit 1802 and an anterior segment imaging camera 1809, and also sends the status of the eye drop aid 100 and the patient's eye drops to a patient support system using an external device and a network system.
  • the status can be sent as data, and as a result, data and information that can be used to support patient treatment can be provided.
  • the invention is an eye drop aid 100 for administering a medical solution in an eye drop container to a patient's eye.
  • An air chamber 102 that serves as an air chamber for air flow, a cylindrical air duct 104 communicating with the air chamber 102, and an eye drop container 106 that is replaceably attached to the upper wall of the air duct 106 in a horizontal state.
  • a trigger arm 107 is provided.
  • One end of the opening of the cylindrical air duct 104 serves as an inlet 104a through which the air flow discharged from the air fan 101 flows through the air chamber 102, while the other end of the opening comes into contact with the area around the patient's eyelids. This becomes an eyepiece port 104d.
  • a liquid medicine introduction hole 104c is formed in the upper wall of the air duct 104 for introducing into the air duct 106 the liquid drops dropped from the nozzle of the eye drop container 106 attached to the eye drop container fixing attachment 105.
  • the patient using the eye drop aid 100 does not need to look upward, and an appropriate amount of the medicinal solution is injected into the patient's eye in a comfortable horizontal position. I can do it. That is, the patient can instill the eye while looking horizontally without looking up by simply pulling the trigger arm 107 of the eye drop aid 100, and the eye drop solution passes through without contacting any parts of the eye drop aid 100. Therefore, the eye drops can be delivered to the patient's eyes without being contaminated by the parts of the eye drop aid 100, and the above-mentioned medicine drop mechanism can reliably drip a certain amount of eye drops, and the patient can easily and reliably drop the eye drops in a comfortable position. And it can be safely instilled into the eyes.
  • the eye drop container fixing attachment 105 can be easily attached to and removed from the eye drop aid 100, making it possible for patients who are instilling multiple eye drops to exchange and administer eye drops without complicated operations.
  • the eye drop aid 100 according to this modification has a configuration in which the air chamber 102 is omitted.
  • the air flow inside the air duct 104 becomes uniformly smooth, so that the air flow between the air fan 101 and the air duct 104 becomes uniform.
  • An air chamber 102 was placed in the air chamber 102.
  • the air outlet of the air fan 101 is directly connected to the air duct 104, and with this configuration, the same effects as in the first embodiment can be achieved, and the device can be made more compact and lightweight. This makes it possible to reduce costs and reduce costs.
  • the present invention is not limited to the configuration of the embodiments described above, and various modifications can be made without changing the spirit of the invention.
  • the usage example shown in FIG. 1 is just one example, and the eye drop aid 100 may be fixedly mounted on a height-adjustable support and the eye drop may be applied while keeping the eye drop in a horizontal state.
  • the size of the eye drop container 106 varies depending on the type of drug, manufacturer, etc., instead of using a complicated mechanism such as the eye drop container pressing mechanism and the pressing position adjustment mechanism as described above, a special product that differs depending on the size of the eye drop container may be used. It is also conceivable to use an eye drop container fixing attachment 105 as a.
  • each time the eye drop container 106 is attached it is not necessary to make fine adjustments to the pressing position of the eye drop container fixing attachment 105, which is convenient for use. That is, if separate eye drop containers 106 of different sizes are attached in advance to the dedicated eye drop container fixing attachment 105 and stored with the caps closed, the eye drop containers can be fixed even for patients who use multiple eye drops. Eye drops can be easily replaced by simply replacing the attachment 105.
  • Embodiment 2 of the eye drop aid according to the present invention will be described below with reference to FIGS. 15 to 21.
  • instillation is carried out from the droplet passage sensor for the drug solution, the anterior segment image capturing camera, the G sensor, the left and right eye detection sensor, the eyepiece sensor, etc. arranged in the eyedrop aid 100 described in the first embodiment.
  • a doctor and a patient share the data using means to monitor the status of eye drop treatment and encourage the patient to continue the eye drop treatment.
  • Embodiment 2 of the present invention will be described in the following order.
  • Configuration of external communication means and network system (9) Operation of patient support software that supports eye instillation (10) Functions and operations of patient support software other than during eye instillation (11)
  • Dedicated software executed on in-hospital terminal equipment (12) Operation of dedicated software executed on the supporter's mobile terminal
  • FIG. 15 shows the overall configuration of a home monitoring system S for supporting patient treatment.
  • Eye dropper 1101 is connected to the Internet 1109 by one of a plurality of connections.
  • Connection means include means via a router 1102 connected to a wired local area network (LAN), means via a wireless router 1103 using short-range wireless such as wireless LAN or Bluetooth, and mobile communication such as a mobile terminal 1104 such as a smartphone. It is connected to the Internet (WAN) by means such as via a network.
  • LAN local area network
  • WAN Internet
  • the information is stored in a mobile terminal 1104, a cloud service 1105 on the Internet, or a fixed server 1110 via the Internet.
  • These eye drop condition data are accumulated together with information on the date and time when the eye drop was applied, eye drop information, and the like.
  • Information on the date and time when the eyedrops were applied is obtained from a clock included in the eyedropper auxiliary tool or a clock on a mobile terminal connected to the eyedropper.
  • the eye drop information is obtained by the eye dropper 1101 automatically identifying the eye drop inserted into the eye drop container fixing attachment, or by the user selecting the eye drop using a function of software installed on the mobile terminal 1104. Information is identified and stored with the data.
  • the cloud service 1105 and the fixed server 1110 are equipped with software that analyzes the accumulated data, and analyzes the data through statistical processing, uses AI (Artificial Intelligence) and deep learning, and analyzes the data using AI (Artificial Intelligence) and deep learning. It becomes possible to determine and implement effective support methods to improve patient adherence.
  • the data stored in the cloud service 1105 and the fixed server 1110 can be composed of data of multiple patients, and with the patient's consent, the above analysis and analysis can be performed using big data composed of multiple patient data. This can lead to improvements in prediction and proposal accuracy.
  • analyzed data can be checked on the terminal device 1107 as data used by medical personnel 1108 for diagnosis and determining treatment policies, and can also be checked on the eye dropper 1101, the patient's mobile terminal 1104, and the supporter's terminal. This can be confirmed using the device 1107 or the like. Furthermore, it is also possible to change the operation of software running on the patient portable terminal 1104 using the analysis data in order to improve patient adherence.
  • FIG. 16 is a configuration diagram showing an example of a patient support system using an external device.
  • the eye drop aid 1201 includes a drop control unit 1201a that pressurizes a part of the eye drop container in conjunction with the drive of the air fan and drips a drop of medicine when the patient operates a trigger arm, and a drop control unit 1201a that is arranged in the eye drop aid.
  • An eye drop condition detection unit 1201b that detects data indicating the eye drop state from a dropped particle passage sensor, an anterior segment image capturing camera, a G sensor, a left/right eye detection sensor, etc., and an eye drop evaluation unit that analyzes the data and evaluates the eye drop state. 1201c, and a communication section 1201d for transmitting the data, analysis results, evaluation results, etc. to the mobile terminal, and receiving information, instructions, etc. from the mobile terminal.
  • This communication unit is a module that enables wired connections such as USB and wired LAN, and short-range wireless connections such as Bluetooth, WiFi, and wireless LAN
  • the patient mobile terminal 1202 includes a control unit 1202a that controls the components of the patient mobile terminal 1202 using a processor such as a CPU and memory to realize various functions, and a memory such as a RAM that stores data received from the eye drop aid.
  • a communication unit 1202c that realizes communication connection to a communication network such as the Internet and communication with an eye drop aid, a screen display unit 1202d such as a liquid crystal panel or an organic EL display, and an operation input unit 1202e such as a touch panel. Equipped with etc.
  • the system works to ensure that eye drop treatment can be continued based on various data including eye drop information and eye drop plans that the patient himself inputs and saves on his mobile device, eye drop implementation information and eye drop status received and accumulated from the eye drop aids, etc. It includes an adherence analysis support section 1202f.
  • the eye drop aid 1201 is equipped with a screen display section, an operation input section, and a storage section so that the eye drop aid 1201 alone can encourage continuation of eye drop treatment.
  • an adherence analysis support section may be provided.
  • FIG. 17 is a configuration diagram showing an example of a patient support system via a network system.
  • the eye drop aid 1301 includes a drop control unit 1301a that pressurizes a part of the eye drop container in conjunction with the drive of the air fan and drips a drop of medicine when the patient operates a trigger arm, and a drop control unit 1301a that is arranged in the eye drop aid.
  • An eye drop condition detection unit 1301b that detects data indicating the eye drop state from a dropped particle passage sensor, an anterior segment image capturing camera, a G sensor, a left/right eye detection sensor, etc., and an eye drop evaluation unit that analyzes the data and evaluates the eye drop state.
  • the unit 1301c transmits the data, analysis results, evaluation results, etc.
  • the communication unit 1301d is provided for communication.
  • This communication unit is a module that enables wired connections such as USB and wired LAN, and short-range wireless connections such as Bluetooth, WiFi, and wireless LAN.
  • the patient mobile terminal 1302 includes a control unit 1302a that controls the components of the patient mobile terminal 1302 using a processor such as a CPU and memory to realize various functions, and a memory such as a RAM that stores data received from the eye drop aid.
  • a communication unit 1302c that realizes a communication connection to a communication network such as the Internet and communication with an eye drop aid, a screen display unit 1302d such as a liquid crystal panel or an organic EL display, and an operation input unit 1302e such as a touch panel. Equipped with etc.
  • eye drop information, eye drop plans, and treatment plans that the patient himself/herself enters directly into a mobile device and saves, or that doctors and pharmacists provide via the Internet, as well as eye drop administration received and stored from the eye drop aids.
  • the device may also include a screen display section, an operation input section, a storage section, and an adherence analysis support section.
  • FIG. 17 shows an example in which the patient mobile terminal 1302 is connected to the Internet via a home LAN, it is also possible to use the patient support system by connecting to a LAN outside the home, including a nursing facility. .
  • the fixed server 1303 receives sensor data, analysis results, and evaluation results sent by the eye drop aid 1031, eye drop information and eye drop plans entered on the patient's mobile terminal, doctor/pharmacist's terminal, and even from the eye drop aid.
  • the communication unit 1303a receives information such as eye drop status data such as daily eye drop status and eye drop implementation status automatically recorded in the patient mobile terminal, and responds when a request is received from the patient mobile terminal 1032 or the in-hospital terminal device 1304.
  • a control unit 1303b that returns information, analyzes various data received by the transmitting/receiving unit using statistical processing, AI, deep learning, etc. to predict disease progression, or is effective for improving patient adherence.
  • An adherence analysis support unit 1303c determines and executes the support method, and collects various data received by the transmitting/receiving unit, analysis results by the adherence analysis support unit 1303c, and patient (contractor) information (contractor ID, password). , medical institution/medical staff in charge, date of birth, gender, healthcare information, scheduled date and time of visit, measurement results of various testing devices, etc.). Although a fixed server is used in the example of FIG. 17, a cloud service or the like may also be used.
  • the in-hospital terminal device 1304 includes an operation input unit 1304a such as a keyboard that accepts input from a doctor, a software execution unit 1304b that executes dedicated software on a web browser, etc., and an operation input unit 1304a that allows data on the eye instillation status of the target patient and information based on AI, etc.
  • a request generation unit 1304c that obtains analysis results, eye drop plans, etc., receives data on target patients stored in the fixed server 1303, test results performed with in-hospital testing equipment, and eye drop plans and treatment plans created by doctors.
  • - Includes a communication unit 1304d for transmitting comments and the like to a fixed server, a screen display unit 1304e, a storage unit 1304f, and the like.
  • the supporter mobile terminal 1305 allows the supporter to input messages to the patient via an operation input unit 1305a such as a touch panel, a software execution unit 1305b that executes dedicated software on a web browser, etc., and an operation input unit 1305a to input messages to the patient. It includes a request generation unit 1305c that obtains eye drop situation data, analysis results by AI, etc., eye drop schedule, etc., a communication unit 1305d, a screen display unit 1305e such as a liquid crystal panel or an organic EL display, a storage unit 1305f, and the like.
  • an operation input unit 1305a such as a touch panel
  • a software execution unit 1305b that executes dedicated software on a web browser, etc.
  • an operation input unit 1305a to input messages to the patient. It includes a request generation unit 1305c that obtains eye drop situation data, analysis results by AI, etc., eye drop schedule, etc., a communication unit 1305d, a screen display unit 1305e such as a liquid crystal panel
  • FIG. 18 is a flowchart showing an example of the operation of patient support software that supports application of eye drops.
  • Patient support software functions as software that supports patients in continuing eye drop treatment and helps maintain and improve adherence.
  • the user installers the patient support software onto the patient portable terminal used in the patient support system via the Internet or the like.
  • the user When the patient support system is operated via a network system as shown in FIG. 17, the user obtains the subscriber ID from the fixed server, sets a password, etc., and records it in the storage units of both the patient mobile terminal and the fixed server. Additionally, other patient (contractor) information (name, date of birth, gender, race, supporter's name, supporter's unique ID, medical institution/pharmacy in charge, doctor in charge, etc.) is also recorded.
  • the supporter's unique ID is a unique ID that is assigned when providing support by installing patient support software on a supporter's mobile device, etc., and allows them to exchange messages over the Internet and access fixed servers to view patient data. It is used when carrying out.
  • the data recorded in the fixed server is recorded in association with the usage contractor ID. Further, the patient support software and the eye drop aid are connected via WiFi or the like, and the unique ID of the eye drop aid is recorded in the storage section of the patient's mobile terminal.
  • Basic eye drop information is registered.
  • Basic information about eye drops includes name of eye drops, target eye (right eye, left eye, both eyes), number of drops per day, number of drops per day, duration of eye drops (time of day), date of prescription, and information on the doctor/pharmacist in charge.
  • Methods for acquiring this information include reading the QR code provided by the pharmacy with the camera of the patient's mobile terminal or eye drop aid;
  • a method is to read the barcode on the eye drops with a camera or barcode reader equipped on a fixed attachment, and obtain information on the corresponding eye drops via the Internet.
  • the eye drop container of the registered eye drop is attached to the eye drop container fixing attachment 105 and inserted into the eye drop aid, and the acquired information of the unique tag of the eye drop container fixing attachment is associated with the basic eye drop information of the eye drop. You can register. This makes it possible to automatically determine the type of eye drops inserted, making it possible to prevent mix-ups of eye drops.
  • an eye drop plan for the day is created based on the basic eye drop information and is displayed on the screen of the patient's mobile terminal to notify the patient.
  • a voice or an alarm sound may be used to warn the user. It may be possible to temporarily or permanently change the eye instillation time setting on this screen.
  • a message prompting the patient to instill the eye is displayed on the screen of the patient's mobile terminal in S1404, and notification is given by voice or alarm sound. At this time, a message may also be automatically sent to registered supporters.
  • the process moves to eye drop support processing execution step S1406.
  • the user can be informed of the current situation by displaying instructions on how to turn on the eye drop aid on the screen, or by expressing the process until communication is established between the eye drop aid and the patient's mobile device using illustrations, animations, audio, etc. It is also possible to make the situation easier to understand and guide smooth operation.
  • the eye drop aid may be expressed using anthropomorphic or anthropomorphic illustrations, animations, sounds, etc.
  • the patient is supported to perform correct and effective eye drop operation using the eye drop aid.
  • Information about the eye drops to be instilled and the target eye are displayed on the screen of the patient's portable terminal in an easy-to-understand manner using images, illustrations, etc., and the user is prompted to insert the eye drop container fixing attachment into the eye drop aid.
  • the user is instructed to check the remaining amount of eye drops or to replace the eye drop bottle with a new one. It is also possible.
  • information on all eye drops may be displayed.
  • the order of eye drops is determined, it is desirable to highlight the eye drops to be instilled in order to distinguish them from other eye drops by color, size, icon display, etc.
  • the RFID tag is read and compared with basic eye drop information to identify the inserted eye drop and provide information on the inserted eye drop. It is also possible to display this on the screen, or to warn the user if the inserted eyedrops are not the correct eyedrops to prompt the user to replace them with the correct eyedrops.
  • the eye drop container fixing attachment is equipped with a camera for photographing the eye drops or a barcode reader for identifying them, the operation will be performed using the eye drop information determined from the camera image and the barcode. It is possible to determine.
  • the patient support software When the patient support software confirms that the eye drops to be instilled are correctly set in the eye drop aid, it displays on-screen instructions on how to instill the eye using the eye drop aid, using illustrations, animations, etc.
  • the patient support software displays on-screen instructions on how to instill the eye using the eye drop aid, using illustrations, animations, etc.
  • FIG. 19 is a diagram showing an example of an eye drop instruction screen.
  • an example is shown in which a plurality of eye drops are instilled at the same time.
  • the eye drops 1501 to be currently instilled are displayed in a large and emphasized manner along with the name of the eye drops, a photograph, etc., and information 1502 about other eye drops is displayed in a small and inconspicuous manner.
  • the current number of eye drops among the eye drops to be instilled at the same time is displayed on 1503 so that the progress status can be grasped.
  • the front face illustration 1504 is arranged in a mirror-inverted manner so that when the patient looks at the screen, the patient's own face is reflected in the mirror, so that the patient can imitate what he sees and operate it, and the left and right eyes can be adjusted. This can prevent mix-ups.
  • a video of the patient's own face captured in real time by a front camera 1508 mounted on the screen of the smartphone may be displayed. . At that time, the video is displayed so that the patient's smartphone screen is mirrored, as if it were reflected in a mirror, with the right eye on the right side of the screen and the left eye on the left side of the screen.
  • a message column 1507 displays operation instructions for the patient, current progress status, and the like.
  • the eye drop aid When a patient approaches the eye drop aid, the eye drop aid is equipped with an automatic left/right eye detection function that can detect whether the eye is the left or right eye. If they do not match, a warning display or sound will be displayed to inform the user that the eye to which the eye drop aid is being applied is incorrect, or if the eye drop aid is placed in the wrong eye, the eye drop aid will automatically perform the instillation operation. You can stop. Since it is difficult to visually confirm the instructions on the screen of the mobile terminal until the eye drop aid is applied to the target eye and the eye is instilled, it is preferable to use voice guidance to guide the instructions.
  • the patient support software sends eye drop status data such as data obtained from various sensors of the eye drop aid, anterior segment images, and eye drop status evaluation results obtained by analyzing these data. receives and analyzes it, and determines whether or not the eye instillation was successful in S1408.
  • an example is a method of determining by combining information from multiple sensors provided on the eye instillation aid and multiple images of the anterior segment in time series. For example, if there is no response from the droplet passage sensor within a certain period of time after the patient performs eyedropping, it can be determined that eyedropping has failed. On the other hand, even if there is a reaction in the dropped particle passage sensor, if it is determined from the value of the G sensor that the eye drop aid is tilted to a certain extent and the eye drop cannot reach the target eye, it can be determined that the eye drop has failed.
  • multiple time-series anterior segment images (videos) taken by the imaging means are analyzed and the eye drops are removed. It can be determined whether the drug has been delivered to the cornea or conjunctiva. For example, if the eye drops are delivered to the target eye with the eyelids open, it is determined whether or not the eyelids are correctly opened by performing preprocessing using various image filters to identify the presence and position of the pupil and iris. It can be judged that the instillation was successful.
  • the general filtering method that uses image processing such as contour extraction
  • the process moves to S1410, and the information on the eye drops performed in the flow (date and time of eye drops, instilled eye drops, eye drop status data, eye drop location, etc.) is stored. Record. If all eye drops have not been completed yet, the process returns to S1406 to instill the next eye drop.
  • the eye drops may flow out of the eye if they are injected continuously in a short period of time, and the eye drops may not be as effective as they should be. Then you can set an appropriate waiting time.
  • illustrations, animations, sounds, etc. may be used to guide the patient.
  • illustrations, animations, or audio may be used to guide the patient to remove the eye drop container fixing attachment from the eye drop aid, close the cap, and put it away each time a single eye drop is completed. .
  • the eye drop situation is evaluated based on the accumulated daily eye drop implementation information, such as whether the eye drops are being applied according to the eye drop plan, and the patient's motivation and adherence to eye drop treatment is scored and notified.
  • Support processing is executed to maintain and improve patient adherence and motivate patients to continue treatment, by providing advice and displaying messages to improve patient adherence, and providing information about the disease being treated and eye drop treatment.
  • a patient support system via a network system
  • the notification method is to install a dedicated patient support software app on the supporter's mobile device, and then automatically notify the patient that the eye drops have been administered from the patient's mobile device through the message function built into the dedicated app. It is also possible to notify using a registered SNS. Supporters who receive the notification can reply with a message.
  • the score decreases and the plants wither and lose their vitality, the character will be motivated to restart the eye drop treatment in order to raise the score and revive the character.
  • the game may be made to progress each time the score increases.
  • the game can proceed to the next stage, or items that can be used in the game can be obtained. Furthermore, it may be possible to share the progress of the game, information on acquired items, etc. with registered supporters, family members, friends, etc. Furthermore, scores and accumulated points may be exchanged for real-world goods and services.
  • the content of the adherence analysis support process executed is recorded and can be used to analyze the relationship between the process content and subsequent changes in patient behavior, and to determine a more effective support process method. It is possible.
  • Adherence analysis support processing is executed not only at the time of eye instillation as shown in Figure 19, but also at various timings, and is used to maintain and improve patient adherence and continue treatment on a daily basis. Provide motivational support.
  • FIG. 20 is an example of an encouragement message display screen.
  • a score 1601, a message of encouragement 1602, etc. are displayed on the screen.
  • the content of the message can be determined depending on the score, eye drop status, visit status, etc., and it is desirable to use positive expressions as much as possible.
  • the contents of 1604 also include the patient's history of eye drops, changes in test results such as intraocular pressure, treatment plans, etc., so that the patient understands his or her condition, characteristics of the disease, goals, etc., maintains and improves adherence, and motivates continued treatment.
  • the content is not limited as long as it leads to the attachment.
  • a more effective timing may be determined based on the patient's reaction history to past messages. For example, the time and place where the probability of tapping 1604 and confirming the content is highest may be analyzed from past reaction history. Regarding the content 1602 of the encouragement message, it is possible to generate an effective message that leads to positive behavior change toward eye drop treatment based on past reaction history and the like.
  • points are awarded when applying eye drops, visiting the hospital, and receiving medicine to increase your score.
  • the size of points may be changed depending on the degree of importance and effect.
  • the score may be decreased. Deterioration in adherence and motivation can be determined based on factors such as a decrease in the rate of instillation, failure to adhere to the instillation time, and delays in visiting the clinic.
  • Visit appointment dates and times can be set by scanning a QR code containing the medical appointment issued by special software running on the in-hospital terminal at the time of the previous visit, using the camera of the patient's mobile terminal or the camera of the eye drop aid; There are two methods: direct registration from dedicated software running on the terminal and registration on a fixed server over the Internet, and direct input by the user using the input function of patient support software.
  • the date when the eye drops will run out is estimated based on the eye drop capacity, the number of prescribed eye drops, and the history of eye drops in the eye drop information. If the estimated date approaches and the scheduled visit date has not been set, the estimated date will be used. A message may be displayed to encourage patients to visit the hospital. At the same time, a function for setting a scheduled visit date or a function for making a reservation for a visit via the Internet may be operated.
  • the patient support software on the patient's mobile device allows you to check the eye condition at any time, test results such as tonometer and visual field test, score status, remaining amount of eye drops, eye drop information, visit appointment date, detailed content about target diseases and eye drops, past information, etc. It is possible to view the exchange of messages.
  • FIG. 21 is an example of a graph showing the relationship between test results, scores, and various events.
  • the visual field sensitivity obtained by the visual field test 1701 the intraocular pressure value measured by the tonometer 1702, the score trend obtained by the patient support software 1703, the date of visit, the start of eye drops, the change of eye drops, etc.
  • Events 1704 are displayed in chronological order.
  • the set target intraocular pressure is displayed on the graph (horizontal dotted line 1706 at the bottom) to clarify the treatment goal.
  • the score may be expressed by the height and color of the bar graph 1707 to indicate adherence and motivation to continue treatment. If you tap the data on the graph, you may be taken to a screen where you can check detailed data.
  • the patient support software automatically issues an alert and notifies the patient and support staff if the patient continues to forget to use eye drops, or if test values such as intraocular pressure worsen, and provide advice and treatment for eye drops. It is possible to deliver messages that motivate people to continue. Additionally, an in-hospital terminal device will also issue an alert, allowing the doctor in charge to remotely support the patient.
  • patients can record comments at any time. Comments include questions and concerns about symptoms, side effects, diseases, and eye drops. By sharing these comments with medical professionals such as doctors and pharmacists, they can become a resource for receiving accurate advice the next time you visit a hospital. Additionally, the patient support system will be able to analyze the content of comments and automatically provide necessary knowledge and information.
  • the doctor can give advice to the patient or change the eye drops or eye drop schedule as necessary.
  • basic information about the eye drops to be prescribed eye drop name, target eye (right eye, left eye, both eyes), number of drops per day, number of drops per day, duration of eye drops (time of day), prescription date, etc.)
  • eye drop name eye drop name
  • target eye right eye, left eye, both eyes
  • number of drops per day number of drops per day
  • duration of eye drops time of day
  • prescription date etc.
  • visit points are automatically awarded and delivered to the patient's mobile device along with a message.
  • Messages can be automatically generated by patient support software based on daily eye drops and test results, the doctor can select from multiple automatically generated comments, or the doctor can input them directly.
  • the message can also be automatically delivered to set supporters. Delivered messages are recorded on a fixed server and can be checked at any time from a patient's mobile device.
  • the basic eye drop information can also be set from dedicated software running on a terminal device at the pharmacy and recorded on a fixed server. It is also possible to read the QR code for electronic medicine notebook registration issued by the pharmacy with a camera mounted on a patient's mobile terminal and record it on a fixed server via patient support software. If dedicated software is running on a pharmacy's terminal device and the pharmacist is registered as the responsible pharmacy, the pharmacist can view data such as the patient's eye drop status, and can provide various advice based on that data.
  • Medical professionals such as doctors and pharmacists not only receive information when a patient visits the hospital, but also receive measurement results such as the patient's daily eye drop status and intraocular pressure that are recorded on a fixed server via dedicated software running on a terminal device. It is possible to check at any time. Furthermore, it is possible for a medical worker to send a message to the patient's portable terminal if necessary. Furthermore, if there is an abnormality in the patient's eye drop score or intraocular pressure measurements, the dedicated software can automatically issue an alert and notify the doctor. With these functions, medical professionals can monitor the status of a patient's eye drop treatment even when the patient is not in the hospital, and can accurately support the maintenance and improvement of patient adherence and continuation of treatment. It becomes possible to support the patient to prevent the deterioration of the condition.
  • the dedicated software executed on the supporter's mobile terminal allows supporters such as family members and caregivers to monitor the continuation status of the patient's eye drop treatment on a daily basis. By deepening their understanding of the disease that the patient is suffering from, the support person works to stay close to the patient and provide support so that the eye drop treatment can be continued.
  • Supporters can check the patient's daily eye drop status and test results such as intraocular pressure recorded on the fixed server at any time via dedicated software running on the terminal device. Furthermore, messages can be exchanged between the patient and the support person as needed.
  • the patient support system uses healthcare information accumulated on patient mobile devices (activity information such as walking/running distance and number of steps, calories burned, sleep information, physical measurement data such as weight, height, BMI, blood pressure and heart rate). ⁇ Utilizing data measured by other devices (such as blood sugar levels), etc., and analyzing the status of the eye drops and various test results, we can analyze the causal relationship between the progress of the target disease and various data, and determine the target disease. Processing that provides suggestions for lifestyle habits that are effective in suppressing the progression of eye disease, maintaining and improving adherence, and providing motivation for continuing eye drop treatment may be performed.
  • the patient support system registers medication information (such as drug name, dosing time, dosage, etc.) for not only eye drops but also other oral medications, patches, and supplements to improve blood pressure and blood sugar levels. It may also be equipped with functions that display messages to prevent forgetting, record medication history, analyze medication status, and encourage patients to maintain and improve adherence and motivate them to continue treatment. In addition, it is possible to simultaneously display the medication status and scores of medications and supplements other than eye drops on the graph in Figure 21, allowing patients to check the graph and data themselves to determine whether they are taking eye drops or other medications or supplements. This data can be used to help physicians understand the relationship between patients and their patients, and to help physicians analyze this data to determine treatment plans and provide advice to patients.
  • medication information such as drug name, dosing time, dosage, etc.
  • the second embodiment is a patient support system for the eyedropper installed in a patient's home or nursing care facility, and includes communication means provided in the eyedropper aid 100 similar to the first embodiment described above.
  • the external device that communicates provides treatment support such as registered patient's eye instillation date and time, notification of eye instillation schedule, tracking and history of eye instillation actions, and cautions against deviations from the patient's treatment plan, as well as from stored data and eye instillation history. Evaluations of the patient's eye drop status and willingness to participate in treatment can be quantified and provided on the display screen of an external device or through audio.
  • the external device that is communicatively connected to the eye drop aid 100 is connected to a fixed server on the Internet, a cloud system, and other Internet terminals, and the numerical data and image data stored in the external device are transferred to the fixed server on the Internet.
  • the results are saved in a cloud system and analyzed, and the analysis results, eye drop treatment history, eye drop status, and evaluation score of the patient's desire for treatment are shared on external devices and other Internet terminals, allowing patients to receive treatment together with their doctors, caregivers, etc. Try to improve your grades. That is, the patient's eye drop condition can be detected and evaluated, and the data can be shared between the doctor and the patient, thereby improving the patient's adherence.
  • the instructions and information conveyed to the patient by software installed in the external device include information on eye drop times, reminders to forget to use eye drops, daily eye drop/medication schedule, eye drop history, consultation instructions, and past data at medical institutions. information, history, medical information, etc.
  • the system evaluates and displays the patient's condition and motivation by scoring and displaying the condition and motivation of the patient based on the condition of the eye drops, the continuity of the eye drops, data from medical institutions, data linked with other diagnostic devices, etc. Furthermore, it displays advice and visual incentives to improve the patient's score, increasing the patient's desire to continue treatment.
  • the home monitoring system uses patient data, medication history, drug types and information, doctor's instructions, appointment reservations, estimates future disease trends using the AI system, and improves motivation to continue treatment.
  • a support system can be built to support patients by providing them with regular advice and encouragement.
  • the present invention is not limited to the configuration of the embodiments described above, and various modifications can be made without changing the spirit of the invention. Furthermore, in order to achieve the object of the present invention, the present invention is implemented as a method that includes steps of characteristic configuration means included in a home monitoring system and a patient support system, or as a program that includes those characteristic steps. You can also.
  • the program can not only be stored in a ROM or the like, but can also be distributed via a recording medium such as a USB memory or a communication network.

Abstract

An eye drop assistance apparatus 100 comprises: an air fan 101; an air chamber 102 serving as an air chamber for an airflow discharged from the air fan 101; a cylindrical air duct 104 in communication with the air chamber 102; an eye drop container fixing attachment 105 on which an eye drop container 106 is mounted so as to be replaceable and which fixes a nozzle of the eye drop container 106 so as to face downward, the nozzle being fixed onto an upper wall of an air duct 106 that is in a horizontal state; an eye drop container pressing mechanism 108 that presses a prescribed position of a side surface of the eye drop container 106 mounted on the eye drop container fixing attachment 105; and a trigger arm 107 that controls an operation of the eye drop container pressing mechanism 108. Due to this configuration, there is no need for a patient to direct their gaze upward when applying the chemical solution in the eye drop container 106, and an appropriate amount of the chemical solution can be applied while the patient is in a comfortable horizontal attitude.

Description

点眼補助具eye drop aid
 本発明は、患者眼の角膜上に、点眼容器内の薬液を点眼する点眼補助具に関する。 The present invention relates to an eye drop aid for instilling a medical solution in an eye drop container onto the cornea of a patient's eye.
 多くの眼疾患において、治療の第一選択は薬液を角膜表面へ点眼することによりなされ、定期的に所定量を継続して点眼することが有効な治療につながる。 For many eye diseases, the first choice of treatment is to instill a medicinal solution onto the corneal surface, and continuous instillation of a prescribed amount on a regular basis leads to effective treatment.
 通常の点眼は、薬液が入った点眼容器より患者が上向きの姿勢で一滴の薬液を角膜上に滴下することにより行われる。 Ordinary eye drops are performed by placing a drop of medicine on the cornea from an eyedropper containing the medicine while the patient is in an upward position.
 しかしながら、薬液を確実に一滴だけ角膜上の適正な位置に滴下することは、健常な成人であっても失敗することがあり、高齢者や障害者にとってはさらに難しい作業で負担となっている。また点眼剤は1剤とは限らず3剤、4剤点眼する場合も少なくなく、患者の点眼は煩雑なものとなっている。 However, even healthy adults sometimes fail to ensure that only one drop of the drug solution is placed in the correct position on the cornea, making the task even more difficult and burdensome for the elderly and people with disabilities. In addition, eye drops are not limited to one drug, but often three or four drugs are instilled into the eyes, making it complicated for patients to administer the eye drops.
 さらに点眼は患者にとって煩雑な作業であるにもかかわらず、長期間にわたって毎日定時に点眼を継続しなければならないため、途中で点眼を諦めて治療から脱落してしまうと言ったような、患者が治療に積極的に参加する意志(アドヒアランス)が維持できなくなっている事例も多くなっている。 Furthermore, although eye drops are a tedious task for patients, they have to continue using them at a fixed time every day for a long period of time, which can lead to patients giving up and dropping out of treatment. There are many cases where patients are unable to maintain their will to actively participate in treatment (adherence).
 このような問題を解決するために点眼作業における滴下位置や滴下量の安定性の課題を解決し、より簡単で確実に点眼を行うための点眼補助装置が開示されている。 In order to solve such problems, an eye-drop assisting device has been disclosed which solves the problem of stability of the drop position and drop amount during eye-dropping work and allows easier and more reliable eye-dropping.
 例えば、特許文献1及び特許文献2に記載の点眼補助具は点眼容器を患者の眼前の所定位置に安定して設置可能で、患者の目に対して斜め上方より点眼できるような構成が開示されている。 For example, the eye drop aid described in Patent Document 1 and Patent Document 2 discloses a configuration in which the eye drop container can be stably placed at a predetermined position in front of the patient's eyes, and the eye drop can be instilled into the patient's eyes from diagonally above. ing.
 特許文献3及び特許文献4に記載の点眼補助具は手動ポンプあるいは圧電マイクロポンプにより薬液を水平に吐出することにより、患者の視線が水平の状態で点眼が可能であり、一回の吐出量も一定に保たれる構成が開示されている。 The eye drop aids described in Patent Document 3 and Patent Document 4 discharge the medicinal solution horizontally using a manual pump or a piezoelectric micropump, so that the eye drop can be administered while the patient's line of sight is horizontal, and the amount of medicine dispensed at one time is also small. A configuration is disclosed that remains constant.
 特許文献5に記載の滴生成デバイスは薬液を霧状の微小粒子にして水平に吐出することにより、患者の視線が水平の状態で定量点眼可能となる構成が開示されている。 The droplet generating device described in Patent Document 5 discloses a configuration in which a medicinal solution is turned into atomized microparticles and discharged horizontally, thereby making it possible to instill a fixed amount into the eyes while the patient's line of sight is horizontal.
 特許文献6にはWiFiなどの無線通信機能により、点眼補助具のセンサーなどから得られた点眼データを外部のスマートフォンなどに送り、インターネットを通じて医師や患者本人が点眼履歴などを確認できるモニタリングシステムが開示されている。 Patent Document 6 discloses a monitoring system that uses a wireless communication function such as WiFi to send eye drop data obtained from a sensor of an eye drop aid to an external smartphone, etc., and allows doctors and patients themselves to check eye drop history etc. via the Internet. has been done.
特開2020-81321JP2020-81321 特開2019-118760JP2019-118760 特開2016-202584JP2016-202584 特開2018-196534JP2018-196534 特開2016-154868JP2016-154868 WO2019-176902WO2019-176902
 しかしながら、上記従来技術においては未だ多くの問題がある。例えば、特許文献1及び特許文献2に開示されている構成においては、点眼液は目の上方より落下するため患者は斜め上方を向かねばならず、首への負担はなくならない。さらに点眼量も患者の操作により決まり安定しないという課題がある。 However, there are still many problems with the above conventional technology. For example, in the configurations disclosed in Patent Document 1 and Patent Document 2, the eye drops fall from above the eyes, forcing the patient to face diagonally upward, which does not eliminate the burden on the neck. Furthermore, there is a problem that the amount of instillation is determined by the patient's operation and is not stable.
 特許文献3及び特許文献4に開示されている構成においては、特許文献3の場合は薬液を一旦補助具内の所定の位置に保持したのちに吐出する、また特許文献4の場合は吐出ポンプへ薬液を導入するために点眼容器内にチューブを挿入し、さらに薬液はマイクロポンプへと送られマイクロポンプにより吐出される。そのため何れの構成においても薬液は補助具内の部品に接触して汚染される可能性があり、さらに複数剤の点眼薬を使う場合は点眼容器の交換・セッティングにも時間がかかる作業となる課題がある。 In the configurations disclosed in Patent Document 3 and Patent Document 4, in the case of Patent Document 3, the medicinal liquid is once held at a predetermined position within the auxiliary device and then discharged, and in the case of Patent Document 4, it is delivered to a discharge pump. A tube is inserted into the eye drop container to introduce the drug solution, and the drug solution is further sent to a micropump and discharged by the micropump. Therefore, in any configuration, there is a possibility that the drug solution may come into contact with parts in the auxiliary device and be contaminated, and when using multiple eye drops, changing and setting up the eye drop containers also becomes a time-consuming task. There is.
 特許文献5に開示されている構成においては、薬液は点眼装置内のタンクハウジングに貯蔵しなければならず、通常の点眼容器をそのまま使うことはできない。またタンクハウジングや圧電エジェクターに薬液が接触するため、薬液が汚染される可能性がある。さらに複数剤の点眼薬を使う場合は、それぞれにこの滴生成デバイスが必要となりコストの面でも負担となるなどの課題がある。 In the configuration disclosed in Patent Document 5, the medical solution must be stored in a tank housing within the eye drop device, and a normal eye drop container cannot be used as is. Furthermore, since the chemical liquid comes into contact with the tank housing and the piezoelectric ejector, there is a possibility that the chemical liquid may be contaminated. Furthermore, when using multiple eye drops, this droplet generation device is required for each, which poses a problem in terms of cost.
 特許文献6に開示されている構成においては、医師や患者による点眼履歴確認や点眼忘れに対する注意喚起などのモニタリングシステムが開示されているが、患者の点眼継続意識(アドヒアランス)を維持あるいは向上させるような、患者へのサポート手段は開示されておらず、どのように患者をサポートしてアドヒアランスを向上させるかという課題がある。 The configuration disclosed in Patent Document 6 discloses a monitoring system that allows doctors and patients to check the history of eye drops and alert them to forgetting to use the eye drops. However, no means of supporting patients is disclosed, and there is a problem of how to support patients and improve adherence.
 本発明は上記課題に鑑みてなされ、点眼容器内の薬液を点眼する際に、患者が視線を上に向ける必要性がなく、横向きの楽な姿勢で適正量の薬液の点眼ができる点眼補助具を提供することを目的とする。 The present invention has been made in view of the above-mentioned problems, and is an eye drop aid that does not require the patient to look up when instilling the drug solution in the eye drop container, and allows the patient to instill an appropriate amount of the drug solution into the eye in a comfortable horizontal position. The purpose is to provide
 上記目的を達成するために本発明は、患者眼に点眼容器内の薬液を投与するための点眼補助具であって、エアファンと、前記エアファンより吐出された空気流の空気室となるエアチャンバーと、前記エアチャンバーと連通された筒形状のエアダクトと、前記点眼容器が交換可能に装着されると共に、水平状態にした前記エアダクトの上側壁に前記点眼容器のノズルを下向きにして固定する点眼容器固定アタッチメントと、前記点眼容器固定アタッチメントに装着された前記点眼容器の側面の所定位置を押圧する点眼容器押圧機構と、前記点眼容器押圧機構の動作を制御するトリガアームと、を備え、前記筒形状のエアダクトの開口の一端側は前記エアファンより吐出された空気流が前記エアチャンバーを介して流入する流入口となる一方、当該開口の他端側は患者の眼瞼周囲が当接する接眼口となり、前記エアダクトの上側壁には、前記点眼容器固定アタッチメントに装着された前記点眼容器のノズルより滴下された薬液滴下粒を前記エアダクト内に導入するための薬液導入孔が形成されることを特徴とする。 In order to achieve the above object, the present invention provides an eye drop aid for administering a medical solution in an eye drop container to a patient's eye, which includes an air fan and an air chamber that serves as an air chamber for the air flow discharged from the air fan. An eye drop in which a chamber, a cylindrical air duct communicating with the air chamber, and the eye drop container are replaceably attached, and the nozzle of the eye drop container is fixed to the upper wall of the air duct in a horizontal state with the nozzle facing downward. The tube includes a container fixing attachment, an eye drop container pressing mechanism that presses a predetermined position on the side surface of the eye drop container attached to the eye drop container fixing attachment, and a trigger arm that controls the operation of the eye drop container pressing mechanism. One end side of the opening of the shaped air duct serves as an inlet through which the air flow discharged from the air fan flows through the air chamber, while the other end side of the opening serves as an eyepiece opening with which the patient's eyelid periphery comes into contact. , a liquid medicine introduction hole is formed in the upper wall of the air duct for introducing into the air duct the liquid drops dropped from the nozzle of the eye drop container attached to the eye drop container fixing attachment. do.
 この点眼補助具において、さらに、患者が前記点眼容器内の薬剤を投与する際に、前記エアダクトを水平状態、又は前記接眼口が前記流入口より高くなる傾斜状態に操作するための操作手段を備えることが好ましい。 This eye drop aid further includes an operating means for operating the air duct into a horizontal state or into an inclined state where the eyepiece port is higher than the inlet port when the patient administers the drug in the eye drop container. It is preferable.
 これらの構成により、空気流により水平方向に移動せしめた薬液の滴下粒は、慣性によりそのまま水平方向に移動し接眼口を通過して角膜に到達できる。また、エアダクトは水平あるいはエアダクト端の流入口側より他端の接眼口側がやや上方となるように、水平を0度とするとエアダクトの角度は水平0度から20度斜め上方の間で配置され、エアファン、エアダクト、アイピースの適切な配置を考慮して角度を決めることができる。 With these configurations, the drops of the drug solution that are moved horizontally by the airflow can move horizontally due to inertia, pass through the eyepiece port, and reach the cornea. In addition, the air duct is arranged horizontally or so that the eyepiece side at the other end is slightly above the inlet side at the end of the air duct, and if the horizontal is 0 degrees, the angle of the air duct is arranged between 0 degrees horizontally and 20 degrees diagonally upward. The angle can be determined by considering the appropriate placement of the air fan, air duct, and eyepiece.
 この点眼補助具において、エアダクトの前記接眼口近傍の側壁には、少なくとも1以上の空気流の排気口が形成されることが好ましい。 In this eye drop aid, it is preferable that at least one airflow exhaust port is formed in the side wall of the air duct near the eyepiece port.
 この点眼補助具において、前記点眼補助具は、さらに、前記エアダクトは開口高さを10mm以上25mm以下、前記点眼容器の薬液滴下口から前記接眼口までの水平距離を20mm以上50mm以下とした場合、前記エアダクト内に前記点眼容器の薬液滴下口から滴下された薬液滴下粒を水平方向に移動させるために必要な前記エアダクト内の空気流の当該薬液滴下粒に対する相対流速を下記(数1)により計算し、且つ得られた当該相対流速に基づいて前記エアダクト内の流速が10m/sec以上40m/sec以下となるように前記エアファンを制御するエアファン制御手段を備えることが好ましい。
 [数1]
 ここで、U:エアダクト内の空気流の流速と薬液の滴下粒との相対速度、L:点眼容器の滴下口からエアダクト接眼口の中心(角膜)までの水平距離、H:点眼容器の滴下口からエアダクト接眼口の中心(角膜)までの垂直距離(滴下口と接眼口中心の高さの差)、m:薬液滴下粒の質量、ρ:空気の密度、d:薬液滴下粒の直径
In this eye drop aid, the eye drop aid further includes: the air duct has an opening height of 10 mm or more and 25 mm or less, and a horizontal distance from the drug solution dripping port of the eye drop container to the eyepiece port of 20 mm or more and 50 mm or less; Calculate the relative flow velocity of the air flow in the air duct with respect to the drug droplet, which is necessary to horizontally move the drug droplet dropped from the drug droplet of the eye drop container into the air duct, using the following (Equation 1). Further, it is preferable to include an air fan control means for controlling the air fan so that the flow velocity in the air duct is 10 m/sec or more and 40 m/sec or less based on the obtained relative flow velocity.
[Number 1]
Here, U: relative velocity between the flow rate of the air flow in the air duct and the droplet of the drug solution, L: horizontal distance from the droplet of the eye dropper to the center (cornea) of the air duct eyepiece, H: droplet of the eyedropper Vertical distance from to the center of the air duct eyepiece (cornea) (difference in height between the droplet and the center of the eyepiece), m: mass of the droplet of the drug solution, ρ: density of air, d: diameter of the droplet of the drug solution
 この点眼補助具において、前記点眼容器固定アタッチメントは、前記点眼容器を下向きで装着可能なセットプレートと、前記点眼容器の押圧位置を調整する押圧位置調整機構と、を備え、前記セットプレートの内側面には、前記点眼容器の側面を押圧支持する支持ガイドが配置され、前記セットプレートの下端は、前記エアダクトの外側壁に形成されたセットガイド溝に着脱可能に嵌合され、前記セットプレートの下側領域には、前記点眼容器が装着された状態において、前記点眼容器のキャップを開閉可能とする開放空間が設けられることが好ましい。 In this eye drop aid, the eye drop container fixing attachment includes a set plate on which the eye drop container can be attached facing downward, and a pressing position adjustment mechanism that adjusts the pressing position of the eye drop container, and the inner surface of the set plate. A support guide is arranged to press and support the side surface of the eye drop container, and the lower end of the set plate is removably fitted into a set guide groove formed on the outer wall of the air duct, and the lower end of the set plate It is preferable that the side region is provided with an open space that allows the cap of the eye drop container to be opened and closed when the eye drop container is attached.
 この構成により、点眼容器固定アタッチメントはエアダクトの流入口と排気口の間の流路上でエアダクトの上面に配置され、点眼容器のノズルがエアダクト上面に設けられた薬液導入孔に挿入され、点眼ノズル先端の点眼口がエアダクトの内側上面付近となるように点眼容器が固定されるよう、点眼容器は点眼容器固定アタッチメントに装着され、点眼容器固定アタッチメントの下部に備えられたセットプレートを該エアダクトに備えられた固定ガイドに差し込む等の簡単に固定できる着脱機構を持つことができる。 With this configuration, the eye drop container fixing attachment is placed on the upper surface of the air duct on the flow path between the air duct inlet and outlet, and the nozzle of the eye drop container is inserted into the drug solution introduction hole provided on the upper surface of the air duct, and the eye drop container fixing attachment is placed on the upper surface of the air duct on the flow path between the air duct inlet and outlet. The eye drop container is attached to the eye drop container fixing attachment so that the eye drop container is fixed such that the eye drop opening is near the inner upper surface of the air duct, and the air duct is provided with a set plate provided at the lower part of the eye drop container fixing attachment. It is possible to have an attachment/detachment mechanism that allows easy fixation, such as by inserting it into a fixed guide.
 この点眼補助具において、前記点眼容器押圧機構は、前記トリガアームの回転軸となるトリガアーム回転軸と、前記トリガアームと連接されて、前記トリガアームが引かれると前記トリガアーム回転軸を介して側方から前記点眼容器を押圧する方向に作用する押圧ロッドと、を備えることが好ましい。 In this eye drop aid, the eye drop container pressing mechanism is connected to a trigger arm rotation axis that is a rotation axis of the trigger arm, and is connected to the trigger arm so that when the trigger arm is pulled, the eye drop container pressing mechanism It is preferable to include a pressing rod that acts in a direction to press the eye drop container from the side.
 この点眼補助具において、前記点眼容器押圧機構は、前記トリガアームと連動して電気駆動により駆動される電動駆動手段と、前記トリガアームが引かれると前記電動駆動手段を用いて側方から前記点眼容器を押圧する方向に作用する押圧ロッドと、を備えることが好ましい。 In this eye drop aid, the eye drop container pressing mechanism includes an electric drive means that is electrically driven in conjunction with the trigger arm, and when the trigger arm is pulled, the eye drop container is pressed from the side using the electric drive means. It is preferable to include a pressing rod that acts in a direction to press the container.
 これらの構成により、点眼容器の一部を押圧する押圧機構は、点眼容器固定アタッチメントの側面に対向するように配置され、点眼容器固定アタッチメントの所定位置に固定された点眼容器の側面を直接押圧してもよいが、押圧位置を適切にするためには点眼容器固定アタッチメントに備えられた押圧位置調整機構を介して押圧する。点眼容器の側面あるいは点眼容器固定アタッチメントの押圧位置調整機構を押圧するために押圧ロッドあるいは押圧カムが備えられる。押圧ロッドはトリガアームと一体とするかリンク機構などにより駆動する。押圧カムは前記トリガアームに連動するギアやリンクなどによりトリガアームの動きをカムの回転運動に変換し駆動するか、あるいは押圧ロッドや押圧カムを電磁アクチュエータやモーターなどで駆動することができる。 With these configurations, the pressing mechanism that presses a part of the eye drop container is arranged to face the side surface of the eye drop container fixing attachment, and directly presses the side surface of the eye drop container fixed at a predetermined position of the eye drop container fixing attachment. However, in order to make the pressing position appropriate, the eye drop container is pressed via a pressing position adjustment mechanism provided in the eye drop container fixing attachment. A pressing rod or a pressing cam is provided to press the side of the eye drop container or the pressing position adjustment mechanism of the eye drop container fixing attachment. The pressing rod is either integrated with the trigger arm or driven by a link mechanism. The pressing cam can be driven by converting the movement of the trigger arm into rotational movement of the cam using a gear or link that interlocks with the trigger arm, or the pressing rod or pressing cam can be driven by an electromagnetic actuator, a motor, or the like.
 この点眼補助具において、前記点眼補助具は、さらに、前記エアダクトの前記流入口付近に配置された空気流の流入コントロール弁と、前記トリガアームと連動する前記点眼容器押圧機構が押圧範囲の最大押圧位置近傍に達したときに前記流入コントロール弁を開く一方、前記トリガアームを開放すると前記流入コントロール弁を閉じる弁駆動機構と、を備えることが好ましい。 In this eye drop aid, the eye drop aid further includes an air flow inflow control valve disposed near the inlet of the air duct, and the eye drop container pressing mechanism interlocked with the trigger arm to apply a maximum pressure within a pressing range. It is preferable to include a valve driving mechanism that opens the inflow control valve when the inflow control valve reaches a position near the position, and closes the inflow control valve when the trigger arm is released.
 この構成のように、エアチャンバーとエアダクトの薬液導入孔の間には空気流の流入をコントロールする流入コントロール弁を配してもよい。流入コントロール弁は弁を閉じると不必要なエアの流入を止めると共に、エアチャンバー内の空気圧を上昇させることが可能で、一時的に空気圧を高圧にするプレナムエアチャンバーとして機能させることができる。流入コントロー弁が開いた際にはプレナムエアチャンバー内の気圧が高くなっているので、空気流は一時的に高い流速で流入するが、所定時間後には定常流速となり、この一時的に高い流速により前記薬液の初期水平加速度を高めることが可能で、風量の少ないエアファンであっても最大静圧が高ければ、流入コントロール弁を開いた直後にエアダクト内の流速は短時間に上昇して薬液の滴下粒を加速させ、確実に薬液を患者眼の角膜に到達させる効果を有する。 As in this configuration, an inflow control valve may be arranged between the air chamber and the chemical liquid introduction hole of the air duct to control the inflow of air flow. When the inflow control valve is closed, it can stop unnecessary air from flowing in and increase the air pressure inside the air chamber, allowing it to function as a plenum air chamber that temporarily increases the air pressure. When the inflow control valve opens, the air pressure inside the plenum air chamber is high, so the airflow temporarily flows in at a high flow rate, but after a predetermined time, the flow rate becomes steady, and this temporarily high flow rate causes the air flow to flow in at a high flow rate. It is possible to increase the initial horizontal acceleration of the chemical solution, and if the maximum static pressure is high even with an air fan with a low air volume, the flow velocity in the air duct will increase in a short time immediately after opening the inflow control valve, increasing the flow rate of the chemical solution. It has the effect of accelerating the droplets and ensuring that the drug solution reaches the cornea of the patient's eye.
 また、この構成により、流入コントロール弁はトリガアームの動きと連係して開閉される。トリガアームを引くと、その動きに連係して点眼容器を押圧する前記押圧機構及び前記薬液滴下機構により、点眼容器から薬液が一滴の滴下粒として吐出されるタイミングに合わせて流入コントロール弁を開き、瞬間的に高速となった空気流により薬液は落下しながら水平方向に加速される。水平方向の加速度が落下加速度に比べ十分に早い場合、薬液はエアダクト内を略水平に移動しエアダクトの接眼口を通過し患者眼角膜に達する。トリガアームをもとの位置に戻すと流入コントロール弁は閉じられ空気の流入は止まり、不必要な空気の流入もなくなり好ましい。 Furthermore, with this configuration, the inflow control valve is opened and closed in conjunction with the movement of the trigger arm. When the trigger arm is pulled, the pressing mechanism that presses the eye drop container in conjunction with the movement and the drug solution dripping mechanism open the inflow control valve in synchronization with the timing at which the drug solution is discharged as a droplet from the eye drop container; The instantaneous high-speed airflow accelerates the chemical liquid in the horizontal direction as it falls. If the horizontal acceleration is sufficiently faster than the falling acceleration, the medical solution moves approximately horizontally within the air duct, passes through the eyepiece port of the air duct, and reaches the cornea of the patient's eye. When the trigger arm is returned to its original position, the inflow control valve is closed and the inflow of air is stopped, which is preferable because unnecessary air inflow is also eliminated.
 この点眼補助具において、前記点眼補助具は、さらに、有線/無線ネットワークを介して外部端末にデータを送信可能な通信手段を備えることが好ましい。 In this eye drop aid, it is preferable that the eye drop aid further include communication means capable of transmitting data to an external terminal via a wired/wireless network.
 上記目的を達成するために本発明は、患者眼に点眼容器内の薬液を投与するための点眼補助具であって、エアファンと、前記エアファンと連通して前記エアファンより吐出された空気流が流れる筒形状のエアダクトと、前記点眼容器が交換可能に装着されると共に、水平状態にした前記エアダクトの上側壁に前記点眼容器のノズルを下向きにして固定する点眼容器固定アタッチメントと、前記点眼容器固定アタッチメントに装着された前記点眼容器の側面の所定位置を押圧する点眼容器押圧機構と、前記点眼容器押圧機構の動作を制御するトリガアームと、を備え、前記筒形状のエアダクトの開口の一端側は前記エアファンより吐出された空気流が流入する流入口となる一方、当該開口の他端側は患者の眼瞼周囲が当接する接眼口となり、前記エアダクトの上側壁には、前記点眼容器固定アタッチメントに装着された前記点眼容器のノズルより滴下された薬液滴下粒を前記エアダクト内に導入するための薬液導入孔が形成されることを特徴とする。 In order to achieve the above object, the present invention provides an eye drop aid for administering a medical solution in an eye drop container to a patient's eye, which comprises an air fan and an air discharged from the air fan in communication with the air fan. a cylindrical air duct through which the air flows; an eye drop container fixing attachment to which the eye drop container is replaceably attached and fixed to the upper wall of the air duct in a horizontal state with the nozzle of the eye drop container facing downward; an eye drop container pressing mechanism that presses a predetermined position on a side surface of the eye drop container attached to a container fixing attachment; and a trigger arm that controls the operation of the eye drop container pressing mechanism; one end of the opening of the cylindrical air duct; The side of the air duct serves as an inlet for the airflow discharged from the air fan, while the other end of the opening serves as an eyepiece opening into which the patient's eyelids come into contact. The eye dropper is characterized in that a drug solution introduction hole is formed for introducing the drug solution drops dropped from the nozzle of the eye drop container attached to the attachment into the air duct.
 上記目的を達成するために本発明は点眼器であって、上記記載の点眼補助具と、点眼容器と、を備えることを特徴とする。 In order to achieve the above object, the present invention is an eye dropper, which is characterized by comprising the eye drop aid described above and an eye drop container.
 本発明に係る点眼補助具は、エアファンと、エアファンより吐出された空気流の空気室となるエアチャンバーと、エアチャンバーと連通された筒形状のエアダクトと、点眼容器が交換可能に装着されると共に水平状態にしたエアダクトの上側壁に点眼容器のノズルを下向きにして固定する点眼容器固定アタッチメントと、点眼容器固定アタッチメントに装着された点眼容器の側面の所定位置を押圧する点眼容器押圧機構と、点眼容器押圧機構の動作を制御するトリガアームと、を備える。エアダクトの上側壁には、点眼容器固定アタッチメントに装着された点眼容器のノズルより滴下された薬液滴下粒をエアダクト内に導入するための薬液導入孔が形成される。この構成により、本発明に係る点眼補助具を利用する患者は点眼容器内の薬液を点眼する際に、視線を上に向ける必要性がなく、横向きの楽な姿勢で適正量の薬液の点眼ができる。 The eye drop aid according to the present invention includes an air fan, an air chamber serving as an air chamber for the air flow discharged from the air fan, a cylindrical air duct communicating with the air chamber, and an eye drop container that are replaceably attached. an eye drop container fixing attachment that fixes the eye drop container with the nozzle facing downward to the upper wall of the air duct in a horizontal state; and an eye drop container pressing mechanism that presses a predetermined position on the side surface of the eye drop container attached to the eye drop container fixing attachment. , and a trigger arm that controls the operation of the eye drop container pressing mechanism. A drug solution introduction hole is formed in the upper wall of the air duct for introducing into the air duct the drug solution drops dropped from the nozzle of the eye drop container attached to the eye drop container fixing attachment. With this configuration, a patient using the eye drop aid according to the present invention does not need to look upward when instilling the drug solution in the eye drop container, and can instill an appropriate amount of drug solution into the eye in a comfortable horizontal position. can.
本発明の実施の形態1に係る点眼補助具を備える点眼器の使用状態を示す斜視図である。FIG. 1 is a perspective view showing a state in which an eyedropper including an eyedropper aid according to Embodiment 1 of the present invention is used. 同上点眼器の断面図である。It is a sectional view of the eyedropper same as the above. ファンの風量―静圧特性グラフの一例を示す図である。FIG. 3 is a diagram showing an example of a fan air volume vs. static pressure characteristic graph. 点眼容器の一例を示す図である。It is a figure showing an example of an eye drop container. (a)同上点眼補助具に備わる点眼容器固定アタッチメントのB-B´線断面図、(b)同上点眼容器固定アタッチメントのA-A´線断面図である。(a) A cross-sectional view taken along the line BB' of the eye drop container fixing attachment provided in the eye drop aid as above, and (b) a cross-sectional view taken along the line AA' of the eye drop container fixing attachment same as the above. (a)同上点眼容器固定アタッチメントを外した状態の点眼補助具の側面図、(b)同上点眼容器固定アタッチメントを外した状態の点眼補助具の斜視図である。(a) A side view of the eye drop aid with the above eye drop container fixing attachment removed, and (b) a perspective view of the eye drop aid with the same eye drop container fixing attachment removed. (a)同上点眼容器を手動で押圧する押圧機構の一例を示す外観図、(b)同上点眼容器を手動で押圧する押圧機構の一例を示す断面図である。(a) An external view showing an example of a pressing mechanism for manually pressing the same eye drop container as above, and (b) a sectional view showing an example of a pressing mechanism for manually pressing the eye drop container same as above. 同上点眼容器を電動で押圧する押圧機構の一例を示す図である。It is a figure which shows an example of the press mechanism which presses an eyedrops same as the above container electrically. 同上点眼補助具に備わるエアファンの動作を説明するための図である。It is a figure for demonstrating the operation|movement of the air fan with which the eye drop aid same as the above is equipped. (a)乃至(c)同上点眼補助具に備わるエアダクトへの空気の流入を手動でコントロールする流入コントロール弁の一例を示す図である。(a) thru|or (c) It is a figure which shows an example of the inflow control valve which manually controls the inflow of the air into the air duct with which the eyedrops aid same as the above is equipped. (a)及び(b)同上点眼補助具に備わるエアダクトへの空気の流入を電動でコントロールする流入コントロール弁の一例を示す図である。(a) and (b) It is a figure which shows an example of the inflow control valve which electrically controls the inflow of the air into the air duct with which the eyedrops aid same as the above is equipped. (a)乃至(c)同上点眼補助具に備わる左右眼検出手段の一例を示す図である。(a) thru|or (c) It is a figure which shows an example of the left-right eye detection means with which the eye-drop aid same as the above is equipped. 同上点眼補助具の機能ブロック図である。It is a functional block diagram of the same eyedrops aid as above. 本発明の実施の形態1の変形例に係る点眼器の断面図である。It is a sectional view of the eye dropper concerning the modification of Embodiment 1 of the present invention. 本発明の実施の形態2に係る点眼補助具と接続される外部通信手段及びネットワークシステムの一例を示す構成図である。It is a block diagram which shows an example of the external communication means and network system connected with the eye drop aid based on Embodiment 2 of this invention. 外部装置による患者サポートシステムの一例を示す構成図である。FIG. 2 is a configuration diagram showing an example of a patient support system using an external device. ネットワークシステムを介した患者サポートシステムの一例を示す構成図である。1 is a configuration diagram showing an example of a patient support system via a network system. 患者サポートソフトウェアの動作の一例を示すフローチャートである。3 is a flowchart illustrating an example of the operation of patient support software. 点眼指示画面の一例を示す図である。It is a figure showing an example of an eye drop instruction screen. 激励メッセージの表示画面の一例を示す図である。It is a figure which shows an example of the display screen of an encouragement message. 検査結果とスコア、各種イベントとの関係を表すグラフの一例を示す図である。It is a figure which shows an example of the graph showing the relationship between a test result, a score, and various events.
(実施の形態1)
 本発明の実施の形態1に係る点眼補助具について図1乃至図13を参照して説明する。本実施の形態1において、点眼補助具は、眼疾患などの治療のために患者に点眼する点眼薬液の滴下粒を、水平又は水平に対し20度以内の斜め上方に流れる空気流の中に滴下して、その空気流の抗力により点眼薬液の滴下粒を略水平に移動させて患者の眼に送達させるものである。
(Embodiment 1)
An eye drop aid according to Embodiment 1 of the present invention will be described with reference to FIGS. 1 to 13. In the first embodiment, the eye drop aid drops droplets of eye drops to be instilled into the eyes of a patient for the treatment of eye diseases, etc., into an air stream flowing horizontally or diagonally upward within 20 degrees to the horizontal. Then, the droplets of the eye drops are moved approximately horizontally by the drag force of the air flow and delivered to the patient's eyes.
 ここでは下記の順序に従って本発明の実施の形態1について説明する。
 (1)点眼容器より滴下された点眼薬液を患者眼へ水平方向に送達させる薬液送達手段の基本的な構成
 (2)点眼容器固定アタッチメントの構成
 (3)点眼容器押圧機構の構成
 (4)エアファンによる空気流発生手段の構成と動作
 (5)エアダクト内へのエア流入をコントロールする弁の構成と動作
 (6)患者の左眼・右眼自動検出
 (7)点眼補助具の電気システムの構成(点眼補助具の機能ブロック図)
Here, Embodiment 1 of the present invention will be described in the following order.
(1) Basic structure of the drug delivery means that horizontally delivers the eye drops dropped from the eye drop container to the patient's eye (2) Structure of the eye drop container fixing attachment (3) Structure of the eye drop container pressing mechanism (4) Air (5) Configuration and operation of the valve that controls air flow into the air duct (6) Automatic detection of the patient's left and right eyes (7) Configuration and electrical system of the eye drop aid (Functional block diagram of eye drop aid)
 (1)点眼容器より滴下された点眼薬液を患者眼へ水平方向に送達させる薬液送達手段の基本的な構成
 最初に、点眼容器より滴下された点眼薬液を患者眼へ水平方向に送達させる薬液送達手段の基本的な構成を図1乃至図3を参照して説明する。なお、本実施の形態1において、点眼補助具100に点眼容器106を装着した状態を点眼器1、点眼器1から点眼容器106を取り外した状態を点眼補助具100と称して説明を行う。
(1) Basic configuration of a drug solution delivery means that horizontally delivers the eye drops dropped from the eye drop container to the patient's eye First, drug solution delivery that delivers the eye drops dropped from the eye drop container horizontally to the patient's eye The basic structure of the means will be explained with reference to FIGS. 1 to 3. In the first embodiment, a state in which the eye drop container 106 is attached to the eye drop aid 100 will be referred to as the eye dropper 1, and a state in which the eye drop container 106 is removed from the eye drop aid 1 will be referred to as the eye drop aid 100.
 図1は、本実施の形態1に係る点眼器1の使用時の斜視図を示し、患者は点眼時には点眼補助具100に備わるグリップ109を左右何れか一方の手で握り、点眼補助具100を略水平状態に保つ。次に、トリガアーム107を指で押下して自らのタイミングで患者眼に点眼容器内の薬液の投与を行う。 FIG. 1 shows a perspective view of the eyedropper 1 according to the first embodiment in use. When instilling the eye, the patient grasps the grip 109 provided on the eyedropper aid 100 with either the left or right hand and holds the eyedropper 100. Keep it almost horizontal. Next, by pressing the trigger arm 107 with a finger, the medical solution in the eye drop container is administered to the patient's eye at the patient's own timing.
 図2は本実施の形態1に係る点眼器1の断面図であり、空気流の発生から薬液の滴下、そして薬液を空気流による抗力と重力の合成力により移動して、患者の角膜表面に到達させる基本的な構成の一例を示している。 FIG. 2 is a cross-sectional view of the eyedropper 1 according to the first embodiment, in which the drug solution is dropped from the generation of airflow, and the drug solution is moved by the combined force of the drag force caused by the airflow and gravity to reach the corneal surface of the patient. An example of the basic configuration to be achieved is shown.
 図2のエアファン101はモーターにより駆動されるファンであり、その送風口101aより送風された空気流はエアチャンバー102に流入し、エアチャンバー102の流出口102aよりエアダクト104の流入口104aへ流入した空気流はエアダクト104の流入口104aとは反対側の接眼口104dの近傍に配された排気口104bより上方及び側方に排出される。エアチャンバー102とエアダクト104の間には空気流を開閉コントロールするための流入コントロール弁103が配置されている。さらにエアダクト104の流入口104aと排気口104bの間のエアダクト104の上面には点眼容器106より滴下された薬液滴下粒をエアダクト104内に導入するための薬液導入孔104cが形成されている。この薬液導入孔104cに点眼容器固定アタッチメント105を接続して、点眼容器固定アタッチメント105には点眼容器106が点眼容器106の薬液滴下口106aが下側となるように固定され、薬液滴下口106aはエアダクト104の薬液導入孔104c付近となるように配置される。点眼口104dの上部には滴下粒通過センサーを配置してもよく、エアダクト104を水平に移動してきた薬液滴下粒が正常に点眼口104dを通過したかを検出できる。また患者はアイピース110、エアダクト104を通し、ハーフミラー117を介して固視標LED116を見ることにより、患者眼を固視させてもよい。カメラ111が赤外光による撮影の場合はハーフミラー117をコールドミラーとしてもよい。なお、エアファン101はモーターによりファンを回転させる手段に限定されるものではなくその他の送風手段でも良い。 The air fan 101 in FIG. 2 is a fan driven by a motor, and the air flow blown from the air outlet 101a flows into the air chamber 102, and then flows from the outlet 102a of the air chamber 102 to the inlet 104a of the air duct 104. The airflow is discharged upward and laterally from an exhaust port 104b arranged near the eyepiece port 104d on the opposite side of the air duct 104 from the inflow port 104a. An inflow control valve 103 is arranged between the air chamber 102 and the air duct 104 to control opening and closing of air flow. Further, a liquid medicine introduction hole 104c is formed on the upper surface of the air duct 104 between the inlet port 104a and the exhaust port 104b of the air duct 104, for introducing the liquid droplets dropped from the eye drop container 106 into the air duct 104. The eye drop container fixing attachment 105 is connected to the drug solution introduction hole 104c, and the eye drop container 106 is fixed to the eye drop container fixing attachment 105 so that the drug solution dripping port 106a of the eye drop container 106 is on the lower side. It is arranged near the chemical liquid introduction hole 104c of the air duct 104. A droplet passage sensor may be placed above the eyedropper 104d, and can detect whether the droplet of the drug solution that has moved horizontally through the air duct 104 has normally passed through the eyedropper 104d. Further, the patient may fixate the patient's eyes by looking at the fixation target LED 116 through the eyepiece 110 and the air duct 104 and the half mirror 117. When the camera 111 takes pictures using infrared light, the half mirror 117 may be a cold mirror. Note that the air fan 101 is not limited to a means for rotating a fan by a motor, and may be any other means for blowing air.
 エアチャンバー102の体積はプレナムエアチャンバーとして機能させるための十分な容積を確保したエアチャンバー102であり、短時間にエアチャンバー102内の気圧を所定の値まで上昇させることを考慮し、取り扱い上も問題のない体積として5×10-5から40×10-5の範囲でエアファン101の能力を考慮して調整することが好ましい。 The air chamber 102 has a sufficient volume to function as a plenum air chamber, and the air chamber 102 has a sufficient volume to function as a plenum air chamber. It is preferable to adjust the volume in consideration of the capacity of the air fan 101 within a range of 5×10 −5 m 3 to 40×10 −5 m 3 as a volume that does not cause problems.
 エアファン101の送風性能は一般的に最大風量と最大静圧により示され送風抵抗がなく風圧が0の時の風量が最大風量であり、送風口が密閉されたような場合に風量が0となった時の空気圧が最大静圧である。エアファン101の特性は図3に示すように横軸を風量、縦軸を静圧に取ったグラフ上に、横軸上にある最大風量ポイント1501から縦軸上にある最大静圧ポイント1502を結ぶ曲線による風量-静圧特性(P-Q特性)として示される。 The air blowing performance of the air fan 101 is generally indicated by the maximum air volume and maximum static pressure.The air volume when there is no air resistance and the wind pressure is 0 is the maximum air volume, and when the air outlet is sealed, the air volume is 0. The air pressure at which this happens is the maximum static pressure. The characteristics of the air fan 101 are as shown in FIG. 3, on a graph where the horizontal axis is the air volume and the vertical axis is the static pressure, from the maximum air volume point 1501 on the horizontal axis to the maximum static pressure point 1502 on the vertical axis. It is shown as an air volume-static pressure characteristic (P-Q characteristic) by a connecting curve.
 ここで、エアダクト104内の空気流の流速計算に関して説明する。薬液滴下機構により滴下された薬液は重力により下方に加速すると共に、エアダクト104内の空気流により水平方向にも加速する。重力加速度は9.8m/secと一定であるので、薬液が水平方向へ飛ぶには、水平加速度が重力加速度より十分高い加速度であることが必要であり、エアダクト104内の空気流が作用して発生する抗力が薬液の滴下粒を重力加速度より十分高い加速度で水平に加速するように作用する必要がある。このような空気流により加速に必要な抗力を発生させるための空気流の流速は、薬液の滴下粒の直径と滴下粒に対する空気流の流速の相対速度より計算できる滴下粒のレイノルズ数より抵抗係数CDを算出し、抵抗係数CDと加速に必要な効力Fより計算して空気流の流速を求めることが好ましい。 Here, calculation of the flow velocity of the air flow within the air duct 104 will be explained. The chemical liquid dropped by the chemical liquid dropping mechanism is accelerated downward by gravity, and also accelerated in the horizontal direction by the air flow within the air duct 104. Since the gravitational acceleration is constant at 9.8 m/ sec2 , the horizontal acceleration must be sufficiently higher than the gravitational acceleration in order for the chemical solution to fly horizontally, and the airflow in the air duct 104 acts. It is necessary that the drag force generated by the droplet of the chemical liquid horizontally accelerates at an acceleration sufficiently higher than the acceleration of gravity. The flow rate of the air flow to generate the drag force necessary for acceleration by such an air flow is determined by the drag coefficient from the Reynolds number of the dropped particle, which can be calculated from the diameter of the dropped particle of the chemical solution and the relative velocity of the air flow to the dropped particle. It is preferable to calculate the flow velocity of the airflow by calculating CD and calculating from the resistance coefficient CD and the effect F required for acceleration.
 流体中の粒子が流体より受ける抗力の扱いは通常三つの領域に分かれている。流体と粒子の相対的速度が非常に小さく粒子径も小さい場合、つまりレイノルズ数が2以下の場合をストークス域として扱い、流体と粒子の相対速度が非常に高く粒子径もレイノルズ数が500から100000の場合をニュートン域として扱い、前記二つの領域の間にあるレイノルズ数が2から500の間をアレン域と呼ぶ。 The treatment of the drag force that particles in a fluid receive from the fluid is usually divided into three areas. When the relative velocity between the fluid and particles is very small and the particle size is small, that is, when the Reynolds number is 2 or less, it is treated as the Stokes region, and when the relative velocity between the fluid and particles is very high and the particle size is between 500 and 100,000, the Reynolds number is 2 or less. The case where the Reynolds number between the above two regions is between 2 and 500 is called the Allen region.
 前記三つの領域における粒子が流体より受ける抗力の抵抗係数CDは以下の[数2]~[数4]で表される。
 [数2]ストークス域
 [数3]アレン域
 [数4]ニュートン域
 ここで、CD:抵抗係数、Rep:レイノルズ数
The drag coefficient CD of the drag force exerted on the particles by the fluid in the three regions is expressed by the following [Equations 2] to [Equations 4].
[Math 2] Stokes range
[Math 3] Allen range
[Math 4] Newton range
Here, CD: drag coefficient, Rep: Reynolds number
 エアダクト104内を移動する前記薬液の滴下粒が、空気流により受ける抗力F及びレイノルズ数Repは下記[数5]及び[数6]であらわされる。
 [数5]
 ここで、F:粒子が受ける抗力、CD:抵抗係数、ρ:空気の密度1.2、U:流体と滴下粒の相対速度、Dp:滴下粒の直径
 [数6]
 ここで、Rep:レイノルズ数、U:流体と滴下粒の相対速度、Dp:滴下粒の直径、ρ:空気の密度1.2、μ:空気の粘性0.000018
The drag force F and Reynolds number Rep that the dropped particles of the chemical liquid moving in the air duct 104 receive from the air flow are expressed by the following [Equation 5] and [Equation 6].
[Number 5]
Here, F: drag force exerted on the particle, CD: drag coefficient, ρ: density of air 1.2, U: relative velocity between the fluid and the dropped particle, Dp: diameter of the dropped particle [Equation 6]
Here, Rep: Reynolds number, U: relative velocity between fluid and dropped particles, Dp: diameter of dropped particles, ρ: density of air 1.2, μ: viscosity of air 0.000018
 薬液の滴下粒を十分水平に加速する抗力を計算するには滴下粒を球と仮定した場合の直径と質量を求めなければならない。点眼容器106は点眼薬のメーカーより様々な形状が市販されているが、点眼容器106から滴下される一滴の薬液量は平均して約0.04mlが一般的である。球の体積の公式より逆算すると、その点眼容器106より滴下される一滴の滴下粒の直径は4.24mmとなる。仮に空気流と滴下粒の相対速度を2m/secとすると[数6]よりレイノルズ数は565.3となり、相対速度が2m/sec以上であればCDは[数4]に示されるニュートン域となる。この場合CDは0.44の一定値となるので[数5]より抗力FはF=1.49×10-5Nとなる。 In order to calculate the drag force that sufficiently horizontally accelerates a dropped droplet of chemical solution, it is necessary to find the diameter and mass of the dropped droplet assuming that it is a sphere. The eye drop container 106 is commercially available in various shapes from eye drop manufacturers, but the average volume of each drop of medicine dropped from the eye drop container 106 is generally about 0.04 ml. Calculating backwards from the formula for the volume of a sphere, the diameter of one droplet dropped from the eye drop container 106 is 4.24 mm. If the relative velocity between the air flow and the dropped particles is 2 m/sec, the Reynolds number will be 565.3 from [Equation 6], and if the relative velocity is 2 m/sec or more, the CD will be in the Newtonian range as shown in [Equation 4]. Become. In this case, since CD is a constant value of 0.44, the drag force F is F=1.49×10 −5 N from [Equation 5].
 薬液の滴下粒を水平方向に飛ばすには、滴下粒を重力加速度9.8m/secより高い加速度で加速させる必要があり、薬液の密度は水とほぼ同じ1000として、滴下粒の体積より質量を4×10-5kgとすると加速度が重力加速度と同じ9.8m/secで加速するとしても抗力Fは3.92×10-4Nとなり、空気流と滴下粒の相対速度が2m/secで得られる1.49×10-5Nよりも大きな抗力が必要となる。従って空気流の流速はさらに高い相対速度が必要であり、レイノルズ数はさらに高くなるので抵抗係数CDはニュートン域で考えればよいこととなる。これ以降は滴下粒が受ける抵抗係数CDは[数4]のニュートン域であるCD=0.44として扱う。 In order to make dropped drops of a chemical solution fly in the horizontal direction, it is necessary to accelerate the dropped drops with an acceleration higher than the gravitational acceleration of 9.8 m/sec 2. Assuming that the density of the drug solution is 1000, which is approximately the same as water, the mass of the dropped drops is greater than the volume of the dropped drops. If it is 4 × 10 -5 kg, even if the acceleration is 9.8 m/sec, which is the same as the gravitational acceleration, the drag force F will be 3.92 × 10 -4 N, and the relative velocity of the air flow and the dropped particles will be 2 m/sec. A drag force greater than the 1.49×10 −5 N obtained by Therefore, the airflow needs to have a higher relative velocity, and the Reynolds number becomes higher, so the drag coefficient CD can be considered in the Newtonian range. From now on, the resistance coefficient CD applied to the dropped particles is treated as CD=0.44, which is in the Newton range of [Equation 4].
 例えばエアダクト104の開口高さを14mmとし、点眼容器106の薬液滴下口106aからエアダクト104の接眼口104dまでの水平距離を30mmとして、エアダクト104の角度が水平となるように配置された場合、薬液の滴下粒は上下寸法14mmの半分の7mm落下する間に30mm水平に移動させることで角膜頂点に達する。点眼容器106から薬液を滴下させる際は当然ながら滴下粒の初速は落下方向も水平方向も0m/secであるので、等加速度運動の下記[数7]より移動距離xはx=1/2at(a:加速度、t:時間)となる。水平移動距離が垂直移動距離の30/7倍であるので水平方向の加速度も30/7倍となり、重力加速度が9.8m/secであるので9.8×30/7で水平加速度は42m/sec必要となる。
 [数7]等加速度運動の公式
 ここで、x:移動距離、v0:初速、a:加速度、t:時間
For example, when the opening height of the air duct 104 is 14 mm, the horizontal distance from the drug solution dripping port 106a of the eye drop container 106 to the eyepiece port 104d of the air duct 104 is 30 mm, and the air duct 104 is arranged so that the angle is horizontal, the drug solution The dropped drop reaches the corneal apex by moving horizontally 30 mm while falling 7 mm, which is half of the vertical dimension of 14 mm. When dropping a medical solution from the eye drop container 106, the initial velocity of the dropped droplets is naturally 0 m/sec both in the falling direction and in the horizontal direction, so from the following [Equation 7] of uniformly accelerated motion, the moving distance x is x = 1/2 at 2 (a: acceleration, t: time). Since the horizontal movement distance is 30/7 times the vertical movement distance, the horizontal acceleration is also 30/7 times, and since the gravitational acceleration is 9.8 m/sec 2 , the horizontal acceleration is 42 m with 9.8 x 30/7. /sec 2 is required.
[Math 7] Formula for uniformly accelerated motion
Here, x: distance traveled, v0: initial velocity, a: acceleration, t: time
 薬液の滴下粒が水平方向に加速度42m/secを得るために必要な空気流による効力は、滴下粒の質量が4×10-5kgとすると1.68×10-3Nとなり、[数5]に代入して空気流の相対流速Uを逆算すると21.2m/secとなり、その時の滴下粒のレイノルズ数は[数6]より5992となる。[数5]のUは相対速度であるので実際のエアダクト内の流速は薬液の滴下粒の速度が上がる分だけ上げる必要があるが、[数7]に初速0m/sec、移動距離30mm、加速度42m/secを代入し時間tを計算すると約0.0378secとなりその時の薬液の滴下粒の水平移動速度vhは1.59m/secとなる。従ってエアダクト104内の空気流の流速は21.2m/secから22.79m/secの範囲で調整されることが好ましい。以上より式をまとめるとエアダクト104内の空気流の流速と薬液の滴下粒の水平相対速度Uは下記[数8]より求めることができる。
 [数8]
 ここで、U:エアダクト内の空気流の流速と薬液の滴下粒との相対速度、L:点眼容器の滴下口からエアダクト接眼口の中心(角膜)までの水平距離、H:点眼容器の滴下口からエアダクト接眼口の中心(角膜)までの垂直距離(滴下口と接眼口中心の高さの差)、m:薬液滴下粒の質量、ρ:空気の密度、d:薬液滴下粒の直径
The effect of the air flow required for the dropped droplet of the chemical solution to obtain an acceleration of 42 m/sec 2 in the horizontal direction is 1.68×10 -3 N, assuming that the mass of the dropped droplet is 4×10 −5 kg, and [number 5] and calculate the relative flow velocity U of the air flow back to 21.2 m/sec, and the Reynolds number of the dropped particles at that time is 5992 from [Equation 6]. Since U in [Equation 5] is the relative velocity, the actual flow velocity in the air duct needs to be increased by the amount that the velocity of the dropping droplets of the chemical solution increases, but in [Equation 7], the initial velocity is 0 m/sec, the moving distance is 30 mm, and the acceleration is When calculating the time t by substituting 42 m/sec 2 , it becomes approximately 0.0378 sec, and the horizontal movement speed vh of the dropped drops of the chemical solution at that time is 1.59 m/sec. Therefore, it is preferable that the flow velocity of the air flow within the air duct 104 is adjusted within the range of 21.2 m/sec to 22.79 m/sec. To summarize the equations from the above, the flow velocity of the air flow in the air duct 104 and the horizontal relative velocity U of the dropped droplets of the chemical solution can be determined from the following [Equation 8].
[Number 8]
Here, U: relative velocity between the flow rate of the air flow in the air duct and the droplet of the drug solution, L: horizontal distance from the droplet of the eye dropper to the center (cornea) of the air duct eyepiece, H: droplet of the eyedropper Vertical distance from to the center of the air duct eyepiece (cornea) (difference in height between the droplet and the center of the eyepiece), m: mass of the droplet of the drug solution, ρ: density of air, d: diameter of the droplet of the drug solution
 エアダクト104内の空気流が薬液の滴下粒をエアダクト104の接眼口104dを通して角膜まで移動させるのに必要な流速はエアダクト104の上下寸法と点眼容器106の薬液滴下口106aからエアダクト104の接眼口104dまでの距離により変化する。上下方向の寸法が大きければ大きいほど加速度は小さくてよく、接眼口104dまでの距離が大きいほど加速度は大きくなければならない。点眼補助具100の構成部品としてのエアダクト104の開口高さが10mmから25mm程度で、点眼容器106の薬液滴下口から接眼口104dまでの水平距離は20mmから50mm程度が、点眼容器106のサイズや患者の顔表面形状などから適用可能なサイズであり、点眼容器106の薬液滴下口106aから接眼口104dまでの距離を50mm以上に離すと空気流に求められる必要流速が著しく大きくなるため好ましくない。この寸法構成範囲より薬液の滴下粒を所定の位置に飛ばすのに必要な空気流の流速は12.97m/secから32.42m/secの範囲で調整されればよく、必要な空気流の流速はエアダクト104の内部形状や角度、気温、気圧などの影響も受けるので、10m/secから40m/secの範囲で調整することができる。 The flow velocity required for the air flow in the air duct 104 to move the droplets of the medical solution to the cornea through the eyepiece port 104d of the air duct 104 is determined by the vertical dimensions of the air duct 104 and from the drug solution dripping port 106a of the eye drop container 106 to the eyepiece port 104d of the air duct 104. It changes depending on the distance. The larger the vertical dimension, the smaller the acceleration should be, and the larger the distance to the eyepiece port 104d, the larger the acceleration should be. The opening height of the air duct 104 as a component of the eye drop aid 100 is approximately 10 mm to 25 mm, and the horizontal distance from the drug solution drip opening of the eye drop container 106 to the eyepiece port 104d is approximately 20 mm to 50 mm, depending on the size of the eye drop container 106 and the like. This is an applicable size depending on the shape of the patient's face surface, etc., and it is not preferable to set the distance from the drug solution dripping port 106a of the eyedropper container 106 to the eyepiece port 104d to be 50 mm or more because the required flow velocity required for the airflow becomes significantly large. Based on this dimensional configuration range, the flow velocity of the air flow required to blow the dropped drops of the chemical solution to a predetermined position may be adjusted within the range of 12.97 m/sec to 32.42 m/sec, and the flow velocity of the air flow required is influenced by the internal shape and angle of the air duct 104, temperature, atmospheric pressure, etc., so it can be adjusted within the range of 10 m/sec to 40 m/sec.
 次に、エアファン101に求められる風量性能に関して説明する。エアファン101により送風された空気流はエアチャンバー102内に流入し、流入コントロール弁103が閉じている場合には、エアの流れが止まりエアチャンバー102内の空気圧が上昇して、一定時間経過後にはエアファン101の最大静圧付近までエアチャンバー102内の気圧は加圧される。トリガアーム107の操作に合わせて流入コントロール弁103が開くとエアチャンバー102内の空気は一気にエアダクト104に流入し空気流の流速は短時間で最大流速まで上昇してから時間経過と共に、エアファン101の送風能力とエアチャンバー102及びエアダクト104内部の空気流の圧力損失Qとのバランスで決まる定常風量に収束する。圧力損失Pは圧力損失係数C及び風量Qにより下記[数9]で示される。
 [数9]
 ここで、P:圧力損失、C:圧力損失係数、Q:風量
Next, the air volume performance required of the air fan 101 will be explained. The air flow blown by the air fan 101 flows into the air chamber 102, and when the inflow control valve 103 is closed, the air flow stops and the air pressure inside the air chamber 102 increases, and after a certain period of time, the air flow stops. The air pressure inside the air chamber 102 is increased to around the maximum static pressure of the air fan 101. When the inflow control valve 103 opens in accordance with the operation of the trigger arm 107, the air in the air chamber 102 flows into the air duct 104 at once, and the air flow speed increases to the maximum flow speed in a short time. The air volume converges to a steady air volume determined by the balance between the air blowing capacity of the air chamber 102 and the pressure loss Q of the air flow inside the air chamber 102 and the air duct 104. The pressure loss P is expressed by the pressure loss coefficient C and the air volume Q as shown in [Equation 9] below.
[Number 9]
Here, P: pressure loss, C: pressure loss coefficient, Q: air volume
 エアダクト104を円筒とした場合には開口高さを14mmとすると内径は14mmとなり、流入口104aから排気口104bまでの距離を50mmとして、エアダクト104の空気流圧力損失を計算する。薬液の滴下粒を角膜へ送達するためのエアダクト104内の空気流速は、点眼容器106の薬液滴下口106aから角膜までの水平距離を30mmとすれば21.2m/secから22.79m/secの範囲で調整されることが上述されている。エアチャンバー102は空間が大きいため圧力損失を無視する。エアダクト104内の空気流の平均流速Umを22m/sec、空気の動粘性係数νを1.582×10-5(1気圧、25度C)とすると、エアダクト104のレイノルズ数Repは下記[数10]よりRep=19469となる、レイノルズ数Repが2310以上の場合は乱流域となるので、管摩擦係数μはプラントルの実験式より求められμは約0.025となる。
 [数10]
 ここで、Rep:レイノルズ数、Um:平均流速、d:管の内径(エアダクトの内径)、ν:動粘性係数
When the air duct 104 is a cylinder, the inner diameter is 14 mm when the opening height is 14 mm, and the air flow pressure loss of the air duct 104 is calculated assuming that the distance from the inlet 104a to the exhaust port 104b is 50 mm. The air flow velocity within the air duct 104 for delivering drops of the drug solution to the cornea is between 21.2 m/sec and 22.79 m/sec, assuming that the horizontal distance from the drug drop opening 106a of the eye drop container 106 to the cornea is 30 mm. It has been mentioned above that the range is adjusted. Since the air chamber 102 has a large space, pressure loss is ignored. Assuming that the average flow velocity Um of the air flow in the air duct 104 is 22 m/sec and the kinematic viscosity coefficient ν of the air is 1.582×10 −5 (1 atm, 25 degrees C), the Reynolds number Rep of the air duct 104 is as follows: 10], Rep=19469, and if the Reynolds number Rep is 2310 or more, it is a turbulent region, so the pipe friction coefficient μ is determined from Prandtl's empirical formula, and μ is about 0.025.
[Number 10]
Here, Rep: Reynolds number, Um: average flow velocity, d: inner diameter of pipe (inner diameter of air duct), ν: kinematic viscosity coefficient
 エアダクト104の摩擦係数μを0.025、空気の密度γを1.2kg/m、重力加速度gを9.8m/secとすると下記[数11]よりエアダクト104の圧力損失は約103.2Pa(1.032×10-4MPa)となる。
 [数11]
 ここで、ΔP:圧力損失、μ:管の摩擦係数、l:管の長さ、d:管の径、γ:空気の密度、Um:平均流速、g:重力加速度
Assuming that the friction coefficient μ of the air duct 104 is 0.025, the air density γ is 1.2 kg/m 3 , and the gravitational acceleration g is 9.8 m/sec 2 , the pressure loss of the air duct 104 is approximately 103. 2Pa (1.032×10 −4 MPa).
[Number 11]
Here, ΔP: pressure loss, μ: coefficient of friction of the pipe, l: length of the pipe, d: diameter of the pipe, γ: density of air, Um: average flow velocity, g: gravitational acceleration
 エアダクト104内の空気の平均流速を22m/secとするにはエアダクト104内に流入する風量が0.203m/min必要である。エアダクト104の圧力損失は103.2Paであるのでエアファン101に求められる性能は風量0.203m/minの時の風圧が103.2Pa以上のエアファン101が必要となる。 In order to set the average flow velocity of the air in the air duct 104 to 22 m/sec, the amount of air flowing into the air duct 104 needs to be 0.203 m 3 /min. Since the pressure loss of the air duct 104 is 103.2 Pa, the performance required of the air fan 101 requires that the air fan 101 has a wind pressure of 103.2 Pa or more when the air volume is 0.203 m 3 /min.
 また本実施の形態1のエアチャンバー102の容積を約7×10-5とすると、エアチャンバー102内の空気圧を0.1秒以内に103.2Pa高めるのに必要な風量は0.085m/sec以上となる必要があるが、エアダクト104内の必要流速を確保するための風量0.203m/minと比べてはるかに小さいので問題はない。 Furthermore, assuming that the volume of the air chamber 102 of the first embodiment is approximately 7×10 −5 m 3 , the air volume required to increase the air pressure within the air chamber 102 by 103.2 Pa within 0.1 seconds is 0.085 m 3 /sec or more, but this is much smaller than the air volume of 0.203 m 3 /min to ensure the required flow velocity in the air duct 104, so there is no problem.
 本実施の形態1のエアダクト104の適切なサイズを考えると、内径を10mmから25mm、点眼容器106の薬液滴下口106aから角膜までの移動距離を20mmから50mm、エアダクト104の流入口104aから排気口104bまでの距離を40mmから70mmの範囲とするのが、点眼補助具100の操作上あるいは持ちやすさを考慮すると適切なサイズである。この範囲よりエアダクト104の内径が25mm、薬液滴下口106aから角膜までの水平移動距離が20mmである場合に必要なエアダクト104内の平均流速は最も低くなり約12.97m/secとなる。同様に内径が10mm距離50mmの場合の平均流速は最も高くなり約32.4m/secとなる。さらにそれぞれの必要風量を求めると内径25mm角膜までの水平移動距離20mmの場合に0.382m/minとなり、内径10mm角膜までの水平移動距離50mmの場合に0.153m/minとなる。またエアダクト104の流入口104aから排気口104bまでの距離を40mmから70mmより圧力損失を計算すると、距離40mmの場合に内径25mm、滴下粒の水平移動距離20mmとして16.1Pa、距離70mmの場合に内径10mm、滴下粒の水平移動距離50mmとして483Paとなる。 Considering the appropriate size of the air duct 104 of the first embodiment, the inner diameter is 10 mm to 25 mm, the moving distance from the drug solution dripping port 106a of the eye drop container 106 to the cornea is 20 mm to 50 mm, and the air duct 104 has an inflow port 104a to an exhaust port. An appropriate size for the distance to 104b is from 40 mm to 70 mm, considering the operation of the eye drop aid 100 and the ease of holding it. From this range, when the inner diameter of the air duct 104 is 25 mm and the horizontal movement distance from the drug solution dripping port 106a to the cornea is 20 mm, the required average flow velocity in the air duct 104 is the lowest, about 12.97 m/sec. Similarly, when the inner diameter is 10 mm and the distance is 50 mm, the average flow velocity is the highest, about 32.4 m/sec. Furthermore, the respective required air volumes are 0.382 m 3 /min when the inner diameter is 25 mm and the horizontal movement distance to the cornea is 20 mm, and when the inner diameter is 10 mm and the horizontal movement distance to the cornea is 50 mm, it is 0.153 m 3 /min. Also, when calculating the pressure loss from the distance from the inlet 104a to the exhaust port 104b of the air duct 104 from 40 mm to 70 mm, when the distance is 40 mm, the inner diameter is 25 mm, and the horizontal movement distance of the dropped particles is 20 mm, it is 16.1 Pa, and when the distance is 70 mm, it is 16.1 Pa. Assuming that the inner diameter is 10 mm and the horizontal movement distance of the dropped particles is 50 mm, the pressure is 483 Pa.
 以上によりエアファン101に必要な送風能力は、エアダクト104内の平均流速とエアダクト104の空気流に垂直な断面面積より計算される風量と圧力損失以上の送風能力が必要であるが、流入コントロール弁103によりエアファン101の最大静圧付近まで高められたエアチャンバー102内の空気圧により、一時的にエアファン101の送風能力より高い風量が得られるため、エアファン101の風量を下げることが可能である。なお本実施の形態1のエアファン101はシロッコファン(遠心ファン)を用いているが、必要とされる送風能力により軸流ファンとしてもよい。 As described above, the air blowing capacity required for the air fan 101 must be greater than the air volume and pressure loss calculated from the average flow velocity in the air duct 104 and the cross-sectional area perpendicular to the air flow of the air duct 104. 103, the air pressure in the air chamber 102 has been increased to around the maximum static pressure of the air fan 101, which temporarily provides an air volume higher than the air blowing capacity of the air fan 101, making it possible to lower the air volume of the air fan 101. be. Although the air fan 101 of the first embodiment uses a sirocco fan (centrifugal fan), an axial fan may be used depending on the required air blowing capacity.
(2)点眼容器固定アタッチメントの構成
 次に、点眼容器固定アタッチメントの構成に関して図4乃至図6を参照して説明する。点眼容器固定アタッチメント105は、点眼容器106を点眼容器固定アタッチメント105に取り外し可能の装着し、さらにエアダクト104上部の所定位置に着脱可能に固定される。この点眼容器固定アタッチメント105を用いることで、点眼容器106の薬液滴下口106aがエアダクト104に対して適正な位置に配置され、薬液をエアダクト104内に滴下することができる。
(2) Configuration of eye drop container fixing attachment Next, the configuration of the eye drop container fixing attachment will be described with reference to FIGS. 4 to 6. The eye drop container fixing attachment 105 removably attaches the eye drop container 106 to the eye drop container fixing attachment 105, and is further removably fixed at a predetermined position above the air duct 104. By using this eye drop container fixing attachment 105, the drug solution dripping port 106a of the eye drop container 106 is placed at an appropriate position with respect to the air duct 104, and the drug solution can be dropped into the air duct 104.
 点眼容器固定アタッチメント105は点眼容器106の形状や寸法に合わせて複数の種類が用意されてもよいが、点眼容器106の薬液滴下口106aはどの点眼容器106であっても同じ位置に配置されるような構成とする。また点眼容器106に対して適切な位置を押圧するために、押圧点調整アーム108の押圧部108aより作用する力を点眼容器106の適切な位置に作用させるための押圧位置調整機構を有している。 A plurality of types of eye drop container fixing attachments 105 may be prepared according to the shape and dimensions of the eye drop container 106, but the drug solution drip opening 106a of the eye drop container 106 is arranged at the same position regardless of which eye drop container 106 is used. The configuration is as follows. In addition, in order to press the eye drop container 106 at an appropriate position, the eye drop container 106 is provided with a pressing position adjustment mechanism for applying the force exerted by the pressing portion 108a of the pressing point adjustment arm 108 to the appropriate position of the eye drop container 106. There is.
 図4は一般的な点眼容器106の一例である。眼科施設などで処方される一般的な点眼剤の点眼容器106は点眼薬液を充填する薬液充填容器401と着脱可能なキャップ402とキャップを螺合するためのねじ部403と点眼薬液を滴下する点眼ノズル404を備える。点眼ノズル404の先端には滴下口405があり、薬液充填容器401は円筒形あるいは円筒形の側面にくぼみ(ディンプル)を設けた形状であり、点眼ノズル404はねじ部403の内側に篏合されている。各サイズはメーカーや薬液の種類によって異なり、薬液充填容器401の直径は18mmから24mm、高さは20mmから30mm、ねじ部403の外径は11mmから17mm、高さは13mmから16mm、点眼ノズル404の径は4mmから6mm、高さは9mmから11mm程度である。 FIG. 4 is an example of a general eye drop container 106. An eye drop container 106 for general eye drops prescribed in ophthalmology facilities, etc. includes a drug solution filling container 401 filled with eye drops, a removable cap 402, a threaded portion 403 for screwing the cap, and an eye drop container for dropping the eye drops. A nozzle 404 is provided. There is a drip opening 405 at the tip of the eye drop nozzle 404, the drug solution filling container 401 has a cylindrical shape or a shape with dimples on the side of the cylinder, and the eye drop nozzle 404 is fitted inside the threaded part 403. ing. Each size varies depending on the manufacturer and the type of drug solution.The diameter of the drug solution filling container 401 is 18 mm to 24 mm, the height is 20 mm to 30 mm, the outer diameter of the threaded part 403 is 11 mm to 17 mm, the height is 13 mm to 16 mm, and the eye drop nozzle 404 The diameter is about 4 mm to 6 mm, and the height is about 9 mm to 11 mm.
 図5は点眼容器固定アタッチメント105の構成図の一例である。点眼容器固定アタッチメント105は点眼容器挿入胴301(セットプレート305)の内側に点眼容器106の側面及び後面を支持する側面支持ガイド302及び後面支持ガイド303を備え、左右の側面支持ガイド302a、302cはそれぞれ左右の支持ガイド押圧板バネ302b及び302dにより内側に押圧され点眼容器306を側面より固定する。側面支持ガイド302a、302cは点眼容器306の薬液充填容器の直径に合わせて18mmから24mmまで押圧可能となるように支持ガイド押圧板バネ302b及び302dのばね定数とたわみ域を決定する。後面支持ガイドは後面位置調整プランジャ303aにより点眼容器306の薬液充填容器の直径に合わせて調整される。点眼容器固定アタッチメント105は側面支持ガイド302及び後面支持ガイド303によって点眼容器306を固定し一体となる。点眼容器挿入胴301の下部には下部口301aが開口しており点眼容器306のねじ部306a及び点眼ノズル306bが挿入される。下部口301aの口径は点眼容器306のキャップ径より大きく、点眼容器306が点眼容器固定アタッチメント105に装着されたままでもキャップを点眼容器306に装着することができる。 FIG. 5 is an example of a configuration diagram of the eye drop container fixing attachment 105. The eye drop container fixing attachment 105 is equipped with a side support guide 302 and a rear support guide 303 that support the side and rear surfaces of the eye drop container 106 inside the eye drop container insertion barrel 301 (set plate 305), and the left and right side support guides 302a, 302c are The eye drop container 306 is fixed from the side by being pressed inward by left and right support guide pressing leaf springs 302b and 302d, respectively. The spring constant and deflection range of the support guide pressing plate springs 302b and 302d are determined so that the side support guides 302a and 302c can be pressed from 18 mm to 24 mm in accordance with the diameter of the drug solution filling container of the eye drop container 306. The rear support guide is adjusted by the rear position adjustment plunger 303a to match the diameter of the drug solution filling container of the eye drop container 306. The eye drop container fixing attachment 105 fixes the eye drop container 306 by means of a side support guide 302 and a rear support guide 303 to form an integral unit. A lower opening 301a is opened at the lower part of the eye drop container insertion barrel 301, into which the threaded portion 306a of the eye drop container 306 and the eye drop nozzle 306b are inserted. The diameter of the lower opening 301a is larger than the diameter of the cap of the eye drop container 306, so that the cap can be attached to the eye drop container 306 even when the eye drop container 306 is attached to the eye drop container fixing attachment 105.
 図2より点眼容器106は点容器固定アタッチメント105のエアファン101側より押圧点調整アーム108の押圧部108aにより押圧され薬液を滴下するが、点眼容器106の直径や高さにより押圧位置が異なるため、点眼容器106に合わせて押圧部108aの位置を適切な位置とする必要がある。 As shown in FIG. 2, the eye drop container 106 is pressed by the pressing part 108a of the pressure point adjustment arm 108 from the air fan 101 side of the eye drop container fixing attachment 105 to drip the medicine, but the pressing position differs depending on the diameter and height of the eye drop container 106. , it is necessary to position the pressing portion 108a appropriately in accordance with the eye drop container 106.
 図5よりトリガアーム107と一体となす押圧ロッド107aの押圧ロッド押圧作用点107bは固定されており、点眼容器固定アタッチメント105の押圧位置調整機構304を介することにより点眼容器106のサイズに合わせた適切な位置を押圧することができる。押圧位置調整機構は、点眼容器106の押圧位置の上下位置及び点眼容器106の押圧幅が調整可能な第一押圧手段(309,310,311)と、第一押圧手段(309,310,311)と対向する位置にあって点眼容器106の押圧幅の調整可能な第二押圧手段(303a)と、を備える。図5の例では点眼容器固定アタッチメント105の上部に配置された調整アーム回転軸308を中心に回転する押圧点調整アーム108には押圧プランジャ309がスリット311に挿入されダブルナット310により固定される。ナット後310bは回転しないように止められており、押圧プランジャ309はナット後310bに回し入れ押圧量が適切な位置までねじこむ。押圧プランジャ309の高さ位置を点眼容器306の適切な高さ位置となるようにスリット311に沿って移動させナット前310aを締めて固定する。押圧ロッド107aの押圧作用点107bが押圧点調整アーム108の所定の位置に接触して押圧すると、押圧点調整アーム107に接続された押圧プランジャ309が点眼容器306の所定の位置を押圧する。これにより点眼容器306の形状やサイズが異なっていても押圧位置を適切な位置とすることができ、確実に一定量の薬液を点眼容器306より滴下することができる。 As can be seen from FIG. 5, the pressing rod pressing point 107b of the pressing rod 107a integrated with the trigger arm 107 is fixed, and can be adjusted to the appropriate position according to the size of the eye drop container 106 via the pressing position adjustment mechanism 304 of the eye drop container fixing attachment 105. You can press the desired position. The pressing position adjustment mechanism includes first pressing means (309, 310, 311) that can adjust the vertical position of the pressing position of the eye drop container 106 and the pressing width of the eye drop container 106, and the first pressing means (309, 310, 311). and a second pressing means (303a) located at a position facing the eye drop container 106 and capable of adjusting the pressing width of the eye drop container 106. In the example of FIG. 5, a pressing plunger 309 is inserted into a slit 311 of a pressing point adjusting arm 108 that rotates around an adjusting arm rotation shaft 308 disposed at the upper part of an eye drop container fixing attachment 105, and is fixed with a double nut 310. The rear nut 310b is stopped so as not to rotate, and the pressing plunger 309 is screwed into the rear nut 310b until the amount of pressure is appropriate. The pressing plunger 309 is moved along the slit 311 so that the height position of the eye drop container 306 becomes an appropriate height position, and the front nut 310a is tightened and fixed. When the pressing point 107b of the pressing rod 107a contacts and presses a predetermined position of the pressing point adjusting arm 108, the pressing plunger 309 connected to the pressing point adjusting arm 107 presses the eye drop container 306 at a prescribed position. Thereby, even if the shape and size of the eye drop container 306 are different, the pressing position can be set to an appropriate position, and a certain amount of the drug solution can be reliably dropped from the eye drop container 306.
 図6は点眼容器固定アタッチメント105を取り外した状態を示す。点眼容器固定アタッチメント105には複数の薬剤を点眼する患者に対して簡単に点眼容器固定アタッチメント105を交換して点眼するためのセットプレート305が設けられている。図6(a)に示すように、点眼容器固定アタッチメント300を点眼補助具100のエアダクト104に接続するセットプレート305をエアダクト104のサイドに設けられたアタッチメントセット用のセットガイド312に差し込むだけで点眼容器固定アタッチメント105はエアダクト104の上部に簡単に固定される。このため、別の点眼薬を使う場合は別の点眼薬固定アタッチメント105に点眼容器106をあらかじめ装着しておくことで、簡単に点眼薬の交換が可能となる。このように、点眼容器固定アタッチメント105は、点眼容器106を下向きで装着可能なセットプレート305と、点眼容器106の押圧位置を調整する押圧位置調整機構と、を備える。セットプレート305の内側面には点眼容器106の側面を押圧支持する支持ガイド(側面支持ガイド302及び後面支持ガイド303)が配置され、セットプレート305の下端はエアダクト104の外側壁に形成されたセットガイド312に着脱可能に嵌合され、セットプレート305の下側領域には点眼容器106が装着された状態において点眼容器106のキャップを開閉可能とする開放空間S1が設けられる。 FIG. 6 shows a state in which the eye drop container fixing attachment 105 is removed. The eye drop container fixing attachment 105 is provided with a set plate 305 for easily replacing the eye drop container fixing attachment 105 and administering the eye drops to a patient who is instilling a plurality of drugs into the eye. As shown in FIG. 6(a), by simply inserting the set plate 305 that connects the eye drop container fixing attachment 300 to the air duct 104 of the eye drop aid 100 into the set guide 312 for the attachment set provided on the side of the air duct 104, the eye drop container fixing attachment 300 can be dropped. The container fixing attachment 105 is easily fixed to the top of the air duct 104. Therefore, when using a different eye drop, the eye drop can be easily replaced by attaching the eye drop container 106 to another eye drop fixing attachment 105 in advance. In this way, the eye drop container fixing attachment 105 includes the set plate 305 to which the eye drop container 106 can be attached facing downward, and the pressing position adjustment mechanism that adjusts the pressing position of the eye drop container 106. Support guides (side support guide 302 and rear support guide 303) that press and support the side surfaces of the eye drop container 106 are disposed on the inner surface of the set plate 305, and the lower end of the set plate 305 is connected to a set formed on the outer wall of the air duct 104. The set plate 305 is removably fitted into the guide 312, and an open space S1 is provided in the lower region of the set plate 305 so that the cap of the eye drop container 106 can be opened and closed when the eye drop container 106 is attached.
 さらに点眼容器固定アタッチメント105にはそれぞれ固有のタグやIDを振りつけるためにタグ、RFID等の電子的なチップや、バーコード、QRコード(登録商標)(これらは点眼容器106の種類及び点眼容器固定アタッチメント105の種類の少なくとも一方を識別するための識別子となる)、あるいはアタッチメント105に切り欠きを付けるなどの形状による判別手段を備えることができる。図2の点眼補助具100はこれらのタグやIDを読み取るためのセンサーやRFID読み取りチップ、カメラ等のタグ読み取りセンサー114を備える。これらのタグやIDをこの判別手段を備えていれば点眼補助具100がそれぞれの点眼容器固定アタッチメント105のタグを読み取ることにより、点眼容器固定アタッチメント105のタグと装着した点眼薬の種類があらかじめ登録されていれば、どの点眼薬が点眼されたかを毎回記録することが可能となる。 Further, each eye drop container fixing attachment 105 is equipped with a tag, an electronic chip such as RFID, a bar code, or a QR code (registered trademark) in order to assign a unique tag or ID to each eye drop container fixing attachment 105. The attachment 105 may be provided with a shape-based identification means (which serves as an identifier for identifying at least one of the types of the fixed attachment 105) or a notch in the attachment 105. The eye drop aid 100 in FIG. 2 includes a tag reading sensor 114 such as a sensor, an RFID reading chip, and a camera for reading these tags and IDs. If the eye drop aid 100 is equipped with this means for identifying these tags and IDs, by reading the tags of each eye drop container fixing attachment 105, the tag of the eye drop container fixing attachment 105 and the type of eye drops attached are registered in advance. If so, it would be possible to record which eye drops were applied each time.
(3)点眼容器押圧機構の構成
 次に、点眼容器押圧機構の構成に関して図7及び図8を参照して説明する。点眼容器押圧機構の押圧ロッドの押圧作用点が直接点眼容器を押圧する構成でもよいが、図7及び図8は点眼容器への押圧を点眼容器の形状に合わせて最適化するために押圧ロッドが点眼容器固定アタッチメントの押圧位置調整機構を介して点眼容器を押圧し、点眼薬液をエアダクト内に滴下させるための押圧機構の例を示す。ここで、図7は手動により押圧する一例であり、図8は電動により押圧する点眼容器押圧機構を示す一例である。
(3) Configuration of eye drop container pressing mechanism Next, the configuration of the eye drop container pressing mechanism will be described with reference to FIGS. 7 and 8. The pressing point of the pressing rod of the eye drop container pressing mechanism may be configured to directly press the eye drop container, but in FIGS. 7 and 8, the pressing rod is configured to An example of a pressing mechanism for pressing the eye drop container via the pressing position adjustment mechanism of the eye drop container fixing attachment and causing the eye drop solution to drip into the air duct is shown. Here, FIG. 7 shows an example of manual pressing, and FIG. 8 shows an example of an eye drop container pressing mechanism that presses electrically.
 図7に示す手動機構による点眼容器押圧機構ではトリガアーム107がエアダクト104の上方に配置されるトリガアーム回転軸501を中心に回転し、トリガアーム107は患者あるいは点眼補助者の指により力を加える手動点502が接眼口104d側に引かれることにより点眼薬液が点眼容器106より滴下され、滴下粒がエアダクト104内の空気流による抗力により接眼口104dに向けて略水平移動され、角膜に到達して点眼される。 In the eye drop container pressing mechanism using a manual mechanism shown in FIG. 7, a trigger arm 107 rotates around a trigger arm rotation axis 501 disposed above the air duct 104, and the trigger arm 107 applies force by a finger of a patient or an eye drop assistant. When the manual point 502 is pulled toward the eyepiece 104d, the eye drops are dripped from the eyedrop container 106, and the drops are moved approximately horizontally toward the eyepiece 104d by the drag force caused by the air flow in the air duct 104, and reach the cornea. Eye drops are applied.
 図7の場合、点眼容器押圧機構は、トリガアーム107の回転軸となるトリガアーム回転軸501と、トリガアーム107と連接されてトリガアーム107が引かれるとトリガアーム回転軸501を介して側方から点眼容器106を押圧する方向に作用する押圧ロッド107aと、を備えている。押圧ロッド107aはトリガアーム回転軸501とエアダクト104の間の適切な高さに配置され、トリガアーム107と押圧ロッド107aは一体となり動作する。トリガアーム107が接眼口104d側に引かれると押圧ロッド107aの押圧作用点107bも接眼口側に動く。押圧作用点107bが点眼容器固定アタッチメント105に配置された押圧点調整アーム108の押圧ロッド押圧位置に接触すると、押圧ロッド107aにより接眼口104d側方向に力が作用し、押圧点調整アーム108を介して点眼容器106を押圧する。トリガアーム107の動作範囲は機械的に制限されているため、一体となっている押圧点調整アーム108も制限位置までしか動かず、常に一定の位置まで点眼容器106を押圧してそれ以上は押圧しない。これにより点眼容器106より滴下される薬液も常に一定量となり患者眼に点眼される。押圧ロッド107aが戻ると点眼容器106にかけられた押圧圧力は解放され点眼容器106は元の形状に戻る。点眼容器106は常に下向きに固定されているため点眼容器106内の薬液も点眼容器106の下部及び点眼ノズルに溜まり容器内の空気は点眼容器106の上方に溜まるので、点眼を開始する際には必ず押圧された分の薬液が滴下し常に一定量の薬液(一滴の薬液)が滴下される。 In the case of FIG. 7, the eye drop container pressing mechanism is connected to the trigger arm rotation shaft 501 which is the rotation axis of the trigger arm 107, and when the trigger arm 107 is pulled, the eye drop container pressing mechanism A pressing rod 107a that acts in a direction to press the eye drop container 106 is provided. The pressing rod 107a is arranged at an appropriate height between the trigger arm rotating shaft 501 and the air duct 104, and the trigger arm 107 and the pressing rod 107a operate together. When the trigger arm 107 is pulled toward the eyepiece 104d, the pressing point 107b of the pressing rod 107a also moves toward the eyepiece. When the pressing point 107b contacts the pressing rod pressing position of the pressing point adjustment arm 108 disposed on the eye drop container fixing attachment 105, force is applied by the pressing rod 107a in the side direction of the eyepiece 104d, and the pressure is applied via the pressing point adjusting arm 108. to press the eye drop container 106. Since the movement range of the trigger arm 107 is mechanically limited, the integrated pressure point adjustment arm 108 can only move up to the limit position, and the eye drop container 106 is always pressed to a certain position and cannot be pressed any further. do not. As a result, a constant amount of the drug solution is always dropped from the eye drop container 106 into the patient's eye. When the pressing rod 107a returns, the pressing force applied to the eye drop container 106 is released and the eye drop container 106 returns to its original shape. Since the eye drop container 106 is always fixed downward, the medicine in the eye drop container 106 also accumulates in the lower part of the eye drop container 106 and in the eye drop nozzle, and the air inside the container accumulates above the eye drop container 106. The amount of chemical liquid that is pressed is always dropped, and a constant amount of chemical liquid (one drop of chemical liquid) is always dropped.
 図8は電動機構による点眼容器106の押圧機構として、電磁ソレノイド606による押圧ロッド605の駆動を示している。この場合の点眼容器押圧機構は、トリガアーム601と連動して電気駆動により駆動される電磁ソレノイド(電動駆動手段)606と、トリガアーム601が引かれると電磁ソレノイド606を用いて側方から点眼容器609を押圧する方向に作用する押圧ロッド605と、を備えている。電動による押圧ロッド605の駆動は、電動モーターによる構成や、電磁ソレノイド、ボイスコイルモーターなどの電磁アクチュエータによる構成が可能である。電磁アクチュエータの場合は直線運動が可能で押圧ロッド605を直接駆動できるが、モーターによる場合は減速ギアを介し、さらに回転運動を直線運動に変えるためのリンク機構あるいはカム機構などが必要となる。図8では電磁ソレノイド606のシャフトに押圧ロッド605を配置し、押圧ロッド605により前記点眼容器固定アタッチメントの押圧点調整アーム610を直接駆動する例を示している。 FIG. 8 shows the driving of the pressing rod 605 by an electromagnetic solenoid 606 as a mechanism for pressing the eye drop container 106 using an electric mechanism. In this case, the eye drop container pressing mechanism uses an electromagnetic solenoid (electric drive means) 606 that is electrically driven in conjunction with the trigger arm 601, and when the trigger arm 601 is pulled, the eye drop container is pressed from the side using the electromagnetic solenoid 606. A pressing rod 605 that acts in a direction to press 609 is provided. The pressing rod 605 can be electrically driven by an electric motor or an electromagnetic actuator such as an electromagnetic solenoid or a voice coil motor. In the case of an electromagnetic actuator, linear motion is possible and the pressing rod 605 can be directly driven, but in the case of a motor, a link mechanism or a cam mechanism is required to convert rotational motion into linear motion via a reduction gear. FIG. 8 shows an example in which a pressing rod 605 is disposed on the shaft of an electromagnetic solenoid 606, and the pressing rod 605 directly drives the pressing point adjustment arm 610 of the eye drop container fixing attachment.
 トリガアーム601はトリガアーム位置センサー602により所定の角度位置が検出される。トリガアーム位置センサー602は反射型のフォトインタラプタであり、トリガアーム601に張り付けられたフォトインタラプタ用反射テープ603を検出できるように配置されており、トリガアーム601の所定の角度位置を検出する構成となっている。トリガアーム601が操作されていない最初の角度位置を「トリガアームスタート位置」とし、トリガアーム601がエアダクト604の接眼口604a側方向に所定の位置まで引かれ、トリガアーム601と一体となった押圧ロッド605により点眼容器押圧機構を介して点眼容器609の押圧が始まる角度位置を「トリガアーム押圧位置」とする。トリガアーム601がトリガアーム押圧位置に達すると電磁ソレノイド606がONとなり押圧ロッド605が押圧を開始する。電磁ソレノイド606のストロークは一定なので押圧量も一定となる。電磁ソレノイド606によって駆動された押圧ロッド605は押圧点調整アーム610を介して点眼容器609を押圧して薬液を滴下させる。押圧ロッド605が動作する動作範囲は一定なので点眼容器609は常に一定の位置まで押圧され、滴下する薬液の量も一定となる。操作者がトリガアーム601を開放するとトリガアーム601はトリガアーム回転軸607に同軸で配置されたトリガアーム戻しばね608によりトリガアームスタート位置まで戻り、トリガアーム位置センサー602によりトリガアームスタート位置に戻ったことが検出されると電磁ソレノイド606をOFFにして点眼容器609の押圧も解放されて点眼容器609は元の形状に戻る。 A predetermined angular position of the trigger arm 601 is detected by a trigger arm position sensor 602. The trigger arm position sensor 602 is a reflective photointerrupter, and is arranged so as to be able to detect the photointerrupter reflective tape 603 attached to the trigger arm 601, and is configured to detect a predetermined angular position of the trigger arm 601. It has become. The first angular position where the trigger arm 601 is not operated is defined as the "trigger arm start position", and the trigger arm 601 is pulled toward the eyepiece 604a side of the air duct 604 to a predetermined position, and the trigger arm 601 is pressed integrally with the trigger arm 601. The angular position at which the rod 605 starts pressing the eye drop container 609 via the eye drop container pressing mechanism is defined as the "trigger arm pressing position." When the trigger arm 601 reaches the trigger arm pressing position, the electromagnetic solenoid 606 is turned on and the pressing rod 605 starts pressing. Since the stroke of the electromagnetic solenoid 606 is constant, the amount of pressure is also constant. The pressing rod 605 driven by the electromagnetic solenoid 606 presses the eye drop container 609 via the pressing point adjustment arm 610 to drip the medical solution. Since the operating range in which the pressing rod 605 operates is constant, the eye drop container 609 is always pressed to a constant position, and the amount of liquid medicine to be dropped is also constant. When the operator releases the trigger arm 601, the trigger arm 601 is returned to the trigger arm start position by a trigger arm return spring 608 disposed coaxially with the trigger arm rotation axis 607, and returned to the trigger arm start position by the trigger arm position sensor 602. When this is detected, the electromagnetic solenoid 606 is turned off, the pressure on the eye drop container 609 is released, and the eye drop container 609 returns to its original shape.
 図8では滴下粒通過センサー611が接眼口604a付近の上部に備えられ、点眼容器609より滴下された薬液滴下粒が接眼口604aを正常に通過したかを検出してコントロールユニットにデータを送信する。この滴下粒通過センサー611により押圧機構が適切に動作し、点眼薬液が正常に接眼口604aを通過したかを確認することができる。図8の滴下粒通過センサー611は反射型のフォトインタラプタで構成され薬液滴下粒が通過する際にエアダクト604の下面からの反射光が滴下粒表面の反射や屈折によりセンサーに戻らなくなることで検出する。なお、この滴下粒通過センサー611は透過型のフォトインタラプタや超音波センサーなどでも検出可能であり、エアダクト604の側面に配置することも可能である。 In FIG. 8, a dropped droplet passage sensor 611 is provided at the upper part near the eyepiece port 604a, and detects whether the droplet of drug solution dropped from the eyedropper container 609 has passed normally through the eyepiece port 604a, and sends the data to the control unit. . This dropped droplet passage sensor 611 allows it to be confirmed whether the pressing mechanism operates properly and whether the eye drops have normally passed through the eyepiece opening 604a. The dropped particle passage sensor 611 in FIG. 8 is composed of a reflective photointerrupter, and detects the reflected light from the lower surface of the air duct 604 when the droplet of the chemical solution passes through, because it is no longer returned to the sensor due to reflection or refraction on the surface of the dropped particle. . Note that this dropped particle passage sensor 611 can also be detected by a transmission type photointerrupter, an ultrasonic sensor, etc., and can also be placed on the side surface of the air duct 604.
(4)エアファンによる空気流発生手段の構成と動作
 次に、エアファンによる空気流発生手段の構成と動作に関して図9を参照して説明する。図9に示すエアファン101はコントロールユニット113により駆動及び電圧をコントロールされ、コントロールユニット113にはトリガアーム位置センサー701の信号、あるいはトリガアーム107の操作部に配置された接触センサー703の信号、あるいはエアダクト104の接眼口104d付近に配置した接眼検出接触センサーにより患者眼が点眼補助具100のアイピース110に接眼されたかを検出する信号などにより操作者による点眼操作の開始を認識してエアファン101を動作させる。その後エアファン101はトリガアーム107が元の位置に戻るまで動作を継続し、戻った時点で停止する。トリガアーム107は、ばね力で常に元の位置に戻る構成になっているので、点眼補助具100の操作者がトリガアーム107を開放するとトリガアーム107は開始位置に自動復帰し、トリガアーム位置センサー701により開始位置に復帰したことを検出してエアファン101を停止する。さらに後述の図13は点眼補助具100の電気システム構成の一例であり、エアファン1804はコントロールユニット1801に備わるエアファン制御部1801aによりコントロールされ手動又は自動的に駆動のON/OFF及び駆動電圧をコントロールされる。
(4) Structure and operation of air flow generating means using an air fan Next, the structure and operation of the air flow generating means using an air fan will be described with reference to FIG. The drive and voltage of the air fan 101 shown in FIG. 9 are controlled by a control unit 113, and the control unit 113 receives a signal from a trigger arm position sensor 701, a signal from a contact sensor 703 disposed at the operating portion of the trigger arm 107, or The air fan 101 is activated by recognizing the start of the eyedrop operation by the operator based on a signal that detects whether the patient's eye is close to the eyepiece 110 of the eyedropper aid 100 by an eyepiece detection contact sensor placed near the eyepiece port 104d of the air duct 104. make it work. Thereafter, the air fan 101 continues to operate until the trigger arm 107 returns to its original position, at which point it stops. The trigger arm 107 is configured to always return to its original position by spring force, so when the operator of the eye drop aid 100 releases the trigger arm 107, the trigger arm 107 automatically returns to the starting position, and the trigger arm position sensor 701, it is detected that the air fan 101 has returned to the starting position, and the air fan 101 is stopped. Furthermore, FIG. 13, which will be described later, is an example of the electrical system configuration of the eye drop aid 100, and the air fan 1804 is controlled by an air fan control section 1801a provided in the control unit 1801, and the drive ON/OFF and drive voltage are controlled manually or automatically. be controlled.
 以上の構成により、エアファン101は点眼時のみ動作することによりエアチャンバー102やエアダクト104に無駄な空気の流入をさせず、駆動電圧のコントロールにより薬液滴下粒を水平に移動せしめるための最適な空気吐出量とすることが可能であり、電力消費を最小限とすると共に、モーターの寿命も延ばす効果がある。また患者の眼がアイピース110に接触した時点又は操作者がトリガアーム107を引き始めた時点でエアファン101は動作開始してエアチャンバー102に空気を送り、操作者がトリガアーム107を引き切り点眼液が点眼容器106から滴下されるまでの時間内にエアチャンバー102内の空気圧を所定の圧力まで上げられるような送風能力をエアファン101は持つ。通常の操作であればこの操作経過時間は0.3秒以上であり、エアチャンバー102内の圧力を適正な圧力まで高めるのに十分な時間を得られる。 With the above configuration, the air fan 101 operates only when the eye is instilled, thereby preventing wasteful air from flowing into the air chamber 102 or the air duct 104, and by controlling the drive voltage, the air fan 101 is operated only when the eye is instilled, and by controlling the drive voltage, the air fan 101 is operated only when the eye is instilled. It is possible to adjust the discharge amount, which has the effect of minimizing power consumption and extending the life of the motor. Furthermore, when the patient's eye comes into contact with the eyepiece 110 or when the operator starts pulling the trigger arm 107, the air fan 101 starts operating and sends air to the air chamber 102, and the operator pulls the trigger arm 107 and applies eye drops. The air fan 101 has the ability to blow air such that the air pressure in the air chamber 102 can be raised to a predetermined pressure within the time until the liquid is dropped from the eye drop container 106. In a normal operation, this operation elapsed time is 0.3 seconds or more, which is sufficient time to increase the pressure in the air chamber 102 to an appropriate pressure.
(5)エアダクト内へのエア流入をコントロールする弁の構成と動作方法
 次に、エアダクト内へのエア流入をコントロールする弁の構成と動作方法(弁駆動機構)に関して図10及び図11を参照して説明する。図10及び図11はエアダクト802への空気流入をコントロールする流入コントロール弁の構成を示す図であり、図10は手動機構による流入コントロール弁の構成の一例であり、図11は電動機構による流入コントロール弁の構成の一例である。
(5) Configuration and operating method of a valve that controls the inflow of air into the air duct Next, refer to FIGS. 10 and 11 regarding the configuration and operating method (valve drive mechanism) of the valve that controls the inflow of air into the air duct. I will explain. 10 and 11 are diagrams showing the configuration of an inflow control valve that controls air inflow into the air duct 802. FIG. 10 is an example of the configuration of an inflow control valve using a manual mechanism, and FIG. 11 is an example of an inflow control valve using an electric mechanism. This is an example of the configuration of a valve.
 図10に示す手動機構による流入コントロール弁の構成においては、流入コントロール弁としてスイング式逆止弁801がエアダクト802の流入口802aの直後に配置されて、エアチャンバー803からの空気の流入をコントロールしている。スイング式逆止弁801は回転軸806により連動する回転リセットアーム801a及び回転止めアーム801bがエアダクト802の外側に配置されている。スイング逆止弁801を閉じると回転止めアーム801bに回転ストッパー804の爪部804aがかかり、爪部804aはバネ804bにより上方に押されるため弁が開かないように制動される。スイング式逆止弁801は通常閉じておりエアファンが送風を開始しても空気流はエアチャンバーにとどまり、エアチャンバー内の気圧を上昇させる。回転ストッパー804はトリガアーム805の動きに連係して作動し、トリガアーム805が操作者によりエアダクト802の接眼口802b側に引かれ、点眼容器押圧機構を介して点眼容器を押圧して点眼薬液が滴下される位置までトリガアーム805が移動するとトリガアーム805に付設されたリリースカム805aにより回転ストッパー804の爪部804aが下方向に押され制動解除方向に移動してスイング式逆止弁801は制動が解除され、エアチャンバー803内の高い空気圧により弁が一気に開いてエアダクト内に空気流が流入する。この動作により発生したエアダクト802内の空気流は、高い流速でエアダクト802内を通過し点眼容器より滴下された薬液滴下粒を患者の角膜方向に飛ばす。 In the configuration of the inflow control valve with a manual mechanism shown in FIG. 10, a swing type check valve 801 is placed immediately after the inflow port 802a of the air duct 802 as an inflow control valve to control the inflow of air from the air chamber 803. ing. The swing type check valve 801 has a rotation reset arm 801 a and a rotation stop arm 801 b that are interlocked by a rotation shaft 806 and are arranged outside the air duct 802 . When the swing check valve 801 is closed, the claw portion 804a of the rotation stopper 804 engages the rotation stopper arm 801b, and the claw portion 804a is pushed upward by the spring 804b, so that the valve is braked so as not to open. The swing type check valve 801 is normally closed, and even when the air fan starts blowing air, the air flow remains in the air chamber, increasing the air pressure inside the air chamber. The rotation stopper 804 operates in conjunction with the movement of the trigger arm 805, and the trigger arm 805 is pulled toward the eyepiece port 802b of the air duct 802 by the operator, and the eye drop container is pressed through the eye drop container pressing mechanism to release the eye drop solution. When the trigger arm 805 moves to the dripping position, the claw portion 804a of the rotation stopper 804 is pushed downward by the release cam 805a attached to the trigger arm 805 and moves in the direction of releasing the brake, and the swing type check valve 801 is braked. is released, and the high air pressure inside the air chamber 803 causes the valve to open all at once, allowing air to flow into the air duct. The air flow within the air duct 802 generated by this operation passes through the air duct 802 at a high flow rate and blows the droplets of the drug solution dropped from the eye drop container toward the patient's cornea.
 トリガアーム805にはスイング式逆止弁801を閉じた位置に戻すための弁リセットバー805bが付設されており、この弁リセットバー805bはトリガアームが開始位置に戻る際にスイング式逆止弁801の回転リセットアーム801aをスイング式逆止弁801が閉じる方向に作用する構成となっている。操作者がトリガアーム805を離すとトリガアーム805はバネ力により開始の位置に戻り、弁リセットバー805bがカム801cを押し回転リセットアーム801aを介してスイング式逆止弁801も閉じる位置に復帰させる。回転ストッパー804の爪部804aはスイング式逆止弁801が閉じる動きを妨げないように緩やかなテーパー形状となっており、スイング式逆止弁801が完全に閉じる位置まで復帰すると爪部804aがスイング式逆止弁801の上辺に引っ掛かりスイング式逆止弁801は閉じた状態を維持する。 The trigger arm 805 is provided with a valve reset bar 805b for returning the swing type check valve 801 to the closed position. The swing type check valve 801 acts on the rotating reset arm 801a in the closing direction. When the operator releases the trigger arm 805, the trigger arm 805 returns to the starting position due to spring force, and the valve reset bar 805b pushes the cam 801c to return the swing type check valve 801 to the closed position via the rotating reset arm 801a. . The claw portion 804a of the rotation stopper 804 has a gently tapered shape so as not to hinder the closing movement of the swing type check valve 801, and when the swing type check valve 801 returns to the completely closed position, the claw portion 804a swings. It is caught on the upper side of the swing type check valve 801, and the swing type check valve 801 maintains the closed state.
 このような手動機構の流入コントロール弁により高速の空気流をエアダクト802内に発生させ薬液の滴下粒を確実に角膜に送達させると共に、点眼操作が終了すると自動的に流入コントロール弁を閉じ、次の点眼操作に向けたリセット動作が完了する。図10の例ではスイング式の逆止弁による例であるが、バタフライ弁、ボール弁、リード弁、ダイヤフラムなどの弁機構を使っても構わない。 Such a manually operated inflow control valve generates a high-speed air flow in the air duct 802 to ensure that the droplets of the drug solution are delivered to the cornea, and when the eye drop operation is completed, the inflow control valve is automatically closed and the next The reset operation for eye drop operation is completed. Although the example shown in FIG. 10 uses a swing type check valve, a valve mechanism such as a butterfly valve, ball valve, reed valve, or diaphragm may also be used.
 図11に示す電動機構による流入コントロール弁の構成においては、流入コントロール弁はスイング式逆止弁901となっており、モーター902及びウォームギア903を介してスイング式逆止弁901の回転軸と連結している。スイング式逆止弁901は弁の開閉状態を検出する弁位置センサー904によりスイング式逆止弁901の開閉状態を検出できる。モーター902はコントロールユニット906によりコントロールされ、コントロールユニット906にはスイング式逆止弁901の開閉状態を検出する弁位置センサー904及びトリガアームの位置を検出するトリガアーム位置センサー905が接続されている。スイング式逆止弁901はトリガアーム805がトリガアームスタート位置にあるときには、モーター902をスイング式の逆止弁901が閉じる位置になるまで回転させスイング式逆止弁901を閉じる。トリガアーム805が操作者によりエアダクトの接眼口方向に引かれ、点眼薬液を滴下するトリガアーム押圧位置まで移動するとコントロールユニット906によりモーター902が駆動されスイング式逆止弁901を開く。トリガアーム905が操作者により解放されトリガアームスタート位置まで戻るとコントロールユニット906はモーター902を逆駆動してスイング式逆止弁901を閉じる位置まで回転させ、その位置を維持する。 In the structure of the inflow control valve using an electric mechanism shown in FIG. 11, the inflow control valve is a swing type check valve 901, and is connected to the rotating shaft of the swing type check valve 901 via a motor 902 and a worm gear 903. ing. The swing type check valve 901 can detect the open/closed state of the swing type check valve 901 using a valve position sensor 904 that detects the open/closed state of the valve. The motor 902 is controlled by a control unit 906, and a valve position sensor 904 that detects the open/closed state of the swing type check valve 901 and a trigger arm position sensor 905 that detects the position of the trigger arm are connected to the control unit 906. When the trigger arm 805 of the swing type check valve 901 is at the trigger arm start position, the motor 902 is rotated until the swing type check valve 901 is in the closing position, thereby closing the swing type check valve 901. When the trigger arm 805 is pulled toward the eyepiece port of the air duct by the operator and moved to the trigger arm pressing position where eye drops are dropped, the control unit 906 drives the motor 902 to open the swing type check valve 901. When the trigger arm 905 is released by the operator and returns to the trigger arm start position, the control unit 906 reversely drives the motor 902 to rotate the swing type check valve 901 to the closed position and maintains that position.
 このような電動機構の流入コントロール弁により高速の空気流をエアダクト802内に発生させ薬液の滴下粒を確実に角膜に送達させると共に、点眼操作が終了すると自動的に流入コントロール弁を閉じ、次の点眼操作に向けたリセット動作が完了する。図11の例ではスイング式逆止弁による例であるが、バタフライ弁、ボール弁、リード弁、ダイヤフラムなどの弁機構を使っても構わない The inflow control valve of such a motorized mechanism generates a high-speed airflow in the air duct 802 to ensure that the droplets of the drug solution are delivered to the cornea, and when the eye drop operation is completed, the inflow control valve is automatically closed and the next The reset operation for eye drop operation is completed. Although the example in Figure 11 uses a swing type check valve, other valve mechanisms such as butterfly valves, ball valves, reed valves, diaphragms, etc. may also be used.
(6)患者の左眼・右眼自動検出(左右眼検出手段)
 次に、患者の左眼・右眼自動検出に関して図12を参照して説明する。患者に対する点眼は、眼疾患の種類・程度・症状により様々なパターンで行われる。患者によっては複数の点眼薬を点眼したり、左右眼で点眼薬の処方が異なっていたり、点眼回数も様々で、患者はどの種類の点眼薬を何時に何回点眼するのかを管理しなければならないが、日常生活において点眼を忘れたり間違えることはしばしば発生する。従って左右眼のそれぞれにどの種類の点眼薬を何時、点眼したのかを点眼履歴として残すことは点眼を管理する患者や患者の介護人にとって有効な手段である。点眼補助具と携帯端末やパソコン等の外部装置をつなぎ、この点眼履歴を外部装置に残すことで点眼等の治療管理を効果的に行うことが可能となる。従って左右眼のどちらに点眼しているかを自動で検出することは治療の記録を残し管理するうえで極めて重要である。
(6) Automatic detection of patient's left and right eyes (left and right eye detection means)
Next, automatic detection of the patient's left eye and right eye will be described with reference to FIG. 12. Eye drops are administered to patients in various patterns depending on the type, degree, and symptoms of the eye disease. Depending on the patient, multiple eye drops may be instilled, the prescription for eye drops may be different for the left and right eyes, and the number of eye drops may vary, so patients must manage which type of eye drops to use, when and how many times. However, in daily life, it often happens that people forget to apply eye drops or make mistakes. Therefore, it is an effective means for the patient who manages the eye drops and the patient's caregiver to keep a record of what kind of eye drops were instilled in each of the left and right eyes and when and when. By connecting the eye drop aid to an external device such as a mobile terminal or a personal computer and leaving the eye drop history on the external device, it becomes possible to effectively manage treatments such as eye drops. Therefore, it is extremely important to automatically detect which eye, the left or the right, the eye is instilled in, in order to keep and manage treatment records.
 図12は点眼補助具が左右眼どちらの眼に接眼しているかを自動で検出する検出方法(左右眼検出手段)の一例である。左右眼のどちらかを検出する例としてよく用いられる方法は、カメラ撮影による患者の顔あるいは眼の撮影画像を解析して左右のどちらであるかを判別する方法や、顎台に患者の顔を固定する場合には顎台に対する点眼器の位置を検出して判別する方法などがあるが、ポータブル型の点眼器1ではより簡便な判別方法が望ましい。図12の例では患者が点眼器のアイピースに患者眼の眼瞼を接した際に点眼器のどちら側の側面近傍に患者の鼻が位置するかを反射式光学センサー1003で検出して判別する方法を示している。 FIG. 12 is an example of a detection method (left and right eye detection means) that automatically detects which eye, left or right, the eye drop aid is in close contact with. Examples of commonly used methods for detecting whether the patient's eyes are left or right include analyzing an image of the patient's face or eyes captured by a camera to determine whether it is the left or right eye, or by placing the patient's face on a chin rest. If the eye dropper is fixed, there is a method of detecting the position of the eye dropper with respect to the chinrest for discrimination, but for a portable eye dropper 1, a simpler discrimination method is desirable. In the example shown in FIG. 12, when the patient touches the eyepiece of the eyedropper with the eyelid of the patient's eye, a reflective optical sensor 1003 is used to detect and determine which side of the eyedropper the patient's nose is located near. It shows.
 患者眼の眼瞼に点眼器のアイピースを接触させた際に患者の鼻は点眼器を構成する点眼補助具のエアダクト側面からやや下方に位置する。図12では点眼補助具のエアダクト1001の両側面下部にそれぞれ反射式光学センサー左1003a及び反射式光学センサー右1003bが配置されている。これらの反射式光学センサー1003はセンサー付近に鼻が存在する場合に、反射式光学センサー1003より照射された赤外光が患者の鼻表面にて反射あるいは散乱して反射式光学センサー1003に戻ってくる光を受光して鼻の存在を検出する。 When the eyepiece of the eyedropper is brought into contact with the eyelid of the patient's eye, the patient's nose is located slightly below the side of the air duct of the eyedropper aid that constitutes the eyedropper. In FIG. 12, a left reflective optical sensor 1003a and a right reflective optical sensor 1003b are arranged at the bottom of both sides of an air duct 1001 of the eye drop aid. These reflective optical sensors 1003 detect that when a patient's nose is near the sensor, infrared light emitted from the reflective optical sensor 1003 is reflected or scattered on the patient's nasal surface and returns to the reflective optical sensor 1003. The presence of the nose is detected by receiving the light coming from the nose.
 反射式光学センサー左1003a及び反射式光学センサー右1003bはコントロールユニット1004に接続されており、検出した信号を送信する。コントロールユニット1004はどちらのセンサーからも鼻の検出信号がない場合、あるいはどちらのセンサーからも検出信号が送信されている場合は、点眼補助具は所定の位置にないか操作者の手などで遮られていると判断し、反射式光学センサー左1003aだけから検出信号が送信されている場合は右眼眼瞼がアイピース1002に接していると判別し、反射式光学センサー右1003bだけから検出信号が送信されている場合は左眼眼瞼がアイピース1002に接していると判別する。 The left reflective optical sensor 1003a and the right reflective optical sensor 1003b are connected to the control unit 1004 and transmit detected signals. If there is no nose detection signal from either sensor, or if a detection signal is being sent from both sensors, the control unit 1004 determines whether the eye drop aid is not in the designated position or is blocked by the operator's hand or the like. If it is determined that the right eyelid is in contact with the eyepiece 1002, and a detection signal is sent only from the left reflective optical sensor 1003a, it is determined that the eyelid of the right eye is in contact with the eyepiece 1002, and a detection signal is transmitted only from the right reflective optical sensor 1003b. If so, it is determined that the eyelid of the left eye is in contact with the eyepiece 1002.
 コントロールユニット1004により判別された左右眼の情報は通信手段によりスマートフォンなどの外部装置に送信され点眼状態の評価や点眼履歴の情報として有効に活用される。また点眼補助具の点眼容器押圧機構や流入コントロール弁が電動の場合は、この左眼・右眼自動検出機能の判別情報により点眼動作をするかしないかを判断して点眼が確実に行われるように動作させることが可能である。 Information on the left and right eyes discriminated by the control unit 1004 is transmitted to an external device such as a smartphone via a communication means, and is effectively used as information for evaluating the eye drop condition and information on the eye drop history. In addition, if the eye drop container pressing mechanism or inflow control valve of the eye drop aid is electric, the discrimination information of the left eye/right eye automatic detection function determines whether or not to perform the eye drop operation to ensure that the eye drop is administered reliably. It is possible to operate the
 以上の左眼・右眼検出システムにより本点眼補助具は簡便に接眼されている眼の左右を検出して点眼補助具の動作を最適化することができ、さらに通信手段により送信された検出情報により、外部装置の患者サポートソフトやインターネット上の患者サポートシステムは点眼状態の評価や点眼履歴の記録を可能とする。本実施の形態1では鼻の検出センサーとして反射式の光学センサーを用いているがセンサーは超音波センサーや静電容量センサー、焦電センサーなどでも構わない。 With the above-mentioned left eye/right eye detection system, this eye drop aid can easily detect the left and right eyes that are close to each other and optimize the operation of the eye drop aid. This allows patient support software on external devices and patient support systems on the Internet to evaluate eye drop conditions and record eye drop history. In the first embodiment, a reflective optical sensor is used as the nose detection sensor, but the sensor may also be an ultrasonic sensor, a capacitance sensor, a pyroelectric sensor, or the like.
(7)点眼補助具の電気システムの構成(機能ブロック図)
 次に、点眼補助具の電気システムの構成(機能ブロック図)に関して図13を参照して説明する。図13は点眼補助具100において電動機構による押圧機構及び流入コントロール弁の場合の電気システム構成の一例を示している。電動による点眼容器押圧機構として電磁ソレノイド1803を用いた構成とし、流入コントロールにはモーター1805による弁駆動を用いた構成としている。
(7) Configuration of the electrical system of the eye drop aid (functional block diagram)
Next, the configuration (functional block diagram) of the electrical system of the eye drop aid will be described with reference to FIG. 13. FIG. 13 shows an example of an electrical system configuration in the case of an electric push mechanism and an inflow control valve in the eye drop aid 100. An electromagnetic solenoid 1803 is used as an electric eye drop container pressing mechanism, and a valve drive by a motor 1805 is used for inflow control.
 点眼補助具100に備わるコントロールユニット1801は、システム全体のコントロール及びエアファン1804、ソレノイド1803、モーター1805の駆動コントロールを成す構成としている。センサーユニット1802はセンサー通信基板1802a、トリガアーム位置センサー1802b、弁位置センサー1802c、接眼センサー1802d、薬液滴下粒通過センサー1802e、接触センサー1802f、左右眼検出センサー1802g、タグ読み取りセンサー1802hを備え、センサー通信基板1802aは各センサーの値をデジタル値に変換してコントロールユニットと通信する構成となっている。 A control unit 1801 provided in the eye drop aid 100 is configured to control the entire system and drive the air fan 1804, solenoid 1803, and motor 1805. The sensor unit 1802 includes a sensor communication board 1802a, a trigger arm position sensor 1802b, a valve position sensor 1802c, an eyepiece sensor 1802d, a droplet passing sensor 1802e, a contact sensor 1802f, a left and right eye detection sensor 1802g, and a tag reading sensor 1802h, and performs sensor communication. The board 1802a is configured to convert the values of each sensor into digital values and communicate with the control unit.
 すなわち、点眼補助具100は、エアダクト104内の所定の位置にエアダクト104を通過する薬液滴下粒を検出可能な滴下粒通過センサー1802eを配置して薬液が正常に角膜まで到達されたかを検出することができる。またトリガアーム107の位置を検出するトリガアーム位置検出センサー1802bや流入コントロール弁の開閉角度を検出する弁位置センサー1802c、点眼補助具100の傾きや動きを検出するGセンサー、患者の左右眼のどちらに接眼しているかを検出する左右眼検出センサー1802gを配置することで、患者の点眼補助具100の操作が適切になされたか、患者への点眼が適切になされたか、あるいは点眼補助具100の動作に異常はないかなどを評価できる。さらにエアチャンバー102内あるいはエアダクト104の流入口104aの近傍に、患者の眼を撮影できるカメラ1809(撮影手段)を配置すれば、点眼薬が患者の眼に送達されたときの、眼の開瞼状態や位置、さらに角膜に送達された点眼薬液の付着状態などを撮影画像により評価できる。 That is, the eye drop aid 100 includes a dropped droplet passage sensor 1802e that can detect droplets of the drug solution passing through the air duct 104 at a predetermined position in the air duct 104 to detect whether the drug solution has normally reached the cornea. I can do it. Additionally, a trigger arm position detection sensor 1802b detects the position of the trigger arm 107, a valve position sensor 1802c detects the opening/closing angle of the inflow control valve, a G sensor detects the tilt and movement of the eye drop aid 100, and a G sensor detects whether the patient's left or right eye By arranging the left and right eye detection sensor 1802g that detects whether the patient's eyes are close to It is possible to evaluate whether there are any abnormalities. Furthermore, if a camera 1809 (photographing means) capable of photographing the patient's eyes is placed inside the air chamber 102 or near the inlet 104a of the air duct 104, the opening of the eyelids when the eye drops are delivered to the patient's eyes is possible. The condition and position, as well as the adhesion state of the eye drops delivered to the cornea, can be evaluated using captured images.
 エアダクト104内に配置された薬液滴下粒通過センサー1802eは光学式の透過型あるいは反射型のセンサーや超音波センサーにより検出する。トリガアーム位置検出センサー1802bはトリガアーム107と連動するポテンショメータやエンコーダ、光学式の透過型あるいは反射型のセンサーによる光学的スリットや反射体の検出、磁気センサーなどにより検出する。弁位置センサー1802cは弁と連動するスイッチや、弁の回転軸に連動するポテンショメータやエンコーダ、あるいは開閉状態を直接に透過型又は反射型の光センサーなどにより検出することが好ましい。なお、本電気システムは例えば点眼補助具100が手動による点眼容器押圧機構及び流入コントロール弁の場合など、システムの構成により必要のない当該機能部を省くことができる。 The chemical droplet passage sensor 1802e disposed in the air duct 104 detects the droplet passage using an optical transmission type or reflection type sensor or an ultrasonic sensor. The trigger arm position detection sensor 1802b is detected by a potentiometer or encoder that is linked to the trigger arm 107, detection of an optical slit or reflector using an optical transmission type or reflection type sensor, a magnetic sensor, or the like. The valve position sensor 1802c is preferably a switch that is linked to the valve, a potentiometer or encoder that is linked to the rotation axis of the valve, or a transmission or reflection type optical sensor that directly detects the open/closed state. Note that, in this electrical system, for example, when the eye drop aid 100 is a manual eye drop container pressing mechanism and an inflow control valve, unnecessary functional units can be omitted depending on the system configuration.
 さらに、コントロールユニット1801はエアファン制御部1801aを備え、エアダクト104内に点眼容器106から滴下された薬液滴下粒を水平方向に移動させるために必要なエアダクト104内の空気流の薬液滴下粒に対する相対流速を上記(数8)により計算し、且つ得られた当該相対流速に基づいて前記エアダクト104内の流速が10m/sec以上40m/sec以下となるようにエアファン101に送る電圧を制御することができる。 Further, the control unit 1801 includes an air fan control section 1801a, and the air flow in the air duct 104 necessary for horizontally moving the droplets of the drug droplet dropped from the eye drop container 106 into the air duct 104 relative to the droplet droplet of the drug solution. Calculate the flow velocity using the above (Equation 8), and control the voltage sent to the air fan 101 so that the flow velocity in the air duct 104 is 10 m/sec or more and 40 m/sec or less based on the obtained relative flow velocity. I can do it.
 また、コントロールユニット1801は前眼部撮影カメラ(撮像手段)1809より送信された画像データを記憶でき、通信ユニット(通信手段)1808を介してWiFiあるいはブルートゥース(登録商標)などの近距離通信によりスマートフォン、パソコン、タブレットPCなどの外部装置とデータ通信をする。通信ユニット1808は、有線/無線ネットワークを介して外部端末に各種の検出データを送信する。なお、カメラ1809はエアチャンバー102内あるいはエアダクト104の流入口104a付近に配置され、エアダクト104を介して眼表面を撮影する。エアダクト104内に配置された開閉弁は流入口104aを遮断するため遮断壁は光が透過する透明な材料として患者の眼を撮影可能とすることが好ましい。 In addition, the control unit 1801 can store image data transmitted from the anterior eye camera (imaging means) 1809, and can communicate with the smartphone via short-range communication such as WiFi or Bluetooth (registered trademark) via the communication unit (communication means) 1808. , communicates data with external devices such as personal computers and tablet PCs. Communication unit 1808 transmits various detection data to an external terminal via a wired/wireless network. Note that the camera 1809 is disposed within the air chamber 102 or near the inlet 104a of the air duct 104, and photographs the ocular surface through the air duct 104. Since the on-off valve disposed in the air duct 104 blocks the inflow port 104a, it is preferable that the blocking wall is made of a transparent material that allows light to pass through so that the patient's eyes can be photographed.
 このように、本実施の形態1に係る点眼補助具100は外部通信手段を構成することが可能で、通信ユニット1808により外部のスマートフォンやパソコン、タブレットPC、Wi-Fi端末などの外部装置に接続し、点眼補助具100に配置された上述のセンサー1802b~1802hにて検出したデータや点眼状態、評価結果さらにカメラ1809にて撮影した患者眼の画像などを送信する。また送信されたデータや画像はスマートフォンやパソコンを介してインターネット上のサーバやクラウドシステムに送られ、これらのデータを患者や患者の家族や介護人などの支援者、医療機関が共有して閲覧・評価可能であり患者の治療をサポートできるホームモニタリングシステムを実現できる。  In this way, the eye drop aid 100 according to the first embodiment can constitute an external communication means, and can be connected to an external device such as an external smartphone, personal computer, tablet PC, or Wi-Fi terminal through the communication unit 1808. Then, the data detected by the above-described sensors 1802b to 1802h arranged in the eyedropper aid 100, the eyedropper status, the evaluation results, and the image of the patient's eye taken by the camera 1809 are transmitted. In addition, the transmitted data and images are sent to servers and cloud systems on the Internet via smartphones and computers, and these data can be shared by patients, patients' families, caregivers and other supporters, and medical institutions for viewing and viewing. A home monitoring system that can be evaluated and support patient treatment can be realized. 
 コントロールユニット1801はセンサーユニット1802や前眼部撮影カメラ1809より送られてきたデータ値や画像データによりシステムをコントロールすると共に外部装置とネットワークシステムによる患者サポートシステムへ点眼補助具100の状態や患者の点眼状態をデータとして送り、その結果、患者の治療サポートに有効なデータや情報を提供できる。 A control unit 1801 controls the system using data values and image data sent from a sensor unit 1802 and an anterior segment imaging camera 1809, and also sends the status of the eye drop aid 100 and the patient's eye drops to a patient support system using an external device and a network system. The status can be sent as data, and as a result, data and information that can be used to support patient treatment can be provided.
 以上の説明のように、本実施の形態1に係る発明は患者眼に点眼容器内の薬液を投与するための点眼補助具100であって、エアファン101と、エアファン101より吐出された空気流の空気室となるエアチャンバー102と、エアチャンバー102と連通された筒形状のエアダクト104と、点眼容器106が交換可能に装着されると共に水平状態にしたエアダクト106の上側壁に点眼容器106のノズルを下向きにして固定する点眼容器固定アタッチメント105と、点眼容器固定アタッチメント105に装着された点眼容器106の側面の所定位置を押圧する点眼容器押圧機構108と、点眼容器押圧機構108の動作を制御するトリガアーム107と、を備える。筒形状のエアダクト104の開口の一端側はエアファン101より吐出された空気流がエアチャンバー102を介して流入する流入口104aとなる一方、当該開口の他端側は患者の眼瞼周囲が当接する接眼口104dとなる。エアダクト104の上側壁には、点眼容器固定アタッチメント105に装着された点眼容器106のノズルより滴下された薬液滴下粒をエアダクト106内に導入するための薬液導入孔104cが形成される。 As described above, the invention according to the first embodiment is an eye drop aid 100 for administering a medical solution in an eye drop container to a patient's eye. An air chamber 102 that serves as an air chamber for air flow, a cylindrical air duct 104 communicating with the air chamber 102, and an eye drop container 106 that is replaceably attached to the upper wall of the air duct 106 in a horizontal state. Controls the operations of the eye drop container fixing attachment 105 that fixes the nozzle facing downward, the eye drop container pressing mechanism 108 that presses a predetermined position on the side of the eye drop container 106 attached to the eye drop container fixing attachment 105, and the eye drop container pressing mechanism 108. A trigger arm 107 is provided. One end of the opening of the cylindrical air duct 104 serves as an inlet 104a through which the air flow discharged from the air fan 101 flows through the air chamber 102, while the other end of the opening comes into contact with the area around the patient's eyelids. This becomes an eyepiece port 104d. A liquid medicine introduction hole 104c is formed in the upper wall of the air duct 104 for introducing into the air duct 106 the liquid drops dropped from the nozzle of the eye drop container 106 attached to the eye drop container fixing attachment 105.
 この構成により、点眼容器106内の薬液を点眼する際に、点眼補助具100を使用する患者が視線を上に向ける必要性がなく、横向きの楽な姿勢で患者眼に適正量の薬液の点眼ができる。すなわち、患者が点眼補助具100のトリガアーム107を引くという簡単な操作だけで患者が上を向くことなく水平視のまま点眼可能であり、点眼薬液は点眼補助具100の部品と非接触で通過するので点眼薬液が点眼補助具100の部品に汚染されることなく患者眼に送達され、上述の薬液滴下機構により一定量の点眼薬液を確実に滴下できると共に、患者は楽な姿勢で簡単・確実かつ安全に点眼することができる。 With this configuration, when instilling the medicinal solution in the eye drop container 106 into the eye, the patient using the eye drop aid 100 does not need to look upward, and an appropriate amount of the medicinal solution is injected into the patient's eye in a comfortable horizontal position. I can do it. That is, the patient can instill the eye while looking horizontally without looking up by simply pulling the trigger arm 107 of the eye drop aid 100, and the eye drop solution passes through without contacting any parts of the eye drop aid 100. Therefore, the eye drops can be delivered to the patient's eyes without being contaminated by the parts of the eye drop aid 100, and the above-mentioned medicine drop mechanism can reliably drip a certain amount of eye drops, and the patient can easily and reliably drop the eye drops in a comfortable position. And it can be safely instilled into the eyes.
 また、点眼容器固定アタッチメント105は簡単に点眼補助具100へ着脱可能であり複数の点眼薬を点眼する患者にとって煩雑な操作なく点眼薬を交換して点眼することが可能となる。 In addition, the eye drop container fixing attachment 105 can be easily attached to and removed from the eye drop aid 100, making it possible for patients who are instilling multiple eye drops to exchange and administer eye drops without complicated operations.
(変形例)
 次に、本発明の実施の形態1の変形例に係る点眼補助具に関して図14を参照して説明する。本変形例に係る点眼補助具100は、エアチャンバー102を省略した構成となる。上記の実施の形態1に係る点眼補助具100ではエアチャンバー102を介して空気流をエアダクト104に流入させるとエアダクト104内の空気流が一様にスムーズとなるためエアファン101とエアダクト104の間にエアチャンバー102を配置した。しかしながら、本変形例ではエアファン101の送風口は直接エアダクト104に連結しており、この構成により上記実施の形態1と同様の作用効果を奏することができると共に、装置の更なるコンパクト化、軽量化や低価格化を図ることができる。
(Modified example)
Next, an eyedrop aid according to a modification of the first embodiment of the present invention will be described with reference to FIG. 14. The eye drop aid 100 according to this modification has a configuration in which the air chamber 102 is omitted. In the eye drop aid 100 according to the first embodiment described above, when the air flow flows into the air duct 104 through the air chamber 102, the air flow inside the air duct 104 becomes uniformly smooth, so that the air flow between the air fan 101 and the air duct 104 becomes uniform. An air chamber 102 was placed in the air chamber 102. However, in this modification, the air outlet of the air fan 101 is directly connected to the air duct 104, and with this configuration, the same effects as in the first embodiment can be achieved, and the device can be made more compact and lightweight. This makes it possible to reduce costs and reduce costs.
 なお、本発明は、上記実施の形態の構成に限られず、発明の趣旨を変更しない範囲で種々の変形が可能である。例えば図1に示す使用例は一例であって点眼補助具100を高さ調整可能な支柱に固定載置し、水平を保った状態で点眼を行っても良い。また例えば、点眼容器106は薬剤の種類、メーカーなどによってサイズが異なるため、上述のような点眼容器押圧機構や押圧位置調整機構の複雑な機構を用いる代わりに、点眼容器のサイズ毎に異なる専用品としての点眼容器固定アタッチメント105を用いることも考え得る。この場合、点眼容器106が装着される度に、点眼容器固定アタッチメント105の押圧位置の微調整などが必要なく使い勝手が良い。すなわち、専用品の点眼容器固定アタッチメント105にそれぞれサイズの異なる別の点眼容器106を予め装着してキャップを閉めて保管しておけば、複数の点眼薬を使用する患者であっても点眼容器固定アタッチメント105を交換するだけで簡単に点眼薬を交換できる。 Note that the present invention is not limited to the configuration of the embodiments described above, and various modifications can be made without changing the spirit of the invention. For example, the usage example shown in FIG. 1 is just one example, and the eye drop aid 100 may be fixedly mounted on a height-adjustable support and the eye drop may be applied while keeping the eye drop in a horizontal state. For example, since the size of the eye drop container 106 varies depending on the type of drug, manufacturer, etc., instead of using a complicated mechanism such as the eye drop container pressing mechanism and the pressing position adjustment mechanism as described above, a special product that differs depending on the size of the eye drop container may be used. It is also conceivable to use an eye drop container fixing attachment 105 as a. In this case, each time the eye drop container 106 is attached, it is not necessary to make fine adjustments to the pressing position of the eye drop container fixing attachment 105, which is convenient for use. That is, if separate eye drop containers 106 of different sizes are attached in advance to the dedicated eye drop container fixing attachment 105 and stored with the caps closed, the eye drop containers can be fixed even for patients who use multiple eye drops. Eye drops can be easily replaced by simply replacing the attachment 105.
(実施の形態2)
 以下、本発明に係る点眼補助具の実施の形態2に関して図15乃至図21を参照して説明する。本実施の形態2は、上記実施の形態1に記載の点眼補助具100に配置された薬液の滴下粒通過センサーや前眼部画像撮影カメラ、Gセンサー、左右眼検出センサー、接眼センサーなどから点眼状態のデータを検出する検出手段と、得られた検出データをもとに点眼の状態を評価する評価手段と、該検出データ及び評価手段による評価データをスマートフォンやタブレットPC、パソコンなどと通信する通信手段とを用いて、該データを医師と患者が共有して、点眼治療の状態観察をすると共に、点眼治療を継続するように患者に働きかけるホームモニタリングシステム及び患者サポートシステムである。なお、上記実施の形態1と同様の構成には同じ符号を付して、その詳細な説明を省略する。
(Embodiment 2)
Embodiment 2 of the eye drop aid according to the present invention will be described below with reference to FIGS. 15 to 21. In the second embodiment, instillation is carried out from the droplet passage sensor for the drug solution, the anterior segment image capturing camera, the G sensor, the left and right eye detection sensor, the eyepiece sensor, etc. arranged in the eyedrop aid 100 described in the first embodiment. A detection means for detecting state data, an evaluation means for evaluating the state of the eye drops based on the obtained detection data, and communication for communicating the detection data and evaluation data by the evaluation means with a smartphone, tablet PC, personal computer, etc. This is a home monitoring system and a patient support system in which a doctor and a patient share the data using means to monitor the status of eye drop treatment and encourage the patient to continue the eye drop treatment. Note that the same components as in the first embodiment are given the same reference numerals, and detailed description thereof will be omitted.
 ここでは下記の順序に従って本発明の実施の形態2について説明する。
 (8)外部通信手段とネットワークシステムの構成
 (9)点眼実施を支援する患者サポートソフトウェアの動作
 (10)点眼時以外の患者サポートソフトウェアの機能及び動作
 (11)院内端末装置で実行される専用ソフトウェアの動作
 (12)支援者携帯端末で実行される専用ソフトウェアの動作
Here, Embodiment 2 of the present invention will be described in the following order.
(8) Configuration of external communication means and network system (9) Operation of patient support software that supports eye instillation (10) Functions and operations of patient support software other than during eye instillation (11) Dedicated software executed on in-hospital terminal equipment (12) Operation of dedicated software executed on the supporter's mobile terminal
(8)外部通信手段とネットワークシステムの構成
 図15は患者の治療をサポートするためのホームモニタリングシステムSの全体構成を示している。点眼器1101は複数の接続手段のうちの一つによりインターネット1109に接続される。接続手段としては有線ローカルエリアネットワーク(LAN)に接続されたルーター1102を介する手段、無線LANやブルートゥースなどの近距離無線により無線ルーター1103を介する手段やスマートフォンなどの携帯端末1104などの移動体通信を介する手段などによりインターネット(WAN)に接続される。
(8) Configuration of external communication means and network system FIG. 15 shows the overall configuration of a home monitoring system S for supporting patient treatment. Eye dropper 1101 is connected to the Internet 1109 by one of a plurality of connections. Connection means include means via a router 1102 connected to a wired local area network (LAN), means via a wireless router 1103 using short-range wireless such as wireless LAN or Bluetooth, and mobile communication such as a mobile terminal 1104 such as a smartphone. It is connected to the Internet (WAN) by means such as via a network.
 点眼器1101に配置された滴下粒通過センサーや前眼部画像撮影カメラ、Gセンサー、左右眼検出センサーなどから得られたデータ並びにそれらのデータをもとに点眼状態を評価したデータは前記接続手段を介して携帯端末1104やインターネット上のクラウドサービス1105や固定サーバ1110に蓄積される。これらの点眼状態データは点眼が実施された日時情報、点眼薬情報などと共に蓄積される。 Data obtained from the droplet passing sensor, anterior segment image capturing camera, G sensor, left and right eye detection sensor, etc. arranged in the eye dropper 1101, as well as data evaluating the eye drop condition based on these data, are transferred to the connection means. The information is stored in a mobile terminal 1104, a cloud service 1105 on the Internet, or a fixed server 1110 via the Internet. These eye drop condition data are accumulated together with information on the date and time when the eye drop was applied, eye drop information, and the like.
 点眼が実施された日時情報は点眼器補助具に具備された時計或いは点眼器と接続された携帯端末の時計から取得される。点眼薬情報は前記点眼容器固定アタッチメントに挿入されている点眼薬を点眼器1101が自動で識別するか、もしくはユーザーが携帯端末1104にインストールしたソフトウェアの機能を用いて選択するなどの方法で点眼薬情報を識別し、前記データと共に蓄積される。 Information on the date and time when the eyedrops were applied is obtained from a clock included in the eyedropper auxiliary tool or a clock on a mobile terminal connected to the eyedropper. The eye drop information is obtained by the eye dropper 1101 automatically identifying the eye drop inserted into the eye drop container fixing attachment, or by the user selecting the eye drop using a function of software installed on the mobile terminal 1104. Information is identified and stored with the data.
 一方、医師や薬剤師などの医療関係者や家族や介護人などの支援者1108は、インターネット1109に接続されたスマートフォンやパソコン、タブレット端末などの端末装置1007を介して前記クラウドサービス1005や固定サーバ1110に蓄積されたデータを随時閲覧・評価・データ解析ができ、患者の治療をサポートする事が可能となる。 On the other hand, medical personnel such as doctors and pharmacists, and supporters 1108 such as family members and caregivers access the cloud service 1005 and the fixed server 1110 via terminal devices 1007 such as smartphones, personal computers, and tablet terminals connected to the Internet 1109. The data accumulated in the system can be viewed, evaluated, and analyzed at any time, making it possible to support patient treatment.
 さらにクラウドサービス1105や固定サーバ1110には蓄積されたデータを解析するソフトウェアが組み込まれ、統計的な処理によるデータの分析や人工知能AI(Artificial Intelligence)やディープラーニングによるデータ解析や今後の予測、患者のアドヒアランス向上のために効果的なサポート方法を決定し実行することが可能となる。 Furthermore, the cloud service 1105 and the fixed server 1110 are equipped with software that analyzes the accumulated data, and analyzes the data through statistical processing, uses AI (Artificial Intelligence) and deep learning, and analyzes the data using AI (Artificial Intelligence) and deep learning. It becomes possible to determine and implement effective support methods to improve patient adherence.
 クラウドサービス1105や固定サーバ1110に蓄積されるデータは複数の患者のデータで構成することが可能であり、患者の同意の上で複数の患者データで構成されるビッグデータを利用して前記解析や予測、提案精度の向上に繋げることが可能となる。 The data stored in the cloud service 1105 and the fixed server 1110 can be composed of data of multiple patients, and with the patient's consent, the above analysis and analysis can be performed using big data composed of multiple patient data. This can lead to improvements in prediction and proposal accuracy.
 これらの解析データは医療関係者1108が診断や治療方針の決定のために利用するデータとして端末装置1107で確認する事が可能であり、さらに点眼器1101や患者の携帯端末1104、支援者の端末装置1107などで確認する事が可能である。また、患者のアドヒアランス向上のために解析データを利用して患者携帯端末1104で動作するソフトウェアの動作を変更する事も可能である。 These analyzed data can be checked on the terminal device 1107 as data used by medical personnel 1108 for diagnosis and determining treatment policies, and can also be checked on the eye dropper 1101, the patient's mobile terminal 1104, and the supporter's terminal. This can be confirmed using the device 1107 or the like. Furthermore, it is also possible to change the operation of software running on the patient portable terminal 1104 using the analysis data in order to improve patient adherence.
 図16は外部装置による患者サポートシステムの一例を示す構成図である。
 点眼補助具1201は患者がトリガアームを操作する事によりエアファンの駆動と連動して点眼容器の一部を加圧して一滴の薬液を滴下する滴下制御部1201aと、点眼補助具に配置された滴下粒通過センサーや前眼部画像撮影カメラ、Gセンサー、左右眼検出センサーなどから点眼の状態を示すデータを検出する点眼状態検出部1201bと、前記データを解析し点眼の状態を評価する点眼評価部1201cと、携帯端末に前記データや解析結果・評価結果などの送信や、携帯端末からの情報や指示などの受信をするための通信部1201dを備える。この通信部はUSBや有線LANなどの有線接続、ブルートゥースやWiFi、無線LANなど近距離無線接続を可能とするモジュールである。
FIG. 16 is a configuration diagram showing an example of a patient support system using an external device.
The eye drop aid 1201 includes a drop control unit 1201a that pressurizes a part of the eye drop container in conjunction with the drive of the air fan and drips a drop of medicine when the patient operates a trigger arm, and a drop control unit 1201a that is arranged in the eye drop aid. An eye drop condition detection unit 1201b that detects data indicating the eye drop state from a dropped particle passage sensor, an anterior segment image capturing camera, a G sensor, a left/right eye detection sensor, etc., and an eye drop evaluation unit that analyzes the data and evaluates the eye drop state. 1201c, and a communication section 1201d for transmitting the data, analysis results, evaluation results, etc. to the mobile terminal, and receiving information, instructions, etc. from the mobile terminal. This communication unit is a module that enables wired connections such as USB and wired LAN, and short-range wireless connections such as Bluetooth, WiFi, and wireless LAN.
 患者携帯端末1202は、CPUなどのプロセッサやメモリを用いて患者携帯端末1202の構成部を制御して各種機能を実現する制御部1202a、RAMなどのメモリであり点眼補助具から受信したデータを蓄積する記憶部1202b、インターネット等の通信網への通信接続や点眼補助具との通信を実現する通信部1202c、液晶パネル又は有機ELディプレイ等の画面表示部1202d、及びタッチパネルなどの操作入力部1202eなどを備える。さらに、患者自身が携帯端末に入力し保存した点眼薬情報・点眼計画や前記点眼補助具から受信し蓄積された点眼実施情報や点眼状況を含む各種データなどに基づいて点眼治療が継続できるよう働きかけるアドヒアランス解析支援部1202fを備える。 The patient mobile terminal 1202 includes a control unit 1202a that controls the components of the patient mobile terminal 1202 using a processor such as a CPU and memory to realize various functions, and a memory such as a RAM that stores data received from the eye drop aid. a communication unit 1202c that realizes communication connection to a communication network such as the Internet and communication with an eye drop aid, a screen display unit 1202d such as a liquid crystal panel or an organic EL display, and an operation input unit 1202e such as a touch panel. Equipped with etc. Furthermore, the system works to ensure that eye drop treatment can be continued based on various data including eye drop information and eye drop plans that the patient himself inputs and saves on his mobile device, eye drop implementation information and eye drop status received and accumulated from the eye drop aids, etc. It includes an adherence analysis support section 1202f.
 なお、点眼補助具1201が携帯端末1202との接続を行わない場合でも点眼補助具1201単独で点眼治療の継続を働きかけることができるよう、点眼補助具1201に画面表示部、操作入力部、記憶部、アドヒアランス解析支援部を備えても良い。 Note that even when the eye drop aid 1201 is not connected to the mobile terminal 1202, the eye drop aid 1201 is equipped with a screen display section, an operation input section, and a storage section so that the eye drop aid 1201 alone can encourage continuation of eye drop treatment. , an adherence analysis support section may be provided.
 図17はネットワークシステムを介した患者サポートシステムの一例を示す構成図である。
 点眼補助具1301は患者がトリガアームを操作する事によりエアファンの駆動と連動して点眼容器の一部を加圧して一滴の薬液を滴下する滴下制御部1301aと、点眼補助具に配置された滴下粒通過センサーや前眼部画像撮影カメラ、Gセンサー、左右眼検出センサーなどから点眼の状態を示すデータを検出する点眼状態検出部1301bと、前記データを解析し点眼の状態を評価する点眼評価部1301cと、広域ネットワークを介して固定サーバ1303や携帯端末に前記データや解析結果・評価結果などの送信や、広域ネットワークを介して固定サーバ1303や携帯端末からの情報や指示などの受信をするための通信部1301dを備える。この通信部はUSBや有線LANなどの有線接続、ブルートゥースやWiFi、無線LANなど近距離無線接続を可能とするモジュールである。
FIG. 17 is a configuration diagram showing an example of a patient support system via a network system.
The eye drop aid 1301 includes a drop control unit 1301a that pressurizes a part of the eye drop container in conjunction with the drive of the air fan and drips a drop of medicine when the patient operates a trigger arm, and a drop control unit 1301a that is arranged in the eye drop aid. An eye drop condition detection unit 1301b that detects data indicating the eye drop state from a dropped particle passage sensor, an anterior segment image capturing camera, a G sensor, a left/right eye detection sensor, etc., and an eye drop evaluation unit that analyzes the data and evaluates the eye drop state. The unit 1301c transmits the data, analysis results, evaluation results, etc. to the fixed server 1303 and mobile terminals via a wide area network, and receives information, instructions, etc. from the fixed server 1303 and mobile terminals via the wide area network. The communication unit 1301d is provided for communication. This communication unit is a module that enables wired connections such as USB and wired LAN, and short-range wireless connections such as Bluetooth, WiFi, and wireless LAN.
 患者携帯端末1302は、CPUなどのプロセッサやメモリを用いて患者携帯端末1302の構成部を制御して各種機能を実現する制御部1302a、RAMなどのメモリであり点眼補助具から受信したデータを蓄積する記憶部1302b、インターネット等の通信網への通信接続や点眼補助具との通信を実現する通信部1302c、液晶パネル又は有機ELディプレイ等の画面表示部1302d、及びタッチパネルなどの操作入力部1302eなどを備える。さらに、患者自身が携帯端末に直接入力して保存するか、あるいは医師や薬剤師がインターネットを介して提供する点眼薬情報・点眼計画・治療計画や、前記点眼補助具から受信し蓄積された点眼実施情報や点眼状況を含む各種データなどに基づいて点眼治療が継続できるよう働きかけるアドヒアランス解析支援部1302fを備える。 The patient mobile terminal 1302 includes a control unit 1302a that controls the components of the patient mobile terminal 1302 using a processor such as a CPU and memory to realize various functions, and a memory such as a RAM that stores data received from the eye drop aid. a communication unit 1302c that realizes a communication connection to a communication network such as the Internet and communication with an eye drop aid, a screen display unit 1302d such as a liquid crystal panel or an organic EL display, and an operation input unit 1302e such as a touch panel. Equipped with etc. Furthermore, eye drop information, eye drop plans, and treatment plans that the patient himself/herself enters directly into a mobile device and saves, or that doctors and pharmacists provide via the Internet, as well as eye drop administration received and stored from the eye drop aids. It includes an adherence analysis support unit 1302f that works to continue eye drop treatment based on information and various data including eye drop status.
 なお、点眼補助具1301が患者携帯端末1302との接続を行わずインターネットを介して直接固定サーバと接続している場合でも点眼補助具単独で点眼治療の継続を働きかけることができるよう、点眼補助具に画面表示部、操作入力部、記憶部、アドヒアランス解析支援部を備えても良い。 Note that even if the eye drop aid 1301 is not connected to the patient's mobile terminal 1302 and is directly connected to a fixed server via the Internet, the eye drop aid 1301 is designed so that the eye drop aid alone can encourage continuation of eye drop treatment. The device may also include a screen display section, an operation input section, a storage section, and an adherence analysis support section.
 図17では患者携帯端末1302が自宅LANを介してインターネットに接続している例を示しているが、介護施設などを含む外出先のLANに接続して患者サポートシステムを利用することも可能である。 Although FIG. 17 shows an example in which the patient mobile terminal 1302 is connected to the Internet via a home LAN, it is also possible to use the patient support system by connecting to a LAN outside the home, including a nursing facility. .
 固定サーバ1303は、点眼補助具1031が送信するセンサーデータや解析結果・評価結果ならびに患者携帯端末での入力や医師・薬剤師の端末で入力された点眼薬情報・点眼計画、さらには点眼補助具から患者携帯端末へ自動的に記録された日々の点眼状態や点眼実施状況などの点眼状況データなどの情報を受け取る通信部1303a、患者携帯端末1032や院内端末装置1304からリクエスト要求を受信した場合にレスポンス情報を返信する制御部1303b、前記送受信部で受け取った各種データを統計的な処理やAI、ディープラーニングなどを用いて解析し疾患の進行などを予測する、あるいは患者のアドヒアランス向上のために効果的なサポート方法を決定し実行などをするアドヒアランス解析支援部1303c、前記送受信部で受け取った各種データや前記アドヒアランス解析支援部1303cでの解析結果、患者(利用契約者)情報(利用契約者ID、パスワード、担当医療機関・医療従事者、生年月日、性別、ヘルスケア情報、来院予定日時、各種検査装置の測定結果など)などを蓄積するデータベースである記憶部1303dなどを備える。図17の例では固定サーバを用いたがクラウドサービスなどを用いても構わない。 The fixed server 1303 receives sensor data, analysis results, and evaluation results sent by the eye drop aid 1031, eye drop information and eye drop plans entered on the patient's mobile terminal, doctor/pharmacist's terminal, and even from the eye drop aid. The communication unit 1303a receives information such as eye drop status data such as daily eye drop status and eye drop implementation status automatically recorded in the patient mobile terminal, and responds when a request is received from the patient mobile terminal 1032 or the in-hospital terminal device 1304. A control unit 1303b that returns information, analyzes various data received by the transmitting/receiving unit using statistical processing, AI, deep learning, etc. to predict disease progression, or is effective for improving patient adherence. An adherence analysis support unit 1303c determines and executes the support method, and collects various data received by the transmitting/receiving unit, analysis results by the adherence analysis support unit 1303c, and patient (contractor) information (contractor ID, password). , medical institution/medical staff in charge, date of birth, gender, healthcare information, scheduled date and time of visit, measurement results of various testing devices, etc.). Although a fixed server is used in the example of FIG. 17, a cloud service or the like may also be used.
 院内端末装置1304は、医師から入力を受け付けるキーボードなどの操作入力部1304a、専用ソフトウェアをWebブラウザなどで実行するソフトウェア実行部1304b、操作入力部1304aを介して対象患者の点眼状況データやAIなどによる解析結果、点眼計画などの取得を行うリクエスト生成部1304c、固定サーバ1303に記憶されている対象患者のデータの受信や、院内の検査装置で実施した検査結果や医師が作成した点眼計画・治療計画・コメントなどの固定サーバへの送信をする通信部1304d、画面表示部1304e、及び記憶部1304fなどを備える。 The in-hospital terminal device 1304 includes an operation input unit 1304a such as a keyboard that accepts input from a doctor, a software execution unit 1304b that executes dedicated software on a web browser, etc., and an operation input unit 1304a that allows data on the eye instillation status of the target patient and information based on AI, etc. A request generation unit 1304c that obtains analysis results, eye drop plans, etc., receives data on target patients stored in the fixed server 1303, test results performed with in-hospital testing equipment, and eye drop plans and treatment plans created by doctors. - Includes a communication unit 1304d for transmitting comments and the like to a fixed server, a screen display unit 1304e, a storage unit 1304f, and the like.
 支援者携帯端末1305は、支援者から患者向けにメッセージ入力などを行うタッチパネルなどの操作入力部1305a、専用ソフトウェアをWebブラウザなどで実行するソフトウェア実行部1305b、操作入力部1305aを介して対象患者の点眼状況データやAIなどによる解析結果、点眼計画などの取得を行うリクエスト生成部1305c、通信部1305d、液晶パネル又は有機ELディプレイ等の画面表示部1305e、及び記憶部1305fなどを備える。 The supporter mobile terminal 1305 allows the supporter to input messages to the patient via an operation input unit 1305a such as a touch panel, a software execution unit 1305b that executes dedicated software on a web browser, etc., and an operation input unit 1305a to input messages to the patient. It includes a request generation unit 1305c that obtains eye drop situation data, analysis results by AI, etc., eye drop schedule, etc., a communication unit 1305d, a screen display unit 1305e such as a liquid crystal panel or an organic EL display, a storage unit 1305f, and the like.
(9)点眼実施を支援する患者サポートソフトウェアの動作
 図18は点眼実施を支援する患者サポートソフトウェアの動作の一例を示すフローチャートである。患者サポートソフトウェアは患者が点眼治療を継続する事をサポートし、アドヒアランスの維持向上を支援するためのソフトウェアとして機能する。該フローチャートの前処理として、ユーザー(患者又は支援者、医療関係者)は前記患者サポートシステムに使用する患者携帯端末にインターネットなどを介して該患者サポートソフトウェアをインストールする。
(9) Operation of patient support software that supports administration of eye drops FIG. 18 is a flowchart showing an example of the operation of patient support software that supports application of eye drops. Patient support software functions as software that supports patients in continuing eye drop treatment and helps maintain and improve adherence. As pre-processing of the flowchart, the user (patient, supporter, medical personnel) installs the patient support software onto the patient portable terminal used in the patient support system via the Internet or the like.
 図17のようにネットワークシステムを介して患者サポートシステムを機能させる場合、ユーザーは固定サーバから利用契約者IDを取得しパスワード設定などを行い、患者携帯端末と固定サーバ双方の記憶部に記録する。また、その他の患者(利用契約者)情報(氏名、生年月日、性別、人種、支援者名、支援者固有ID、担当医療機関・薬局、担当医など)も記録する。支援者固有IDは支援者の携帯端末などに患者サポートソフトウェアをインストールして支援する場合に割り当てられる固有のIDであり、インターネットを介したメッセージのやり取りや、固定サーバにアクセスして患者データの閲覧を行う場合などに利用される。固定サーバ内に記録されるデータは前記利用契約者IDに紐付けられて記録される。また、該患者サポートソフトウェアと点眼補助具とをWiFiなどで接続し該点眼補助具の固有IDを患者携帯端末の記憶部に記録する。 When the patient support system is operated via a network system as shown in FIG. 17, the user obtains the subscriber ID from the fixed server, sets a password, etc., and records it in the storage units of both the patient mobile terminal and the fixed server. Additionally, other patient (contractor) information (name, date of birth, gender, race, supporter's name, supporter's unique ID, medical institution/pharmacy in charge, doctor in charge, etc.) is also recorded. The supporter's unique ID is a unique ID that is assigned when providing support by installing patient support software on a supporter's mobile device, etc., and allows them to exchange messages over the Internet and access fixed servers to view patient data. It is used when carrying out. The data recorded in the fixed server is recorded in association with the usage contractor ID. Further, the patient support software and the eye drop aid are connected via WiFi or the like, and the unique ID of the eye drop aid is recorded in the storage section of the patient's mobile terminal.
 S1401では、点眼基本情報の登録を行う。点眼基本情報には点眼薬名称、対象眼(右眼、左眼、両眼)、一日の点眼回数、1回の滴下回数、点眼時間(時間帯)、処方日、担当医師・薬剤師情報などがある。これらの情報を取得する方法としては、薬局で提供されるQRコードを前記患者携帯端末のカメラや点眼補助具のカメラで読み込む方法、前記患者携帯端末のカメラや点眼補助具のカメラ、あるいは点眼容器固定アタッチメントに具備されたカメラもしくはバーコードリーダなどで点眼薬に記載のバーコードを読み込み、インターネットを介して対応する点眼薬の情報を取得する方法、院内端末上で実行される専用ソフトウェアから発行される点眼基本情報を含むQRコードなどを前記患者携帯端末のカメラや点眼補助具のカメラで読み込む方法、医師・薬剤師が院内端末上で実行される専用ソフトウェアから直接登録しインターネットで固定サーバに登録する方法、ユーザーが患者サポートソフトウェアの入力機能を用いて直接入力する方法、或いはこれらの方法を組み合わせる方法などがある。 In S1401, basic eye drop information is registered. Basic information about eye drops includes name of eye drops, target eye (right eye, left eye, both eyes), number of drops per day, number of drops per day, duration of eye drops (time of day), date of prescription, and information on the doctor/pharmacist in charge. There is. Methods for acquiring this information include reading the QR code provided by the pharmacy with the camera of the patient's mobile terminal or eye drop aid; A method is to read the barcode on the eye drops with a camera or barcode reader equipped on a fixed attachment, and obtain information on the corresponding eye drops via the Internet. A method of reading a QR code containing basic eye drop information using the camera of the patient's mobile terminal or the camera of an eye drop aid, or a method in which a doctor or pharmacist registers it directly from dedicated software running on an in-hospital terminal and registers it on a fixed server over the Internet. There are two methods: a method in which the user directly inputs data using the input function of the patient support software, and a method in which these methods are combined.
 さらに、登録した点眼薬の点眼容器を点眼容器固定アタッチメント105に装着して点眼補助具に挿入し、取得された該点眼容器固定アタッチメントの固有タグの情報を該点眼薬の点眼基本情報に関連付けて登録する事ができる。それにより挿入されている点眼薬の種類を自動的に判別することが可能となり、点眼薬の取り違えなどを防ぐ事が可能となる。 Furthermore, the eye drop container of the registered eye drop is attached to the eye drop container fixing attachment 105 and inserted into the eye drop aid, and the acquired information of the unique tag of the eye drop container fixing attachment is associated with the basic eye drop information of the eye drop. You can register. This makes it possible to automatically determine the type of eye drops inserted, making it possible to prevent mix-ups of eye drops.
 S1402では、設定した時間になると前記点眼基本情報を基にその日の点眼計画を作成して患者携帯端末の画面に表示して通知する。その際、音声やアラーム音で注意を促してもよい。この画面で一時的、又は恒久的に点眼時間の設定を変更する事ができてもよい。 In S1402, when the set time comes, an eye drop plan for the day is created based on the basic eye drop information and is displayed on the screen of the patient's mobile terminal to notify the patient. At this time, a voice or an alarm sound may be used to warn the user. It may be possible to temporarily or permanently change the eye instillation time setting on this screen.
 S1403では、点眼時間になったらS1404で患者携帯端末の画面上に点眼を促すメッセージを表示し、音声やアラーム音で通知する。この際、登録された支援者にも自動的にメッセージを送信してもよい。S1405でユーザーによって点眼補助具の電源が入れられ点眼補助具と患者携帯端末の通信が確立すると、点眼支援処理実行ステップS1406に移行する。この間、点眼補助具の電源をONする方法を画面に表示する、あるいは点眼補助具と患者携帯端末との通信が確立するまでの様子をイラストやアニメーション、音声などで表現する事でユーザーに現在の状況を理解しやすくしスムーズな操作を誘導する事も可能である。また、親しみやすさを向上して患者の点眼治療に対するモチベーションを向上させる目的で、該点眼補助具を擬人化や擬生物化したイラストやアニメーション、音声などで表現してもよい。 In S1403, when it is time for eye instillation, a message prompting the patient to instill the eye is displayed on the screen of the patient's mobile terminal in S1404, and notification is given by voice or alarm sound. At this time, a message may also be automatically sent to registered supporters. When the user turns on the power of the eye drop aid and establishes communication between the eye drop aid and the patient's portable terminal in S1405, the process moves to eye drop support processing execution step S1406. During this time, the user can be informed of the current situation by displaying instructions on how to turn on the eye drop aid on the screen, or by expressing the process until communication is established between the eye drop aid and the patient's mobile device using illustrations, animations, audio, etc. It is also possible to make the situation easier to understand and guide smooth operation. Further, in order to improve familiarity and improve the patient's motivation for eye drop treatment, the eye drop aid may be expressed using anthropomorphic or anthropomorphic illustrations, animations, sounds, etc.
 S1406では患者が点眼補助具を用いて正しく効果的な点眼操作を行うための支援を行う。患者携帯端末の画面に点眼すべき点眼薬の情報や対象眼を画像やイラストなどを用いて分かりやすく表示し、該点眼薬補助具に点眼容器固定アタッチメントを挿入するようユーザーに促す。なお、点眼薬の容量や点眼実績から点眼対象の点眼薬の残量が少ない或いは無いと判断した場合、ユーザーに点眼薬の残量を確認させる或いは点眼薬ボトルを新しい物に交換するよう指示することも可能である。同一時間帯に複数の点眼を行う場合には、全ての点眼薬情報を表示してもよい。点眼の順番が決まっている場合などは、これから点眼する点眼薬の表示を色や大きさ、アイコン表示などで他の点眼薬と区別するために強調表示するのが望ましい。ユーザーが点眼容器固定アタッチメントに装着された点眼薬を点眼補助具に挿入すると、RFIDのダグを読み取り点眼基本情報と照合して挿入されている点眼薬を識別し、挿入されている点眼薬の情報を画面に表示する、あるいは挿入されている点眼薬が点眼すべき点眼薬でない場合には警告して正しい点眼薬に取替えるようユーザーに促すことも可能である。なお、点眼容器固定アタッチメントに点眼薬を撮影するためのカメラや識別するためのバーコードリーダが具備されている場合には、該カメラ画像や該バーコードから判断された点眼薬情報を用いて動作を決定することが可能である。 In S1406, the patient is supported to perform correct and effective eye drop operation using the eye drop aid. Information about the eye drops to be instilled and the target eye are displayed on the screen of the patient's portable terminal in an easy-to-understand manner using images, illustrations, etc., and the user is prompted to insert the eye drop container fixing attachment into the eye drop aid. In addition, if it is determined that there is little or no remaining amount of eye drops to be instilled based on the capacity of the eye drops or the history of eye drops, the user is instructed to check the remaining amount of eye drops or to replace the eye drop bottle with a new one. It is also possible. When a plurality of eye drops are administered during the same time period, information on all eye drops may be displayed. When the order of eye drops is determined, it is desirable to highlight the eye drops to be instilled in order to distinguish them from other eye drops by color, size, icon display, etc. When the user inserts the eye drops attached to the eye drop container fixing attachment into the eye drop aid, the RFID tag is read and compared with basic eye drop information to identify the inserted eye drop and provide information on the inserted eye drop. It is also possible to display this on the screen, or to warn the user if the inserted eyedrops are not the correct eyedrops to prompt the user to replace them with the correct eyedrops. In addition, if the eye drop container fixing attachment is equipped with a camera for photographing the eye drops or a barcode reader for identifying them, the operation will be performed using the eye drop information determined from the camera image and the barcode. It is possible to determine.
 患者サポートソフトウェアが点眼対象の点眼薬が点眼補助具に正しくセットされたことを確認すると、点眼補助具を用いた点眼方法を画面上にイラストやアニメーションをなど用いて表示する。特にユーザーが点眼する対象眼(左右眼)を間違えないために、対象眼側に点眼補助具を当てている顔のイラストなどを表示する事で左右眼の取り違えを防ぐようにする事が望ましい。 When the patient support software confirms that the eye drops to be instilled are correctly set in the eye drop aid, it displays on-screen instructions on how to instill the eye using the eye drop aid, using illustrations, animations, etc. In particular, in order to prevent the user from mistaking the target eye (left and right) for which the eye drops are being applied, it is desirable to display an illustration of a face with the eye drop aid applied to the target eye to prevent confusion between the left and right eyes.
 図19は点眼指示画面の一例を示す図である。ここでは同時刻に複数の点眼薬を点眼する場合の例を示している。現在点眼すべき点眼薬1501を点眼薬名や写真などと共に大きく強調して表示し、それ以外の点眼薬の情報1502は小さく目立たないように表示している。また、同時刻に点眼する点眼薬のうち今何個目であるかを1503に表示し、進行状況を把握できるようにしている。正面顔イラスト1504は患者が画面を見たときに患者自身の顔が鏡に映っているような鏡映反転の配置とする事で、見たままを真似して操作する事ができ、左右眼の取り違いを防止できる。正面顔イラスト1504の代わり、又は該正面顔イラストとオーバーラップさせるように、スマートフォンの画面側に搭載されているフロントカメラ1508で患者自身の顔をリアルタイムで撮影している動画を表示してもよい。その際、動画は患者からスマートフォンの画面を見て鏡に映っているような鏡映反転の向き、つまり右眼が画面の右側、左眼が画面の左側に写るように表示する。正面顔イラスト1504や患者顔のリアルタイム動画の点眼対象眼側に矢印などと共に対象眼表示1505を配置し、さらに点眼補助具のイラスト1506を点眼対象眼に当てているように表示することで、患者がどちらの眼に点眼補助具を当てるべきかを一目で分かりやすく示すことができる。メッセージ欄1507には、患者への操作指示や現在の進行状況などを表示する。 FIG. 19 is a diagram showing an example of an eye drop instruction screen. Here, an example is shown in which a plurality of eye drops are instilled at the same time. The eye drops 1501 to be currently instilled are displayed in a large and emphasized manner along with the name of the eye drops, a photograph, etc., and information 1502 about other eye drops is displayed in a small and inconspicuous manner. Furthermore, the current number of eye drops among the eye drops to be instilled at the same time is displayed on 1503 so that the progress status can be grasped. The front face illustration 1504 is arranged in a mirror-inverted manner so that when the patient looks at the screen, the patient's own face is reflected in the mirror, so that the patient can imitate what he sees and operate it, and the left and right eyes can be adjusted. This can prevent mix-ups. Instead of the front face illustration 1504, or to overlap with the front face illustration, a video of the patient's own face captured in real time by a front camera 1508 mounted on the screen of the smartphone may be displayed. . At that time, the video is displayed so that the patient's smartphone screen is mirrored, as if it were reflected in a mirror, with the right eye on the right side of the screen and the left eye on the left side of the screen. By arranging the target eye display 1505 along with an arrow etc. on the side of the eye to which the eye is being instilled in the front face illustration 1504 or the real-time video of the patient's face, and by displaying the illustration 1506 of the eye drop aid as if it is placed on the eye to which the eye is being instilled, can clearly show at a glance which eye the eyedrop aid should be applied to. A message column 1507 displays operation instructions for the patient, current progress status, and the like.
 患者が点眼補助具を接眼すると点眼補助具に具備された左右眼自動検出機能により接眼している眼が左右のどちらであるかを検知できるが、実際に検知した眼と点眼すべき対象眼が一致しない場合には、警告表示や警告音などにより点眼補助具を接眼している眼が間違っていることをユーザーに知らせる、或いは間違っていた場合には点眼補助具での点眼動作を自動的に停止しても良い。点眼補助具を28対象眼に当てて点眼するまでの間は携帯端末の画面の指示を目視で確認する事が難しいため、音声案内による指示誘導を行うとよい。 When a patient approaches the eye drop aid, the eye drop aid is equipped with an automatic left/right eye detection function that can detect whether the eye is the left or right eye. If they do not match, a warning display or sound will be displayed to inform the user that the eye to which the eye drop aid is being applied is incorrect, or if the eye drop aid is placed in the wrong eye, the eye drop aid will automatically perform the instillation operation. You can stop. Since it is difficult to visually confirm the instructions on the screen of the mobile terminal until the eye drop aid is applied to the target eye and the eye is instilled, it is preferable to use voice guidance to guide the instructions.
 S1407でユーザーが点眼を実施すると、点眼補助具の各種センサーから得られたデータや前眼部画像、及びそれらのデータを解析して得られた点眼状態の評価結果など点眼状態データを患者サポートソフトウェアが受信して解析し、S1408で点眼が成功したか否かを判定する。 When the user administers eye drops in S1407, the patient support software sends eye drop status data such as data obtained from various sensors of the eye drop aid, anterior segment images, and eye drop status evaluation results obtained by analyzing these data. receives and analyzes it, and determines whether or not the eye instillation was successful in S1408.
 点眼が成功したか否かの判定方法は限定しないが、点眼補助具に具備された複数のセンサー情報と時系列の複数の前眼部画像を組み合わせて判定する方法が上げられる。例えば、点眼行為が患者により実施された後のある一定期間内に滴下粒通過センサーの反応が無い場合は点眼失敗と判定できる。一方滴下粒通過センサーに反応があった場合でもGセンサーの値から点眼補助具の傾きがある一定上に大きく点眼薬が対象眼まで届かないと判断される場合には点眼失敗と判断できる。滴下粒通過センサーとGセンサーの値から対象眼の位置まで点眼薬が到達したと判断された場合、撮影手段により撮影された複数の時系列前眼部画像(動画)を解析して、点眼薬が角膜や結膜に送達されたかを判断する事ができる。例えば各種画像フィルタなどを用いて前処理を行い瞳孔や虹彩の存在や位置を同定する事により正しく開瞼しているか否かを判定し、開瞼状態で点眼薬が対象眼に送達された場合は点眼成功と判断する事ができる。また、一般的なフィルタリングが輪郭抽出などの画像処理を用いる方法以外にも点眼成功・失敗の画像パターンを学習した人工知能やディープラーニングを用いて点眼の成功失敗を判定する方法を用いてもよい。 There are no limitations to the method of determining whether or not eye instillation has been successful, but an example is a method of determining by combining information from multiple sensors provided on the eye instillation aid and multiple images of the anterior segment in time series. For example, if there is no response from the droplet passage sensor within a certain period of time after the patient performs eyedropping, it can be determined that eyedropping has failed. On the other hand, even if there is a reaction in the dropped particle passage sensor, if it is determined from the value of the G sensor that the eye drop aid is tilted to a certain extent and the eye drop cannot reach the target eye, it can be determined that the eye drop has failed. When it is determined that the eye drops have reached the position of the target eye based on the values of the dropped particle passage sensor and the G sensor, multiple time-series anterior segment images (videos) taken by the imaging means are analyzed and the eye drops are removed. It can be determined whether the drug has been delivered to the cornea or conjunctiva. For example, if the eye drops are delivered to the target eye with the eyelids open, it is determined whether or not the eyelids are correctly opened by performing preprocessing using various image filters to identify the presence and position of the pupil and iris. It can be judged that the instillation was successful. In addition to the general filtering method that uses image processing such as contour extraction, it is also possible to use a method that uses artificial intelligence or deep learning that has learned image patterns of success and failure of eye drops to determine success or failure of eye drops. .
 点眼に成功したと判断した場合にはS1409に移行する。成功しなかった場合にはその旨をユーザーに通知しS1406に戻る。 If it is determined that the eye instillation was successful, the process moves to S1409. If unsuccessful, the user is notified of this and the process returns to S1406.
 S1409で同時刻に行うべき点眼行為が全て完了した場合にはS1410に移行し、該フローの中で実施した点眼実施情報(点眼実施日時、点眼した点眼薬、点眼状態データ、点眼場所など)を記録する。まだ全ての点眼行為が終了していない場合には、次の点眼薬を点眼するためS1406に戻る。複数の点眼薬を連続で点眼する場合、短時間に連続的に点眼すると点眼薬が眼から流れ出してしまい、点眼薬の効果が十分得られない場合があるため、2剤目以降の点眼支援処理では適切な待ち時間を設定してもよい。また、点眼した点眼薬の効果が発揮されるようにするための眼を閉じて待つ行為を促すために、その方法をイラストやアニメーション、あるいは音声などを用いて患者を誘導してもよい。さらに一剤点眼が完了する毎に点眼補助具から点眼容器固定アタッチメントを抜き取り、キャップを閉めて片付けるまでの行為を促すために、イラストやアニメーション、あるいは音声などを用いて患者を誘導してもよい。 If all the eye drops to be performed at the same time have been completed in S1409, the process moves to S1410, and the information on the eye drops performed in the flow (date and time of eye drops, instilled eye drops, eye drop status data, eye drop location, etc.) is stored. Record. If all eye drops have not been completed yet, the process returns to S1406 to instill the next eye drop. When instilling multiple eye drops in succession, the eye drops may flow out of the eye if they are injected continuously in a short period of time, and the eye drops may not be as effective as they should be. Then you can set an appropriate waiting time. Further, in order to encourage the patient to close their eyes and wait for the effect of the eye drops to be exerted, illustrations, animations, sounds, etc. may be used to guide the patient. Furthermore, illustrations, animations, or audio may be used to guide the patient to remove the eye drop container fixing attachment from the eye drop aid, close the cap, and put it away each time a single eye drop is completed. .
 S1411では、蓄積された日々の点眼実施情報に基づいて点眼計画通りに点眼が実施できているかなどの点眼状況を評価し、患者の点眼治療に対する意欲やアドヒアランスをスコア化して通知し、そのスコアを上げるためのアドバイスの提供やメッセージの表示、治療を行っている疾患や点眼治療に関する情報の提供などを行い、患者のアドヒアランスの維持向上や治療継続を動機付ける支援処理が実行される。 In S1411, the eye drop situation is evaluated based on the accumulated daily eye drop implementation information, such as whether the eye drops are being applied according to the eye drop plan, and the patient's motivation and adherence to eye drop treatment is scored and notified. Support processing is executed to maintain and improve patient adherence and motivate patients to continue treatment, by providing advice and displaying messages to improve patient adherence, and providing information about the disease being treated and eye drop treatment.
 さらに、ネットワークシステムを介した患者サポートシステムの場合、点眼を実施したことを登録した家族や介護人などの支援者に通知することも可能である。通知の方法は、患者サポートソフトウェアの専用アプリを支援者の携帯端末などにインストールしておき、専用アプリに搭載しているメッセージ機能を通じて、患者携帯端末から点眼を実施した旨を自動で通知する方法や、登録したSNSを利用して通知する事も可能である。通知を受け取った支援者はメッセージを返信することが可能である。 Furthermore, in the case of a patient support system via a network system, it is also possible to notify registered supporters such as family members and caregivers that eye drops have been administered. The notification method is to install a dedicated patient support software app on the supporter's mobile device, and then automatically notify the patient that the eye drops have been administered from the patient's mobile device through the message function built into the dedicated app. It is also possible to notify using a registered SNS. Supporters who receive the notification can reply with a message.
 スコアを上げるための動機付けとなるようにゲーミフィケーションの要素を取り入れても良い。治療継続に結びつくスコアアップの動機付けに繋がる方法であれば、その手法を限定しない。例えば、スコアの点数を動植物などのキャラクターの成長や状態に結びつける事で、正しく点眼治療を続けるとキャラクターが成長したり元気になったり喜んだりするなどのポジティブな変化が見られることが楽しみになり点眼治療を継続する動機付けに繋げる。逆にスコアが下がると植物が枯れて元気が無くなったりするとそのキャラクターが復活するようにスコアを上げるべく点眼治療を再開する動機付けとなる。また、スコアが上がる毎にゲームが進行するよう動作させてもよい。例えば、スコアや点眼継続日数が基準を満たすと、ゲームが次のステージに進む事ができる、あるいはゲームで使用できるアイテムを獲得できるなどの方法でもよい。さらに、ゲームの進行状況や獲得したアイテムの情報などを登録した支援者家族や友人などと共有することを可能にしても良い。また、スコアや貯まったポイントなどを現実世界の商品やサービスと交換できるようにしても良い。なお、実行されたアドヒアランス解析支援処理の内容は記録され、その処理内容とその後の患者の行動変容との関係性などを分析し、さらに効果的な支援処理の方法決定のために活用する事が可能である。 You may also incorporate elements of gamification to motivate you to improve your score. There are no limitations on the method as long as it is a method that motivates score improvement that leads to continued treatment. For example, by linking the score to the growth and condition of characters such as animals and plants, you can look forward to seeing positive changes such as characters growing, becoming more energetic, and becoming happy if you continue to use eye drops properly. This will lead to motivation to continue eye drop treatment. On the other hand, if the score decreases and the plants wither and lose their vitality, the character will be motivated to restart the eye drop treatment in order to raise the score and revive the character. Alternatively, the game may be made to progress each time the score increases. For example, if the score or the number of days the eye drops meet the criteria, the game can proceed to the next stage, or items that can be used in the game can be obtained. Furthermore, it may be possible to share the progress of the game, information on acquired items, etc. with registered supporters, family members, friends, etc. Furthermore, scores and accumulated points may be exchanged for real-world goods and services. The content of the adherence analysis support process executed is recorded and can be used to analyze the relationship between the process content and subsequent changes in patient behavior, and to determine a more effective support process method. It is possible.
 S1412では、本日予定されていた全ての点眼が完了したかを自動で判断し、完了した場合は処理を終了し、完了していない場合には次の点眼時間まで待機する。 In S1412, it is automatically determined whether all eye drops scheduled for today have been completed, and if completed, the process ends, and if not completed, the process waits until the next eye drop time.
(10)点眼時以外の患者サポートソフトウェアの機能及び動作
 アドヒアランス解析支援処理は、図19のような点眼実施時だけでは無く、様々なタイミングで実行され、日常的に患者のアドヒアランス維持向上や治療継続を動機付ける支援を行う。
(10) Functions and operations of patient support software other than during eye instillation Adherence analysis support processing is executed not only at the time of eye instillation as shown in Figure 19, but also at various timings, and is used to maintain and improve patient adherence and continue treatment on a daily basis. Provide motivational support.
 支援方法の一例として励ましのメッセージを提供する方法がある。図20は激励メッセージ表示画面の一例である。画面にはスコア1601、激励のメッセージ1602などを表示する。メッセージの内容はスコアや点眼状況、来院状況などに応じて内容を決定する事が可能であり、できるだけポジティブな表現が望ましい。また文字や音声のメッセージだけでは無く、1603のようにキャラクターがメッセージの内容に合わせた表情で話しかけるような表現にする事で、より親しみやすさを演出することも可能である。またスコアや点眼状況、来院状況、治療開始からの経過期間などに合わせて、1604のようにアドヒアランスを維持向上するために効果的な対象疾患の知識や情報を提供し、患者がボタンなどをタップしてその内容(詳細コンテンツ)を開き確認したらポイントを付与しスコアをアップするよう動作させてもよい。1604の内容は他にも患者自身の点眼履歴や眼圧などの検査結果の推移、治療計画など、患者が自身の病状と疾患の特徴、目標などを理解しアドヒアランスの維持向上や治療継続の動機付けに繋がる内容であればその内容を限定しない。 An example of a support method is to provide messages of encouragement. FIG. 20 is an example of an encouragement message display screen. A score 1601, a message of encouragement 1602, etc. are displayed on the screen. The content of the message can be determined depending on the score, eye drop status, visit status, etc., and it is desirable to use positive expressions as much as possible. In addition to text and voice messages, it is also possible to create a more friendly atmosphere by having the characters speak with facial expressions that match the content of the message, as in 1603. In addition, we provide knowledge and information about the target disease that is effective in maintaining and improving adherence, such as 1604, based on the patient's score, eye drop status, visit status, and time elapsed since the start of treatment, allowing the patient to tap a button, etc. After opening the content (detailed content) and confirming it, points may be given to increase the score. The contents of 1604 also include the patient's history of eye drops, changes in test results such as intraocular pressure, treatment plans, etc., so that the patient understands his or her condition, characteristics of the disease, goals, etc., maintains and improves adherence, and motivates continued treatment. The content is not limited as long as it leads to the attachment.
 メッセージの通知タイミングは過去のメッセージに対する患者の反応履歴などを基により効果的なタイミングを決定してもよい。例えば1604をタップして内容を確認する確率が一番高い時間や場所を過去の反応履歴から解析してもよい。激励メッセージの内容1602についても過去の反応履歴などから点眼治療に対するポジティブな行動変容に繋がる効果的なメッセージを生成することが可能である。 As for the message notification timing, a more effective timing may be determined based on the patient's reaction history to past messages. For example, the time and place where the probability of tapping 1604 and confirming the content is highest may be analyzed from past reaction history. Regarding the content 1602 of the encouragement message, it is possible to generate an effective message that leads to positive behavior change toward eye drop treatment based on past reaction history and the like.
 前記詳細コンテンツの確認時以外に、点眼実施時、来院時、薬の受取り時にはポイントが付与されスコアアップするように動作する。ポイントの大きさは重要度や効果に応じて変更してもよい。さらに、アドヒアランスの低下や点眼治療の継続意欲が低下していると判断される場合はスコアを低下させるように動作しても良い。アドヒアランス低下や意欲低下は点眼実施率の低下、点眼時刻が守られない場合、来院が滞る場合などを判断材料にしても良い。 In addition to checking the detailed content, points are awarded when applying eye drops, visiting the hospital, and receiving medicine to increase your score. The size of points may be changed depending on the degree of importance and effect. Furthermore, if it is determined that adherence is decreasing or the desire to continue eye drop treatment is decreasing, the score may be decreased. Deterioration in adherence and motivation can be determined based on factors such as a decrease in the rate of instillation, failure to adhere to the instillation time, and delays in visiting the clinic.
 来院予約日時が近づいたら、来院予約日時や病院名、担当医などを知らせるメッセージを表示し、来院忘れを防止するよう機能する。来院予約日時の設定は、前回来院時に院内端末上で実行される専用ソフトウェアから発行される診療予約を含むQRコードなどを前記患者携帯端末のカメラや点眼補助具のカメラで読み込む方法、医師が院内端末上で実行される専用ソフトウェアから直接登録しインターネットで固定サーバに登録する方法、ユーザーが患者サポートソフトウェアの入力機能を用いて直接入力する方法などがある。 As the appointment date and time approaches, a message will be displayed informing you of the appointment date and time, the name of the hospital, the doctor in charge, etc., to prevent you from forgetting to come to the hospital. Visit appointment dates and times can be set by scanning a QR code containing the medical appointment issued by special software running on the in-hospital terminal at the time of the previous visit, using the camera of the patient's mobile terminal or the camera of the eye drop aid; There are two methods: direct registration from dedicated software running on the terminal and registration on a fixed server over the Internet, and direct input by the user using the input function of patient support software.
 点眼薬情報の点眼薬の容量、処方された点眼薬の数、点眼実績から点眼薬が無くなる日を推定し、推定日が近づいても来院予定日が設定されていない場合には、推定日までに来院を促すメッセージを表示しても良い。同時に来院予定日を設定する機能や、来院の予約をインターネット経由で行う機能を動作させてもよい。 The date when the eye drops will run out is estimated based on the eye drop capacity, the number of prescribed eye drops, and the history of eye drops in the eye drop information.If the estimated date approaches and the scheduled visit date has not been set, the estimated date will be used. A message may be displayed to encourage patients to visit the hospital. At the same time, a function for setting a scheduled visit date or a function for making a reservation for a visit via the Internet may be operated.
 患者携帯端末の患者サポートソフトウェアでは随時点眼状況、眼圧計や視野検査などの検査結果、スコアの状況、点眼薬の残量、点眼薬情報、来院予約日、対象疾患や点眼薬に関する詳細コンテンツ、過去のメッセージのやり取りなどを閲覧する事が可能である。 The patient support software on the patient's mobile device allows you to check the eye condition at any time, test results such as tonometer and visual field test, score status, remaining amount of eye drops, eye drop information, visit appointment date, detailed content about target diseases and eye drops, past information, etc. It is possible to view the exchange of messages.
 各種検査結果は点眼状況やスコアの推移、来院や点眼薬の変更などのイベントなどと一緒にグラフや表などで関連性を分かりやすく表示する事が可能である。図21は検査結果とスコア、各種イベントとの関係を表すグラフの一例である。この例では上段から順番に視野検査で得られた視野感度1701、眼圧計で測定した眼圧値1702、患者サポートソフトウェアで得られたスコアの推移1703、来院日や点眼開始、点眼薬変更などのイベント1704を時系列に並べて表示している。視野感度については任意の期間における複数の測定値の近似直線(この例では一点鎖線1705)を各データ値と共に表示する事で、その期間の感度低下度合いを示し、期間毎の感度低下度合いの変化を分かりやすく表示している。眼圧値については設定された目標眼圧をグラフ上に表示(この底では水平の点線1706)し、治療の目標を明確にしている。スコアは棒グラフ1707の高さや色でアドヒアランスや治療継続に対する意欲の高さを表現してもよい。グラフ上のデータをタップすると詳細データを確認する画面に遷移してもよい。 Various test results can be displayed in graphs and tables in an easy-to-understand manner, along with eye drop status, score trends, and events such as hospital visits and changes in eye drops. FIG. 21 is an example of a graph showing the relationship between test results, scores, and various events. In this example, in order from the top, the visual field sensitivity obtained by the visual field test 1701, the intraocular pressure value measured by the tonometer 1702, the score trend obtained by the patient support software 1703, the date of visit, the start of eye drops, the change of eye drops, etc. Events 1704 are displayed in chronological order. Regarding visual field sensitivity, by displaying an approximate straight line (dotted chain line 1705 in this example) of multiple measured values in a given period together with each data value, it shows the degree of sensitivity decrease in that period, and changes in the degree of sensitivity decrease in each period. are displayed in an easy-to-understand manner. Regarding the intraocular pressure value, the set target intraocular pressure is displayed on the graph (horizontal dotted line 1706 at the bottom) to clarify the treatment goal. The score may be expressed by the height and color of the bar graph 1707 to indicate adherence and motivation to continue treatment. If you tap the data on the graph, you may be taken to a screen where you can check detailed data.
 この例のグラフより、点眼治療を開始するとある程度眼圧が低下し、視野の進行も点眼前に比べて抑えられているが、目標眼圧に達していない事が分かる。点眼開始から2回目の来院日に点眼薬を変更し、点眼治療を正しく続けていると(高いスコア続いていることから判断できる)目標眼圧に達し次の来院時の検査で視野の進行がさらに抑えられていることが分かる。その後スコアが低下すると眼圧が高くなっている事が分かる。患者はこのグラフを確認することで、点眼治療の効果や目標、継続することの意義を理解する事ができ、さらにアドヒアランスの維持向上や継続治療に対する動機付けとなる。さらに、患者サポートソフトウェアは点眼忘れが続きスコアが低下する、あるいは眼圧などの検査値が悪化した場合には、自動的にアラートを発し患者や支援者に知らせ、改善のためのアドバイスや点眼治療継続の動機付けとなるようなメッセージを配信する事が可能である。さらに院内端末装置でもアラートを発し、担当医師が遠隔で患者を支援する事を可能とする。 From the graph of this example, it can be seen that once the eye drop treatment was started, the intraocular pressure decreased to some extent and the progression of the visual field was suppressed compared to before the eye drops, but the target intraocular pressure was not reached. If the eye drops are changed on the second visit after starting the eye drops, and the eye drop treatment is continued correctly (as judged by the continued high score), the target intraocular pressure will be reached and visual field progress will be observed in the test at the next visit. It can be seen that it is further suppressed. After that, if the score decreases, it becomes clear that the intraocular pressure has increased. By checking this graph, patients can understand the effects and goals of eye drop treatment, as well as the significance of continuing it, and it can further motivate them to maintain and improve adherence and continue treatment. In addition, the patient support software automatically issues an alert and notifies the patient and support staff if the patient continues to forget to use eye drops, or if test values such as intraocular pressure worsen, and provide advice and treatment for eye drops. It is possible to deliver messages that motivate people to continue. Additionally, an in-hospital terminal device will also issue an alert, allowing the doctor in charge to remotely support the patient.
 さらに、患者は随時コメントを記録する事が可能である。コメントには気になる症状や副作用、疾患や点眼薬に関する疑問や質問などが上げられる。これらのコメントは、医師・薬剤師などの医療従事者と共有することにより、次回来院時などに的確なアドバイスを受けるための材料などになり得る。また、患者サポートシステムがコメントの内容を解析し、自動で必要な知識や情報を提供することが可能となる。 Additionally, patients can record comments at any time. Comments include questions and concerns about symptoms, side effects, diseases, and eye drops. By sharing these comments with medical professionals such as doctors and pharmacists, they can become a resource for receiving accurate advice the next time you visit a hospital. Additionally, the patient support system will be able to analyze the content of comments and automatically provide necessary knowledge and information.
 これらの機能により患者サポートソフトウェアは日常的に患者に寄り添い、点眼治療を継続する事をサポートし、アドヒアランスの維持向上を支援する事が可能となる。 These functions allow the patient support software to be close to the patient on a daily basis, support the continuation of eye drop treatment, and help maintain and improve adherence.
(11)院内端末装置で実行される専用ソフトウェアの動作
 院内端末装置で実行される専用ソフトウェアは、医師や薬剤師などの医療従事者が患者の来院時のみではなく、日常的に患者に寄り添い患者自身で点眼治療を継続できるよう支援するように動作する。
(11) Operation of dedicated software executed on in-hospital terminal devices Dedicated software executed on in-hospital terminal devices is used by medical professionals such as doctors and pharmacists not only when patients visit the hospital, but also on a daily basis when they are with patients. It works to support the continuation of eye drop treatment.
 ここで来院時の動作の一例について説明する。患者が来院し問診などの後に、必要な各種検査(屈折検査、視力検査、眼圧測定、視野検査、眼底検査など)が実施され、その後に医師の診察が行われる。診察室において医師が対象患者を指定すると専用ソフトウェアは固定サーバから対象患者の日常の点眼状況やスコアなどを読み出し、各種データを表示することで医師は患者の日常における点眼治療状況を把握する事が可能となる。また、当日の検査結果が固定サーバに記録され、患者携帯端末や支援者携帯端末からも最新の検査結果の閲覧が可能となる。なお、図21と同じように点眼状況はやスコアの推移、来院や点眼薬の変更などのイベントなどと一緒にグラフや表などで関連性を分かりやすく表示する事も可能である。 Here, an example of the behavior when visiting the hospital will be explained. After the patient visits the hospital and is interviewed, various necessary tests (refraction test, visual acuity test, intraocular pressure measurement, visual field test, ophthalmoscopy, etc.) are conducted, followed by an examination by a doctor. When a doctor specifies a target patient in the examination room, the dedicated software reads the patient's daily eye drop status and score from a fixed server, and displays various data, allowing the doctor to understand the patient's daily eye drop treatment status. It becomes possible. In addition, the test results of the day are recorded on the fixed server, and the latest test results can be viewed from the patient's mobile terminal or the supporter's mobile terminal. In addition, as in FIG. 21, it is also possible to display the relationship in an easy-to-understand manner in a graph or table along with the eye drop status, score changes, and events such as visits to the hospital and changes in eye drops.
 医師は専用ソフトウェアに表示される患者データに基づいて、患者にアドバイスを行う、あるいは必要に応じて点眼薬や点眼計画などを変更する事などが可能である。また、処方する点眼薬の点眼基本情報(点眼薬名称、対象眼(右眼、左眼、両眼)、一日の点眼回数、1回の滴下回数、点眼時間(時間帯)、処方日など)を設定し、固定サーバに記録する事ができる。 Based on the patient data displayed on the dedicated software, the doctor can give advice to the patient or change the eye drops or eye drop schedule as necessary. In addition, basic information about the eye drops to be prescribed (eye drop name, target eye (right eye, left eye, both eyes), number of drops per day, number of drops per day, duration of eye drops (time of day), prescription date, etc.) ) can be set and recorded on a fixed server.
 さらに次回の来院予約を行い固定サーバに記録する。 Additionally, make a reservation for your next visit and record it on the fixed server.
 最後に来院ポイントが自動的に付与され、メッセージと共に患者携帯端末に配信される。メッセージは日々の点眼状況や検査結果などに基づいて患者サポートソフトウェアが自動で生成する方法、自動生成された複数のコメントを医師が選択する方法、医師が直接入力する方法などが可能である。前記メッセージは設定した支援者にも自動的に配信する事が可能である。配信メッセージは固定サーバに記録され、患者携帯端末などからいつでも確認する事ができる。 Finally, visit points are automatically awarded and delivered to the patient's mobile device along with a message. Messages can be automatically generated by patient support software based on daily eye drops and test results, the doctor can select from multiple automatically generated comments, or the doctor can input them directly. The message can also be automatically delivered to set supporters. Delivered messages are recorded on a fixed server and can be checked at any time from a patient's mobile device.
 前記点眼基本情報は、薬局の端末装置で動作する専用ソフトウェアから設定し、固定サーバに記録することも可能である。また薬局で発行される電子お薬手帳登録用のQRコードを患者携帯端末に搭載のカメラで読み取り、患者サポートソフトウェアを介して固定サーバに記録する事も可能である。薬局の端末装置に専用ソフトウェアが動作し担当薬局として登録されている場合、薬剤師が患者の点眼状況などのデータを閲覧する事ができ、それらに基づいて各種アドバイスなどを行う事も可能である。 The basic eye drop information can also be set from dedicated software running on a terminal device at the pharmacy and recorded on a fixed server. It is also possible to read the QR code for electronic medicine notebook registration issued by the pharmacy with a camera mounted on a patient's mobile terminal and record it on a fixed server via patient support software. If dedicated software is running on a pharmacy's terminal device and the pharmacist is registered as the responsible pharmacy, the pharmacist can view data such as the patient's eye drop status, and can provide various advice based on that data.
 医師や薬剤師などの医療従事者は、患者が来院した場合のみでは無く、端末装置上で動作する専用ソフトウェアを介して、固定サーバに記録された患者の日々の点眼状況や眼圧などの測定結果を随時確認する事が可能である。さらに、必要に応じて患者携帯端末に医療従事者からメッセージを送ることが可能である。さらに、患者の点眼スコアや眼圧測定値に異常があった場合に専用ソフトウェアが自動的にアラートを発し医師に知らせることが可能である。これらの機能により、医療従事者は患者が来院しない間も患者の点眼治療の状況などを把握し、患者のアドヒアランスの維持向上と治療継続を的確に支援する事が可能となり、また遠隔においても病状の悪化を防ぐために患者を支援する事が可能となる。 Medical professionals such as doctors and pharmacists not only receive information when a patient visits the hospital, but also receive measurement results such as the patient's daily eye drop status and intraocular pressure that are recorded on a fixed server via dedicated software running on a terminal device. It is possible to check at any time. Furthermore, it is possible for a medical worker to send a message to the patient's portable terminal if necessary. Furthermore, if there is an abnormality in the patient's eye drop score or intraocular pressure measurements, the dedicated software can automatically issue an alert and notify the doctor. With these functions, medical professionals can monitor the status of a patient's eye drop treatment even when the patient is not in the hospital, and can accurately support the maintenance and improvement of patient adherence and continuation of treatment. It becomes possible to support the patient to prevent the deterioration of the condition.
(12)支援者携帯端末で実行される専用ソフトウェアの動作
 支援者の携帯端末で実行される専用ソフトウェアは、家族や介護者などの支援者が患者の点眼治療の継続状況などを日常的把握し、支援者自身も患者の患っている疾患に対する理解を深める事で、患者に寄り添い点眼治療を継続できるよう支援するように動作する。
(12) Operation of dedicated software executed on the supporter's mobile terminal The dedicated software executed on the supporter's mobile terminal allows supporters such as family members and caregivers to monitor the continuation status of the patient's eye drop treatment on a daily basis. By deepening their understanding of the disease that the patient is suffering from, the support person works to stay close to the patient and provide support so that the eye drop treatment can be continued.
 支援者は、端末装置上で動作する専用ソフトウェアを介して、固定サーバに記録された患者の日々の点眼状況や眼圧などの検査結果などを随時確認する事が可能である。さらに、必要に応じて患者と支援者との間でメッセージのやり取りが可能である。 Supporters can check the patient's daily eye drop status and test results such as intraocular pressure recorded on the fixed server at any time via dedicated software running on the terminal device. Furthermore, messages can be exchanged between the patient and the support person as needed.
 さらに患者が日々の点眼を実施したり、来院したりするイベント毎に患者サポートソフトウェアが支援者の携帯端末に配信する通知を受け取ることも可能である。また、対象疾患に関する知識や情報を閲覧する事も可能である。
 これらの機能により、支援者は患者の点眼治療の状況などを把握し、患者のアドヒアランスの維持向上と治療継続を的確に支援する事が可能となる。
Furthermore, it is also possible to receive notifications delivered by the patient support software to the supporter's mobile terminal for each event such as when the patient performs daily eye drops or visits the hospital. It is also possible to view knowledge and information regarding the target disease.
These functions enable supporters to grasp the status of a patient's eye drop treatment and accurately support the maintenance and improvement of patient adherence and continuation of treatment.
 患者サポートシステムは、患者携帯端末などに蓄積されたヘルスケア情報(ウォーキング・ランニングの距離や歩数、消費カロリーなどのアクティビティ情報、睡眠情報、体重・身長・BMIなどの身体測定データ、血圧・心拍数・血糖値など他の機器による測定データなど)などを活用して、前記点眼状況や各種検査結果など共に分析することにより、対象疾患の進行と各種データとの因果関係などを解析し、対象疾患の進行抑制などに効果的な生活習慣の提案やアドヒアランス維持向上並びに点眼治療継続のための動機付けとなるような処理を実行しても良い。また、複数患者の点眼状況や各種検査結果、並びにヘルスケア情報を固定サーバに蓄積してビッグデータを構築し、それらを活用した人工知能やディープラーニングの技術を用いてさらに精度の高い進行抑制手法の解明やアドヒアランスの維持向上、治療継続の動機付けとなる処理を構築し実行しても良い。さらに、血圧値やアクティビティ情報などの患者のヘルスケア情報は、図21のグラフに眼圧・視野などの検査結果やスコア、イベントなどと同時に表示する事も可能であり、患者自身がそのグラフやデータを確認する事で生活習慣の改善に活用してもよい。また、医師が確認する事で有効と思われる生活習慣などに対するアドバイスを行う事も可能となる。 The patient support system uses healthcare information accumulated on patient mobile devices (activity information such as walking/running distance and number of steps, calories burned, sleep information, physical measurement data such as weight, height, BMI, blood pressure and heart rate).・Utilizing data measured by other devices (such as blood sugar levels), etc., and analyzing the status of the eye drops and various test results, we can analyze the causal relationship between the progress of the target disease and various data, and determine the target disease. Processing that provides suggestions for lifestyle habits that are effective in suppressing the progression of eye disease, maintaining and improving adherence, and providing motivation for continuing eye drop treatment may be performed. In addition, we will build big data by accumulating multiple patients' eye drop conditions, various test results, and healthcare information on a fixed server, and use artificial intelligence and deep learning technology to utilize this data to create even more accurate progression prevention methods. It is also possible to construct and execute processes that will help clarify the issue, maintain and improve adherence, and motivate continued treatment. Furthermore, patient healthcare information such as blood pressure values and activity information can be displayed simultaneously with test results such as intraocular pressure and visual field, scores, and events on the graph in Figure 21, allowing patients to view the graphs and events themselves. By checking the data, you can use it to improve your lifestyle habits. Furthermore, it is also possible to give advice on lifestyle habits that are considered effective by checking with a doctor.
 患者サポートシステムは、点眼薬のみでは無く血圧改善や血糖値改善などのための他の飲み薬や貼り薬、サプリメントなどの服薬情報(薬の名称、服薬時間、服薬量など)を登録し、服薬忘れを防止するためのメッセージの表示や、服薬履歴を記録して服薬状況を分析し、アドヒアランス維持向上や治療継続の動機付けとなるような患者への働きかけを行う機能を搭載してもよい。また、図21のグラフに点眼薬以外の薬やサプリメントの服薬状況やスコアを同時に表示する事も可能であり、患者自身がグラフやデータを確認する事で、点眼治療と他の飲み薬やサプリメントとの関連性を理解することや、担当医師がこれらのデータを分析して治療方針の決定や患者に対するアドバイスを行うために役立てることができる。 The patient support system registers medication information (such as drug name, dosing time, dosage, etc.) for not only eye drops but also other oral medications, patches, and supplements to improve blood pressure and blood sugar levels. It may also be equipped with functions that display messages to prevent forgetting, record medication history, analyze medication status, and encourage patients to maintain and improve adherence and motivate them to continue treatment. In addition, it is possible to simultaneously display the medication status and scores of medications and supplements other than eye drops on the graph in Figure 21, allowing patients to check the graph and data themselves to determine whether they are taking eye drops or other medications or supplements. This data can be used to help physicians understand the relationship between patients and their patients, and to help physicians analyze this data to determine treatment plans and provide advice to patients.
 以上のように、本実施の形態2は、患者宅内や介護施設に設置された前記点眼器の患者サポートシステムであって、上述の実施の形態1と同様の点眼補助具100に備わる通信手段と通信をする外部装置は登録された患者の点眼日時、点眼予定の通知、点眼行為の追跡及び履歴の記憶、患者の治療計画逸脱に対する注意などの治療サポートと、さらに記憶されたデータや点眼履歴より患者の点眼状況や治療参加に対する意欲の評価を数値化し、外部装置の表示画面や音声により提供することができる。 As described above, the second embodiment is a patient support system for the eyedropper installed in a patient's home or nursing care facility, and includes communication means provided in the eyedropper aid 100 similar to the first embodiment described above. The external device that communicates provides treatment support such as registered patient's eye instillation date and time, notification of eye instillation schedule, tracking and history of eye instillation actions, and cautions against deviations from the patient's treatment plan, as well as from stored data and eye instillation history. Evaluations of the patient's eye drop status and willingness to participate in treatment can be quantified and provided on the display screen of an external device or through audio.
 また、点眼補助具100と通信接続された外部装置はインターネット上にある固定サーバやクラウドシステム及び他のインターネット端末と接続し、外部装置に記憶された数値データや画像データをインターネット上の固定サーバやクラウドシステムに保存して解析し、解析結果、点眼治療履歴、点眼状況や患者の治療意欲の評価スコアを外部装置及び他のインターネット端末にて共有し、患者及び医師や介護人などと共に患者の治療成績向上を図る。すなわち、患者の点眼状態を検出及び評価してそのデータを医師と患者が共有し、患者のアドヒアランスを向上させることができる。 In addition, the external device that is communicatively connected to the eye drop aid 100 is connected to a fixed server on the Internet, a cloud system, and other Internet terminals, and the numerical data and image data stored in the external device are transferred to the fixed server on the Internet. The results are saved in a cloud system and analyzed, and the analysis results, eye drop treatment history, eye drop status, and evaluation score of the patient's desire for treatment are shared on external devices and other Internet terminals, allowing patients to receive treatment together with their doctors, caregivers, etc. Try to improve your grades. That is, the patient's eye drop condition can be detected and evaluated, and the data can be shared between the doctor and the patient, thereby improving the patient's adherence.
 また、外部装置に搭載されたソフトウェアにより患者に伝える指示や情報として、点眼時刻のお知らせ、点眼忘れの注意喚起、一日の点眼・投薬予定、点眼履歴、受診指示、医療機関での過去のデータや履歴、医療情報などがある。また患者の治療継続の動機づけとして点眼状態、点眼継続性、医療機関のデータ、他の診断装置との連携データなどにより患者の状態や意欲などをスコア化して評価し表示する。さらにスコアを上げるための助言や画像によるインセンティブを表示して患者の治療継続意欲を向上させる。 In addition, the instructions and information conveyed to the patient by software installed in the external device include information on eye drop times, reminders to forget to use eye drops, daily eye drop/medication schedule, eye drop history, consultation instructions, and past data at medical institutions. information, history, medical information, etc. In addition, to motivate patients to continue treatment, the system evaluates and displays the patient's condition and motivation by scoring and displaying the condition and motivation of the patient based on the condition of the eye drops, the continuity of the eye drops, data from medical institutions, data linked with other diagnostic devices, etc. Furthermore, it displays advice and visual incentives to improve the patient's score, increasing the patient's desire to continue treatment.
 またさらに、外部通信手段によりスマートフォンやパソコン、タブレットPC等の外部装置と接続して患者のデータを共有・分析することにより、患者の状態を医療機関、患者及び患者の支援者が患者の治療継続状況や意志を確認して患者を支援することが可能なホームモニタリングシステムを構築できる。さらに、外部装置に搭載されたソフトウェアにより点眼・投薬など患者の日々の治療行為を支援すると共に、治療継続意欲を向上させるための助言や励ましを患者の治療参加状況に合わせて適切に提供することができる。 Furthermore, by connecting to external devices such as smartphones, personal computers, and tablet PCs using external communication means and sharing and analyzing patient data, medical institutions, patients, and patient supporters can monitor the patient's condition and continue the patient's treatment. It is possible to build a home monitoring system that can support patients by confirming their situation and intentions. Furthermore, the software installed in the external device supports the patient's daily treatment activities such as eye drops and medication, and also provides appropriate advice and encouragement to improve the patient's desire to continue treatment, depending on the patient's participation in treatment. I can do it.
 すなわち、本実施の形態2に係るホームモニタリングシステムでは患者のデータや投薬履歴、薬の種類や情報、医師の指示、受診の予約、AIシステムによる今後の病状トレンドの推測、治療継続意欲向上のための定期的な助言・励ましなどを患者に提供して患者をサポートするサポートシステムを構築することができる。 In other words, the home monitoring system according to Embodiment 2 uses patient data, medication history, drug types and information, doctor's instructions, appointment reservations, estimates future disease trends using the AI system, and improves motivation to continue treatment. A support system can be built to support patients by providing them with regular advice and encouragement.
 なお、本発明は、上記実施の形態の構成に限られず、発明の趣旨を変更しない範囲で種々の変形が可能である。また、本発明の目的を達成するために、本発明は、ホームモニタリングシステム及び患者サポートシステムに含まれる特徴的な構成手段をステップとする方法としたり、それらの特徴的なステップを含むプログラムとして実現することもできる。そして、そのプログラムは、ROM等に格納しておくだけでなく、USBメモリ等の記録媒体や通信ネットワークを介して流通させることもできる。 Note that the present invention is not limited to the configuration of the embodiments described above, and various modifications can be made without changing the spirit of the invention. Furthermore, in order to achieve the object of the present invention, the present invention is implemented as a method that includes steps of characteristic configuration means included in a home monitoring system and a patient support system, or as a program that includes those characteristic steps. You can also. The program can not only be stored in a ROM or the like, but can also be distributed via a recording medium such as a USB memory or a communication network.
 1 点眼器
 100 点眼補助具
 101 エアファン
 102 エアチャンバー
 103 流入コントロール弁
 104 エアダクト
 104a 流入口
 104b 排気口
 104c 薬液導入孔
 104d 接眼口
 105 点眼容器固定アタッチメント
 106 点眼容器
 106a 薬液滴下口
 107 トリガアーム
 107a,605 押圧ロッド(点眼容器押圧機構)
 108 押圧点調整アーム
 109 グリップ(操作手段)
 302 側面支持ガイド(支持ガイド)
 303 後面支持ガイド(支持ガイド)
 303a プランジャ(第二押圧手段)
 305 セットプレート
 309 押圧プランジャ(第一押圧手段)
 310 ダブルナット(第一押圧手段)
 310a ナット前(第一押圧手段)
 310b ナット後(第一押圧手段)
 311 スリット(第一押圧手段)
 312 セットガイド溝
 501 トリガアーム回転軸
 606 ソレノイド(電動駆動手段)
 801 スプリング逆止弁(流入コントロール弁)
 1003 反射式光学センサー(左右眼検出手段)
 1801a エアファン制御部(エアファン制御手段)
 S1 開放空間
1 Eye dropper 100 Eye drop aid 101 Air fan 102 Air chamber 103 Inflow control valve 104 Air duct 104a Inflow port 104b Exhaust port 104c Liquid introduction hole 104d Eyepiece port 105 Eye drop container fixing attachment 106 Eye drop container 106a Drug solution dripping port 107 Trigger arm 107a ,605 Pressing rod (eye drop container pressing mechanism)
108 Pressure point adjustment arm 109 Grip (operation means)
302 Side support guide (support guide)
303 Rear support guide (support guide)
303a plunger (second pressing means)
305 Set plate 309 Pressing plunger (first pressing means)
310 Double nut (first pressing means)
310a Before nut (first pressing means)
310b After nut (first pressing means)
311 Slit (first pressing means)
312 Set guide groove 501 Trigger arm rotation axis 606 Solenoid (electric drive means)
801 Spring check valve (inflow control valve)
1003 Reflective optical sensor (left and right eye detection means)
1801a Air fan control unit (air fan control means)
S1 open space

Claims (11)

  1.  患者眼に点眼容器内の薬液を投与するための点眼補助具であって、
     エアファンと、
     前記エアファンより吐出された空気流の空気室となるエアチャンバーと、
     前記エアチャンバーと連通された筒形状のエアダクトと、
     前記点眼容器が交換可能に装着されると共に、水平状態にした前記エアダクトの上側壁に前記点眼容器のノズルを下向きにして固定する点眼容器固定アタッチメントと、
     前記点眼容器固定アタッチメントに装着された前記点眼容器の側面の所定位置を押圧する点眼容器押圧機構と、
     前記点眼容器押圧機構の動作を制御するトリガアームと、を備え、
     前記筒形状のエアダクトの開口の一端側は前記エアファンより吐出された空気流が前記エアチャンバーを介して流入する流入口となる一方、当該開口の他端側は患者の眼瞼周囲が当接する接眼口となり、
     前記エアダクトの上側壁には、前記点眼容器固定アタッチメントに装着された前記点眼容器のノズルより滴下された薬液滴下粒を前記エアダクト内に導入するための薬液導入孔が形成される、ことを特徴とする点眼補助具。
    An eye drop aid for administering a medical solution in an eye drop container to a patient's eye,
    air fan and
    an air chamber serving as an air chamber for the air flow discharged from the air fan;
    a cylindrical air duct communicating with the air chamber;
    an eye drop container fixing attachment on which the eye drop container is replaceably attached and fixed to the upper wall of the air duct in a horizontal state with the nozzle of the eye drop container facing downward;
    an eye drop container pressing mechanism that presses a predetermined position on a side surface of the eye drop container attached to the eye drop container fixing attachment;
    a trigger arm that controls the operation of the eye drop container pressing mechanism,
    One end side of the opening of the cylindrical air duct serves as an inlet through which the air flow discharged from the air fan flows through the air chamber, while the other end side of the opening serves as an inlet where the patient's eyelids come into contact. Becomes a mouth,
    A liquid medicine introduction hole is formed in the upper wall of the air duct for introducing into the air duct the liquid drops dropped from the nozzle of the eye drop container attached to the eye drop container fixing attachment. Eye drop aid.
  2.  前記点眼補助具は、さらに、
     患者が前記点眼容器内の薬剤を投与する際に、前記エアダクトを水平状態、又は前記接眼口が前記流入口より高くなる傾斜状態に操作するための操作手段を備える、ことを特徴とする請求項1記載の点眼補助具。
    The eye drop aid further includes:
    A claim further comprising an operating means for operating the air duct in a horizontal state or in an inclined state in which the eyepiece port is higher than the inlet port when the patient administers the drug in the eye drop container. The eye drop aid according to 1.
  3.  前記エアダクトの前記接眼口近傍の側壁には、少なくとも1以上の空気流の排気口が形成される、ことを特徴とする請求項1又は2記載の点眼補助具。 The eye drop aid according to claim 1 or 2, wherein at least one airflow exhaust port is formed in a side wall of the air duct near the eyepiece port.
  4.  前記点眼補助具は、さらに、
     前記エアダクトはその開口高さを10mm以上25mm以下、前記点眼容器の薬液滴下口から前記接眼口までの水平距離を20mm以上50mm以下とした場合、前記エアダクト内に前記点眼容器の薬液滴下口から滴下された薬液滴下粒を水平方向に移動させるために必要な前記エアダクト内の空気流の当該薬液滴下粒に対する相対流速を下記(数1)により計算し、且つ得られた当該相対流速に基づいて前記エアダクト内の流速が10m/sec以上40m/sec以下となるように前記エアファンを制御するエアファン制御手段を備える、ことを特徴とする請求項1又は2記載の点眼補助具。
    [数1]
     ここで、U:エアダクト内の空気流の流速と薬液の滴下粒との相対速度、L:点眼容器の滴下口からエアダクト接眼口の中心(角膜)までの水平距離、H:エアダクトの開口高さ、m:薬液滴下粒の質量、ρ:空気の密度、d:薬液滴下粒の直径
    The eye drop aid further includes:
    When the opening height of the air duct is 10 mm or more and 25 mm or less, and the horizontal distance from the drug solution dripping port of the eye drop container to the eyepiece port is 20 mm or more and 50 mm or less, the drug solution can be dripped from the drug solution dripping port of the eye drop container into the air duct. Calculate the relative flow velocity of the air flow in the air duct with respect to the chemical droplet, which is necessary to move the chemical droplet in the horizontal direction, using the following (Equation 1), and based on the obtained relative flow velocity, The eye drop aid according to claim 1 or 2, further comprising an air fan control means for controlling the air fan so that the flow velocity in the air duct is 10 m/sec or more and 40 m/sec or less.
    [Number 1]
    Here, U: Relative velocity between the flow rate of the air flow in the air duct and the dropped droplet of the drug solution, L: Horizontal distance from the droplet of the eye drop container to the center (cornea) of the air duct eyepiece, H: Opening height of the air duct , m: mass of the droplet of the chemical solution, ρ: density of air, d: diameter of the droplet of the drug solution
  5.  前記点眼容器固定アタッチメントは、
     前記点眼容器を下向きで装着可能なセットプレートと、
     前記点眼容器の押圧位置を調整する押圧位置調整機構と、を備え、
     前記セットプレートの内側面には、前記点眼容器の側面を押圧支持する支持ガイドが配置され、
     前記セットプレートの下端は、前記エアダクトの外側壁に形成されたセットガイド溝に着脱可能に嵌合され、
     前記セットプレートの下側領域には、前記点眼容器が装着された状態において、前記点眼容器のキャップを開閉可能とする開放空間が設けられる、ことを特徴とする請求項1又は2記載の点眼補助具。
    The eye drop container fixing attachment is
    a set plate on which the eye drop container can be attached facing downward;
    A pressing position adjustment mechanism that adjusts the pressing position of the eye drop container,
    A support guide that presses and supports a side surface of the eye drop container is disposed on the inner surface of the set plate,
    The lower end of the set plate is removably fitted into a set guide groove formed on the outer wall of the air duct,
    The eye drop aid according to claim 1 or 2, wherein an open space is provided in a lower region of the set plate to allow the cap of the eye drop container to be opened and closed when the eye drop container is attached. Ingredients.
  6.  前記点眼容器押圧機構は、
     前記トリガアームの回転軸となるトリガアーム回転軸と、
     前記トリガアームと連接されて、前記トリガアームが引かれると前記トリガアーム回転軸を介して側方から前記点眼容器を押圧する方向に作用する押圧ロッドと、を備えることを特徴とする請求項1又は2記載の点眼補助具。
    The eye drop container pressing mechanism is
    a trigger arm rotation axis that is a rotation axis of the trigger arm;
    Claim 1, further comprising: a pressing rod connected to the trigger arm and acting in a direction to press the eye drop container from the side via the trigger arm rotation axis when the trigger arm is pulled. Or the eye drop aid described in 2.
  7.  前記点眼容器押圧機構は、
     前記トリガアームと連動して電気駆動により駆動される電動駆動手段と、
     前記トリガアームが引かれると前記電動駆動手段を用いて側方から前記点眼容器を押圧する方向に作用する押圧ロッドと、を備えることを特徴とする請求項1又は2記載の点眼補助具。
    The eye drop container pressing mechanism is
    an electric drive means that is electrically driven in conjunction with the trigger arm;
    The eye drop aid according to claim 1 or 2, further comprising a pressing rod that acts in a direction to press the eye drop container from the side using the electric drive means when the trigger arm is pulled.
  8.  前記点眼補助具は、さらに、
     前記エアダクトの前記流入口付近に配置された空気流の流入コントロール弁と、
     前記トリガアームと連動する前記点眼容器押圧機構が押圧範囲の最大押圧位置近傍に達したときに前記流入コントロール弁を開く一方、前記トリガアームを開放すると前記流入コントロール弁を閉じる弁駆動機構と、を備えることを特徴とする請求項1又は2記載の点眼補助具。
    The eye drop aid further includes:
    an air flow inflow control valve disposed near the inlet of the air duct;
    a valve driving mechanism that opens the inflow control valve when the eye drop container pressing mechanism interlocked with the trigger arm reaches a maximum pressing position of a pressing range, and closes the inflow control valve when the trigger arm is released; The eye drop aid according to claim 1 or 2, further comprising: an eye drop aid according to claim 1;
  9.  前記点眼補助具は、さらに、有線/無線ネットワークを介して外部端末にデータを送信可能な通信手段を備える、ことを特徴とする請求項1又は2記載の点眼補助具。 The eye drop aid according to claim 1 or 2, further comprising a communication means capable of transmitting data to an external terminal via a wired/wireless network.
  10.  患者眼に点眼容器内の薬液を投与するための点眼補助具であって、
     エアファンと、
     前記エアファンと連通して前記エアファンより吐出された空気流が流れる筒形状のエアダクトと、
     前記点眼容器が交換可能に装着されると共に、水平状態にした前記エアダクトの上側壁に前記点眼容器のノズルを下向きにして固定する点眼容器固定アタッチメントと、
     前記点眼容器固定アタッチメントに装着された前記点眼容器の側面の所定位置を押圧する点眼容器押圧機構と、
     前記点眼容器押圧機構の動作を制御するトリガアームと、を備え、
     前記筒形状のエアダクトの開口の一端側は前記エアファンより吐出された空気流が流入する流入口となる一方、当該開口の他端側は患者の眼瞼周囲が当接する接眼口となり、
     前記エアダクトの上側壁には、前記点眼容器固定アタッチメントに装着された前記点眼容器のノズルより滴下された薬液滴下粒を前記エアダクト内に導入するための薬液導入孔が形成される、ことを特徴とする点眼補助具。
    An eye drop aid for administering a medical solution in an eye drop container to a patient's eye,
    air fan and
    a cylindrical air duct that communicates with the air fan and allows airflow discharged from the air fan to flow;
    an eye drop container fixing attachment on which the eye drop container is replaceably attached and fixed to the upper wall of the air duct in a horizontal state with the nozzle of the eye drop container facing downward;
    an eye drop container pressing mechanism that presses a predetermined position on a side surface of the eye drop container attached to the eye drop container fixing attachment;
    a trigger arm that controls the operation of the eye drop container pressing mechanism,
    One end side of the opening of the cylindrical air duct serves as an inlet into which the air flow discharged from the air fan flows, while the other end side of the opening serves as an eyepiece port against which the patient's eyelid periphery comes into contact;
    A liquid medicine introduction hole is formed in the upper wall of the air duct for introducing into the air duct the liquid drops dropped from the nozzle of the eye drop container attached to the eye drop container fixing attachment. Eye drop aid.
  11.  請求項1又は請求項10記載の点眼補助具と、点眼容器と、を備えることを特徴とする点眼器。 An eyedropper comprising the eyedropper aid according to claim 1 or claim 10 and an eyedropper container.
PCT/JP2022/029571 2022-08-01 2022-08-01 Eye drop assistance apparatus WO2024028963A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/JP2022/029571 WO2024028963A1 (en) 2022-08-01 2022-08-01 Eye drop assistance apparatus
JP2022554277A JP7179399B1 (en) 2022-08-01 2022-08-01 Eye drop aid
JP2022179195A JP2024020115A (en) 2022-08-01 2022-11-09 Home monitoring system and patient support system using eye drop aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/029571 WO2024028963A1 (en) 2022-08-01 2022-08-01 Eye drop assistance apparatus

Publications (1)

Publication Number Publication Date
WO2024028963A1 true WO2024028963A1 (en) 2024-02-08

Family

ID=84237888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/029571 WO2024028963A1 (en) 2022-08-01 2022-08-01 Eye drop assistance apparatus

Country Status (2)

Country Link
JP (2) JP7179399B1 (en)
WO (1) WO2024028963A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502689A (en) * 1992-11-04 1996-03-26 ベスパック・パブリック・リミテッド・カンパニー Supply device
JP2017533798A (en) * 2014-11-03 2017-11-16 インフィールド・メディカル,リミテッド・ライアビリティ・カンパニー Chemical dispenser
JP2021104241A (en) * 2019-12-26 2021-07-26 参天製薬株式会社 Instillation auxiliary tool having cylindrical structure and instillation device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502689A (en) * 1992-11-04 1996-03-26 ベスパック・パブリック・リミテッド・カンパニー Supply device
JP2017533798A (en) * 2014-11-03 2017-11-16 インフィールド・メディカル,リミテッド・ライアビリティ・カンパニー Chemical dispenser
JP2021104241A (en) * 2019-12-26 2021-07-26 参天製薬株式会社 Instillation auxiliary tool having cylindrical structure and instillation device

Also Published As

Publication number Publication date
JP7179399B1 (en) 2022-11-29
JP2024020115A (en) 2024-02-14

Similar Documents

Publication Publication Date Title
JP3213184U (en) Eye drop dispenser
US20200323417A1 (en) Apparatus and method for recognition of inhaler actuation
US20210398651A1 (en) Method and system for performing remote treatment and monitoring
US8733935B2 (en) Method and system for performing remote treatment and monitoring
US10535248B2 (en) Method of and apparatus for targeted interactive health status notification and confirmation
JP7005660B2 (en) Control device for aerosol spray system
JP2018183598A (en) Device for enabling patient self-testing and treatment self-administration and system using device for managing patient's health care
JP2016502429A (en) Implementation and monitoring of drug delivery
AU2016260313A1 (en) Electronic drop dispensing device and method of operation thereof
JP6712961B2 (en) Communication system and communication control device
US20240024594A1 (en) Nasal applicator
EP3311788A1 (en) Ocular instillation assisting tool
WO2023273525A1 (en) Medicine dispensing robot
US20210345952A1 (en) Controlling operation of drug administration devices using surgical hubs
KR20220088703A (en) Coordination of drug delivery
CN116583313A (en) Patient monitoring using a drug administration device
US20160354240A1 (en) Automated Eye Drop Instillation
WO2024028963A1 (en) Eye drop assistance apparatus
JP7365331B2 (en) eye drop aid
WO2023273522A1 (en) Visual drug dispensing method, electronic device, and storage medium
DE102020121044A9 (en) nasal applicator
WO2023273524A1 (en) Medicine dispensing robot
CN117377509A (en) Inhaler monitoring device
JP2017153873A (en) Eye drop container monitoring system
EP4023276A1 (en) Nasal applicator

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22953952

Country of ref document: EP

Kind code of ref document: A1